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Cancer chemoprevention aims to prevent, delay, or reverse carcinogenesis. Thai Traditional 
Medicine (TTM) could be a source for cancer chemopreventive agents and – more broadly –
could play a role in cancer prevention. Using an ethnopharmacology approach this thesis aims 
to understand the pharmacological basis of some of these botanical drugs and to discover 
new extracts which could be useful in cancer prevention. 
Interviews with 33 TTM practitioners revealed the five characteristics of cancer in TTM 
(mareng), which is described as an accumulation of waste, chronic inflammation, chronic 
illnesses (krasai), bad condition of body fluids (‘luead’ and ‘namlueang’), and imbalance of 
dhātu si. Further analysis of preventive methods led to the five strategies for preventing 
mareng. To link TTM actions to pharmacology, we proposed that three strategies, removal of 
waste, liver protection, and prevention from krasai, can be linked to the antioxidant system.  
After screening of fifty-two extracts, fifteen exhibited protective effect in a liver cancer cell line. 
Among them, ethanol extracts of Thunbergia laurifolia leaves (TLe) and Senegalia rugata 
leaves (SR1e) exhibited the most potent activities in the induction of NQO1 enzyme and 
glutathione. Upregulation of antioxidant genes and radical scavenging were among their 
protective mechanisms. While TLe induced NQO1 expression, SR1e upregulated the 
expression of Nrf2. Both extracts did not induce CYP1A1 expression nor reduce cell viability 
of primary rat hepatocytes which provided preliminary safety profile. Using HPLC-HRMS-SPE-
ttNMR, we could identify some active constituents in the extracts.  
This is the first report analysing how cancer is perceived in TTM, what prevention strategies 
are used, linking this to pharmacological models, and on chemopreventive properties of TLe 
and SR1e and some of their constituents. The evidence supports the potential use of these 
medicinal plants in cancer prevention. Future work should be performed with more TTM 











This thesis presents an analysis of knowledge in Thai traditional medicine (TTM) and links it 
to biomedical concepts and practical lab-based experiment, as well as provides in vitro 
pharmacological properties and phytochemical profiles of selected medicinal plants. This is 
the first time that characteristics of cancer in TTM (or mareng) were systematically analysed 
and grouped. The findings have direct impacts on providing scientific evidence for medicinal 
plants used in TTM and characteristics of cancer in TTM through a combination of 
ethnopharmacological and biomedical research. The proposed concept is also beneficial for 
future research on cancer in TTM or TTM drugs for cancer treatment and prevention. 
Moreover, it is fruitful for TTM education, most importantly at university level. Our results can 
be used as preliminary data for future research grants on TTM or cancer drug discovery, as 
well as another PhD project.  
For non-academia impacts, our data supports TTM practice and the integration of TTM to the 
main health care system. It could help local business, such as farmers and herbal medicine 
manufacturers, which are usually small and medium-sized enterprises (SMEs). In addition, it 
is also helpful in the promotion and conservation of TTM.  
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Chapter 1 General introduction 
1.1. Cancer- a global health problem  
According to the World Health Organization (WHO), non-communicable diseases (NCDs), 
especially cardiovascular diseases, cancer, and chronic respiratory diseases, caused more 
deaths than all other causes combined in 2012. Globally, cancer was the second leading 
cause of death, ranked behind cardiovascular diseases (World Health Organization, 2014). In 
2012, there were 14.1 million new cancer cases and 8.2 million deaths from cancer worldwide 
(Ferlay et al., 2015). It was predicted that the number of new cancer cases would be over 20 
million per year by 2025 (Bray, 2014). According to Cancer Research UK, more than 1 in 3 
people in the UK will develop some form of cancer during their lifetime (Cancer Research UK, 
2014).  
Although there have been successes in the treatment of some cancers, such as certain types 
of leukaemia and lymphoma, the management of cancer is still challenging, with the overall 
mortality of cancer patients1 still above 50%, especially in developing countries (Figure 1-1). 
The concept that cancers are an outcome of over-proliferating cells has led to the extensive 
research of cytotoxic drugs. Unfortunately, these drugs are also toxic to normal cells; such as 
those in bone marrow, heart, lungs, gastrointestinal tract, kidney, and brain. This in turn results 
in the failure of these organs and often leads to cancer patient mortality. Therefore, there is 
an increased interest in more targeted therapies. However, it is still difficult to cure advanced 
cancer patients because of the genetic heterogeneity and the tumour burden characteristic 
(Sporn and Suh, 2000). 
                                                     
1 The sources of the WHO mortality database are from annual reports submitted by its Member States  
from their civil registration systems, which the cause-of-death data is coded according to the ICD-9 and 




Figure 1-1 Incidence and mortality from all cancers except non-melanoma cancer based on  WHO,  
2012 (estimated age-standardised rate per 100,000) (Ervik et al., 2016). 
 
1.2. Carcinogenesis  
Cancer develops after a long period of multiple exposures to carcinogens as it can be seen 
that cancer incidence increases with increasing age. Carcinogenesis (also called oncogenesis 
and tumourigenesis) is a multistep process where normal cells become cancerous. It is 
caused by both genetic and epigenetic alterations that result in an imbalance between cell 
proliferation and cell death. An epigenetic alteration is a change in gene expression without 
changes to the DNA sequence. More than 600 cancer-related genes are known to carry 
epigenetic changes (Landis-Piwowar and Iyer, 2014, Weston and Harris, 2003). Processes 
that promote carcinogenesis include genomic instability, abnormal cell proliferation, 
reprogramming of the stromal environment, and aberrant differentiation between epithelial and 
mesenchymal states (EMT/MET). Carcinogenesis is generally divided into three main steps - 
cancer initiation, promotion, and progression (Elinav et al., 2013, Weinberg, 2014).     
Carcinogens play an important role in tumour initiation. These agents often form an adduct 
with DNA, and then this carcinogen-DNA adduct (Figure 1-2) leads to mutation during DNA 
synthesis, proto-oncogene activation, and tumour-suppressor gene inactivation. Tumour 
promotion is the step where the numbers of initiated DNA damaged cells are increased by 
tumour promoters. Tumour promoters are not directly carcinogenic. They promote clonal 
expansion of initiated cells, increase cell proliferation of mutated cells, and also enable the 
effect of low concentration tumour initiators to be carcinogenic. In the progression step, 
precancerous cells/benign tumours transform into malignancy by a sequence of mutations 
and epigenetic alterations of DNA. This event affects the genes that control cell proliferation, 
survival, and other characteristics associated with the cancer cell phenotype. In the early 
phase of progression, cancer cells multiply in or near the original site and result in a primary 
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tumour mass. A variety of human tumours later undergo invasion-metastasis cascade and 
travel throughout the body. Cancer metastasis is responsible for approximately 90% of cancer 
deaths (Weinberg, 2014, Knowles and Selby, 2005). Figure 1-3 illustrates tumour 
development in various sites.  
 
 
Figure 1-2 Benzo(a)pyrene-DNA adduct. The well-known carcinogen forms a covalent bond with 
deoxyguanosine in DNA (in the blue circle) (Poirier, 2012). 
 
 
Figure 1-3 Multi-step tumourigenesis in different sites. CIN = cervical intraepithelial neoplasia, CIS = 
carcinoma in situ, DCIS = ductal carcinoma in situ, PIN = prostatic intraepithelial neoplasia (Weinberg, 
2014). 
 
1.3. Cancer prevention and chemopreventive agents 
The most important strategy for primary prevention of cancer is to avoid or minimize exposures 
to risk factors. A complementary approach is to make the body become more resistant to 
mutagens and carcinogens, as well as to suppress progression of the disease (De Flora and 
Ferguson, 2005). Some recognised risk factors, including lifestyles and diet, are presented in 
Image unavailable due to copyright restriction 
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Figure 1-4. Multiple lines of evidence show that more than 30% of common cancer could be 
prevented by modifying the diet, weight, and physical activity. Strong evidence suggests that 
non-starchy vegetables, fruits, physical activity, dietary fibre, and garlic reduce the risks of 
cancer (World Cancer Research Fund International, 2016a).  
 
Figure 1-4 Summary of factors that increase or decrease risk of cancer. 1Includes evidence on foods 
containing carotenoids for mouth, pharynx, larynx, 2Includes evidence on foods containing carotenoids 
for mouth, pharynx, larynx, lung, 3For stomach, probable increased risk of non-cardia cancer only, 4For 
colorectum, evidence is from milk and studies using supplements, 5Probable increased risk for 
oesophageal squamous cell carcinoma only, 6For oesophagus, convincing increased risk for 
oesophageal squamous cell carcinoma only. For kidney, based on evidence for alcohol consumption 
up to 30 grams/day, 7For lung, evidence is from studies using high-dose supplement in smokers, 
8Convincing decreased risk of colon not rectum, 9For oesophagus, convincing increased risk for 
adenocarcinoma only. For stomach, probable increased risk of cardiac cancer only. For prostate, 
probable increased risk of advanced prostate cancer only, 10Adult attained height in unlikely to directly 
influence the risk of cancer. It is a marker for genetic, environmental, hormonal and nutritional factors 
affecting growth during the period from preconception to completion of linear growth (World Cancer 
Research Fund International, 2016b). 
 
1.3.1. Cancer chemopreventive agents 
Cancer chemoprevention is the use of natural, synthetic, or biological substances to prevent, 
reverse, suppress, or retard carcinogenesis (Gong et al., 2011). Since the development of 
cancer is a multi-step process and takes time, it is possible to prevent initiated cells to become 
cancerous. For instance, Vitamin A analogues are able to cause regression of the lesions of 
leucoplakia and reduce the development of squamous cancer by the ability to modulate the 
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differentiation of epithelial cells (Tobias and Hochhauser, 2015). The success of 
chemoprevention using tamoxifen also provides relevant evidence. Tamoxifen is the first FDA 
approved chemopreventive agent to prevent breast cancer and was found to reduce its 
incidence by 50% in women at high risk (Anand et al., 2008).  
Clinically, chemopreventive agents are used by healthy individuals potentially with 
premalignant lesions or increased risk, such as an inherited cancer syndrome or a family 
history of cancer, as well as to prevent cancer recurrence after cancer therapy. At molecular 
level, chemopreventive agents can be divided into blocking agents and suppressing agents 
(Figure 1-5) (Landis-Piwowar and Iyer, 2014). 
 
Figure 1-5 Major categories of cancer chemopreventive agents based on molecular mechanisms. 
 
1.3.1.1. Blocking agents mechanisms 
Blocking agents are agents that inhibit cancer initiation. The first approach is to block the 
uptake of carcinogens/mutagens by modification of transmembrane transport to inhibit their 
penetration or stimulate the pumping out. The second way is a modulation of phase I or phase 
II enzyme. Many of phase I enzymes, especially some isoforms of CYPs, are known to activate 
procarcinogens into carcinogens. Phase II enzymes are responsible for detoxification of 
carcinogens and reactive metabolites, as well as protection from reactive oxygen species 
(ROS) and electrophiles. Thus, the general idea is to inhibit phase I and induce phase II 
enzymes. Once mutated DNA has already formed, it is important to inhibit the replication of 
cells carrying mutated DNA and activate DNA repair mechanisms. Some epigenetic changes 
also lead to cancer initiation. Therefore, correction of hypomethylation or inhibition of histone 
deacetylation are also among blocking mechanisms. Moreover, telomerases and oncogenes 
have also been considered to be primary prevention (Landis-Piwowar and Iyer, 2014, Steward 
and Brown, 2013, De Flora and Ferguson, 2005). 
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1.3.1.2. Suppressing agents mechanisms 
Suppressing agents reduce or delay cancer promotion and progression by several 
mechanisms. Firstly, it is important to inhibit cancer cell proliferation. Many agents have been 
investigated for the activity to down-regulate signal transduction pathways, such as NF-κB, 
mTOR, and STAT3. Another approach is to inhibit some isoforms of CYPs that are involved 
in the modulation of signal transduction to hormone responsive element. For instance, 
aromatase inhibitors block the activity of aromatase (CYP19) resulting in the down-regulation 
of the survival signal by oestrogen which lead to the decrease in breast cancer metastasis. A 
proposed method to delay or reduce metastasis is to induce apoptosis and inhibit 
angiogenesis, EMT, invasion, and dissemination (Landis-Piwowar and Iyer, 2014). In addition, 
inhibition of COX-2 expression is also a target because it results in the inhibition of PGE2 
production. PGE2 plays important roles in promoting cancer angiogenesis and cell 
proliferation, as well as suppression of cancer cell apoptosis (Thun, 2012). Inhibition of tumour 
promotion could also be performed by prevention of ROS and free radicals formation and 
modulation of the immune system (De Flora and Ferguson, 2005). 
1.3.2. Natural sources: providers of cancer chemopreventive agents   
Consumption of vegetables, fruits, and dietary fibre has been recommended in cancer 
prevention  (World Cancer Research Fund International, 2016a). Multiple lines of evidence 
showed that phytochemicals have potential to prevent or treat cancer. For example, a 
European Prospective Investigation into Cancer and Nutrition (EPIC) cohort study involving 
about 11 years of follow-up of 477,312 men and women from 10 European countries showed 
an inverse association between consumption of flavonols and lignans and risk of bladder 
cancer (Zamora Ros et al., 2014). Another EPIC study suggested that the intake of lignans 
before breast cancer diagnosis may help to improve the survival among postmenopausal 
women, but not in premenopausal women (Kyrø et al., 2015).  
As natural sources, especially plants, have proved to be a good source for chemopreventive 
agents, many research groups have extensively studied phytochemicals for this purpose. 
Phytochemicals that are well-known for their anti-cancer or chemopreventive properties 
include genistein from soy, resveratrol from red grapes, peanuts, and berries, epigallocatechin 
gallate from green tea, lycopene from tomatoes, lupeol from mangoes, curcumin from 
turmeric, indole-3-carbinol from cruciferous vegetables, and diallyl sulfide from garlic and 
related taxa. These compounds have shown pharmacological activities as blocking or 
suppressing agents, such as protection against oxidative stress, induction of apoptosis, 
modulation of phase II enzymes, and regulation of immune system (Singh et al., 2012).  
However, regardless their excellent in vitro and in vivo activities, the development of 
phytochemicals into approved cancer chemopreventive agents are still challenging due to 
several important reasons. Firstly, it is difficult to design intervention studies to evaluate the 
effectiveness of such preventive intervention. For example, clinical studies investigating the 
effect of green tea on liver diseases; including liver cancer, suffered from several major 
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limitations, such as improper comparison between control and treatment groups, no 
randomisation, and selection bias (Darvesh and Bishayee, 2013). Secondly, the effectiveness 
of phytochemicals to reduce cancer risk vary among population, such as in the case of soy-
rich diets that showed inverse association with breast cancer only in Asian women, but could 
not be confirmed in European women (Spagnuolo et al., 2015). Thirdly, the development of 
preparations that overcome/enhance their bioavailability also needs to be considered. 
Moreover, the question regarding the different effects between a single compound and whole 
extracts or products is debatable, as well as the safety of isolated compounds.      
1.4. Ethnopharmacology and the development of chemopreventive agents 
Ethnopharmacology is ‘a multidisciplinary area of research concerned with the observation, 
description, and experimental investigation of indigenous drugs and their biological activity’ 
(Rivier and Bruhn, 1979). It also focuses on the understanding of the benefits and risks of 
traditional medicine with the aim to provide better and safer uses (Heinrich, 2015).  
One of the classic example of drug discovery using ethnopharmacology approach is the 
discovery of curare. Curare is a plant extract used to make poison-tipped hunting arrows by 
certain wild tribes in South America. The French researcher, Claude Bernard (1813 – 1878), 
was the first one who studied curare. He noticed that the animals did not show sign of pain or 
nervousness. Later, we understood that it kills animals by paralyzing their muscle, including 
muscles of respiration, and the death occurs as a result of suffocation (Heinrich, 2015). The 
very first attempts of using curare for therapeutic purposes were for treatment of spastic 
paralysis, for moderating the convulsions in the shock-therapy of certain psychoses, and as 
an adjunct to anaesthesia in surgery. However, major problems of the drug during that time 
regarding the origin, composition, and quality of the extract have limited its uses. Its active 
component, d-tubocurarine, was isolated from the crude extract by H. King in 1935 
(Wintersteiner and Dutcher, 1943) and has led to the successful use as medicine. After that, 
d-tubocurarine has been used as muscle relaxant in abdominal operations and adjunct to 
anaesthesia in surgery (Prescott et al., 1946).  
The curare case study exemplifies that new drugs can be discovered through 
ethnopharmacology research. Nowadays the approach is commonly used for research on 
traditional Chinese medicine (TCM) in Asia, as well as research on medicinal plants in Brazil, 
Mexico, and South Africa. To date, a fourth of ethnopharmacological research is about anti-
cancer effects of traditionally used plants (Heinrich, 2015). This is not a surprise as the 
previous development of anti-cancer agents has greatly relied on natural sources. More than 
60% of the available cancer drugs are developed from natural products. Well-known examples 
include paclitaxel from Taxus brevifolia Nutt. (Taxaceae), vincristine and vinblastine from 
Catharanthus roseus (L.) G.Don (Apocynaceae), and etoposide (a podophyllotoxin derivative) 
from Podophyllum peltatum L. (Berberidaceae) (Gordaliza, 2007).  
Herbal medicine is the use of plants or plant mixture to take care of health problems. It has 
been the main treatment method in most traditional medicines, such as TCM, Ayurvedic 
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medicine, and Thai traditional medicine. Therefore, it is noteworthy to study herbal medicine 
for the discovery of new leads.  
1.5. Thai traditional medicine 
The Kingdom of Thailand has its own system of traditional medicine called “Thai Traditional 
Medicine” (TTM). TTM is considered a holistic medicine. In the past decades, it has gained 
more importance especially in chronic diseases, including cancer. The system is in harmony 
with Thai culture and associated with Buddhism. Various forms of practices, namely herbal 
medicine, massage, midwifery, maternal and child health care, Buddhist rites, and other rituals 
related to belief in supernatural power, are practiced in the system (Chokevivat and 
Chuthaputti, 2005). In the old days, the knowledge (both oral and textual) was transmitted 
through a process of apprenticeship. Ancient texts were passed on only through this process 
and mostly only among family members. In recent decades this has resulted in a loss of 
knowledge when no one in the family wanted to carry on the practice. To preserve the 
knowledge passed from the ancestors, King Rama III (reign: 1824 – 1851) and Rama V (reign: 
1868 – 1910) led the collection and publication of available knowledge and old scriptures and 
made them available to all Thai people.  Since the reign of King Rama V, the most recognized 
and probably the most important sources of TTM knowledge have been the inscriptions at 
Wat Pho (a Buddhist temple in Bangkok, Thailand) and two old text books (khamphi); 
Phaetthayasat Songkhro2 and Wetchasuksa3 (Mulholland, 1979). Nowadays a degree in TTM 
can be acquired from a four-year curriculum available from 25 institutes/ universities/ colleges 
(updated in 2017). Basic knowledge of TTM can also be studied in many schools across the 
country. 
In TTM, dhātu (the elements), utu (the seasons), ayu (age), and kala (time) are believed to be 
the main samutthan (causal factors) of diseases. For instance, the fire element is dominant in 
people aged between 16 and 30 years. Therefore, the fire element is likely to be the cause of 
illnesses in this group. The body comprises four elements (dhātu si) namely earth (dhātu din), 
water (dhātu nam), wind (dhātu lom), and fire (dhātu fai). The number of components of each 
element in the body is 20 for earth, 12 for water, 6 for wind, and 4 for fire (Figure 1-6). Wind 
and fire are untouchable, while earth and water form 32 parts of the body. Health problems 
are caused by the imbalance of the four elements (Foundation for the promotion of Thai 
traditional medicine and Ayurved Thamrong School Center of applied Thai traditional 
medicine, 2007b).     
                                                     
2 A collection of ancient khamphi which was published the first time in 1961. It is used nowadays as a 
manual for people studying Thai traditional medicine and pharmacy. 
3 A manual for students of Thai traditional medicine originally edited and published in 1909. 
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Figure 1-6 The components of each element in the body within the context of Thai Traditional Medicine 
(Lumlerdkij 2017) 
 
In the past decades, TTM has gained importance especially in chronic diseases, including 
chronic pain and cancer. Although scientific evidence to support the use of Thai traditional 
drugs in cancer is lacking, medical experience and anecdotal accounts of the benefits of TTM 
against the disease are well known throughout Thailand. However, little systematic 
information is available about the knowledge and practice of Thai healers (officially called Thai 
traditional practitioners in the country) regarding ‘cancer’. 
1.6. Potential of Thai medicinal plants as cancer chemoprevention 
The main textbook describing uses of herbal medicine in TTM; Khamphi Sapphakhunya 
(Foundation for the promotion of Thai traditional medicine and Ayurved Thamrong School 
Center of applied Thai traditional medicine, 2007a), was reviewed and ten well-studied and 
important plants were selected. Then a literature search was performed using mainly Pubmed 
and Web of Science databases, as well as manual search in Google Scholar to find scientific 
and biomedical evidence for the use of these plants for cancer prevention. Keywords included 
plant names, compound names, cancer, chemoprevention, antioxidant, and protection. The 
main focus was on blocking and supressing mechanisms (see section 1.3.1), as well as 
tumour inhibition in vivo. We excluded studies that reported positive activities at 
unphysiologically high concentrations of test samples e.g. 1000 mg/kg in vivo or 250 g/ml in 
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cell cultures. Antioxidant assays without suitable positive controls to allow comparisons were 
also excluded. The search was limited to the period of 1990 – 2017.    
Garlic is well-known for its medicinal properties and remarkable biological activities; including 
cancer chemoprevention. In TTM, the bulb was used as carminative, for treatment of diseases 
in the chest, indigestion, constipation, fever caused by Semha (water element) abnormality, 
ringworm, and for hair nourishment. The leaf has been used as an expectorant, a diaphoretic, 
for treatment of bruises, for stomach pain and to improve blood circulation (Foundation for the 
promotion of Thai traditional medicine and Ayurved Thamrong School Center of applied Thai 
traditional medicine, 2007a). Globally garlic (Allium sativum L.) and other allium vegetables; 
including garlic, onions, shallots, leeks and chives, are known as ‘healthy diet’ and often 
associated with the reduction in cancer risk. Several meta-analyses of population-based 
studies have been performed and reported differently for the association of allium vegetable 
consumption and risk of cancer, especially for colorectal and gastric cancer. Kodali and Eslick 
(2015), who performed meta-analysis of a total of 8,621 cases and 14,889 controls, concluded 
that garlic intake was associated with reduced risk of gastric cancer (Kodali and Eslick, 2015). 
This is in agreement with Zhou et al. (2011) who also found that increased garlic and garlic 
stalks consumption was associated with a reduced gastric cancer risk (Zhou et al., 2011). 
However, there was no correlation found between garlic intake and reduced risk of colorectal 
cancer (Hu et al., 2014).     
Although the effectiveness of garlic to reduce cancer risk still needs information from more 
population-based study, the use in cancer prevention has been backed by a lot of mechanistic 
studies. Their chemopreventive properties have been reviewed extensively elsewhere 
(Nicastro et al., 2015, Guercio et al., 2014, Schäfer and Kaschula, 2014, Mikaili et al., 2013, 
Melino et al., 2011). Briefly, in vitro and in vivo studies reported that garlic, onion, and their 
allyl sulfur compounds interfered with cancer initiation and cancer promotion. The blocking 
and suppression mechanisms include suppression of bioactivation of dietary carcinogens (e.g. 
nitrosamine and heterocyclic amines), induction of NQO1 and heme oxygenase 1 (HMOX-1) 
enzymes and their regulator Nrf2, cancer cell cycle arrest, induction of apoptosis via several 
pathways; including JNK, ERK1/2, and p38; p53, NFκB, Bcl-2/Bax and caspase. Their crude 
extracts and various organosulfur compounds including alliin, allicin, DADS exhibited 
antioxidant properties, such as inhibition of lipid peroxidation and radical scavenging activity 
(Nicastro et al., 2015). Water and ethanol extracts of garlic and some compounds also showed 
immunomodulatory activity by stimulation of lymphocyte proliferation, macrophage 
phagocytosis, macrophage, and the release of cytokines such as IL2, IL12, TNF-α and IFNγ, 
and promotion of NK cell number and activity (Schäfer and Kaschula, 2014).   
Table 1-1 presents traditional uses and pharmacological activities related to cancer 
chemoprevention of nine selected plants used in TTM. Most of them or their isolated 
compounds/fractions exhibited antioxidant properties or anti-cancer effects; such as inducing 
apoptosis and suppressing tumour growth. This shows that herbal medicine in TTM is a 
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potential source for cancer chemopreventive agents. However, as most studies were 
performed in specific types of tumour or cell lines, such as liver cancer, skin cancer, and 
prostate cancer, the information would be useful only for the prevention in high risk population 
or secondary prevention.  
Since it is impractical and difficult to prevent cancer in all sites, we should have a strategy that 
is beneficial for cancer prevention in general. Based on the philosophy of holistic medicine like 
TTM, we believe that it is possible to develop such strategy. This question has led to the aims 
and development of the study plan of this thesis.
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Table 1-1 Selected medicinal plants used in Thai traditional medicine: traditional uses and related pharmacological activities regarding chemoprevention  
Plants Traditional uses  
(from Khamphi Sappakhunya) 
Extracts/ active 
ingredients 






Young fruit: antidiarrheal, 
antidysenteric, treatment of 
fever and fix wind element 
Mature fruit: nourish fire 
element 
Ripe fruit: promotes digestion, 
carminative, nourish fire 
element, relieve thirst 
Root: treatment of cough, 
asthma, phlegm, fever, 
abnormal vaginal discharge  
Methanol extract 
of the whole 
plant 
In vivo, 25 and 50 mg/kg 
BW orally, normal saline 
(con) 
Pre-treatment of A. marmelos for 7 days suppressed lipid peroxidation, xanthine oxidase and 
release of serum toxicity marker enzymes namely SGOT, LDH, and SGPT in a dose-dependent 
manner in male Wistar rats. (Khan and Sultana, 2009). It also decreased the incidence of liver 
carcinogenesis initiated by diethylnitrosamine and promoted by 2-acetyl aminofluorene (2-AAF) 
in male Wistar rats, together with the ability to restore the level of glutathione, GST, glutathione 
peroxidase (GPx), inhibited MDA formation, early markers of tumour promotion; ODC activity 
and hepatic DNA synthesis (Khan and Sultana, 2011). 
Methanol extract 
of the leaf 
In vitro, 0 – 110 µg/ml, 
ascorbic acid (pos) 
The extract exhibited DPPH scavenging property with IC50 value of 46.7 µg/ml, whereas IC50 




from stem bark 
Various cell lines, 0-500 
µg/ml, ethanol extract 
from the fruit of Emblica 
officinalis (pos) 
The fraction showed a strong inhibitory activity against cell proliferation of K562 leukemia cells 
(IC50 = 25 μg/ml), B-lymphoid Raji (IC50 = 5 μg/ml), but showed weak to moderate effects in T-
lymphoid Jurkat,  erythroleukemic HEL, melanoma Colo38, breast cancer MCF7 and MDAMB-
231 cell lines (IC50 values were between 50 - 500 μg/ml) (Lampronti et al., 2003). 
Hydro-alcohol 
extract of the 
fruit 
In vivo, 50 mg/kg BW/ 
day orally, water (neg) 
Treatment of the extract, before and after DMBA application, significantly reduced the incidence 
of DMBA-induced skin papillomas to 70% of the control, as well as the size and weight of the 
papillomas in Swiss albino mice. It also prolonged the average latency period (time lag between 
the application of the promoter and the appearance of 50% of tumours) from 7.88 in control 
group to 9.3 – 10.3 weeks in treated groups (Agrawal et al., 2010). 
Ethanol extract 
of the leaf 
In vivo, 400 mg/kg BW, 
normal saline (neg) 
 
In vivo, 50 and 100 
mg/kg BW orally, water 
(neg), butylated 
hydroxyanisole (pos) 
Administration of the extract once daily for six days increased the survival of tumour bearing 
mice up to 43 days after the tumour cell inoculation. No survivors in the saline control group 
(Jagetia et al., 2005).  
The extract enhanced the basal levels of antioxidant enzymes, such as GST, superoxide 
dismutase, catalase, GPx, and glutathione reductase in lung or liver of Swiss albino mice. It 
also elevated the levels of phase I enzymes, such as cytochrome P450 (Singh et al., 2000).  
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Plants Traditional uses  
(from Khamphi Sappakhunya) 
Extracts/ active 
ingredients 





Cell cultures, 25 – 300 
µg/ml, DMSO (con) 
The fraction down-regulated anti-apoptotic genes (Bcl-2, mdm2, COX-2 and cmyb) and up-
regulated pro-apoptotic genes (Bax, Bak1, Caspase-8, Caspase-9 and ATM) in Jurkat cells (50 
µg/ml) and IMR-32 cells (84.5 µg/ml) (Sain et al., 2014). 
Lupeol Cell cultures, 20 – 80 
µM, DMSO (neg) 
In vivo, 1 mg/animal i.p., 
corn oil (neg) 
 
 
Cell culture, 1 - 20 µM, 
N/A 
Cell culture, 30 – 50 µM, 
DMSO:alcohol (con)  
  
 
Cell culture, 10 – 150 
µM, DMSO (con) 
 
Cell culture, 6.25 – 200 
µM, DMSO (con) 
 
Cell culture, 1 – 30 µM, 
DMSO:alcohol (neg)  
In vivo, 1 mg/animal i.p., 
corn oil (neg) 
Lupeol exhibited cytotoxicity in non-metastatic melanoma cells WM35 (IC50 = 34 µM) and 
metastatic melanoma cells 451Lu (IC50 = 38 µM), induced apoptosis, PARP cleavage, caspase-
3 activation, G1 cell cycle arrest, and caused a shift of Bax/Bcl-2 ratio toward apoptosis in 451Lu 
cells. In 451Lu xenograft nude mice, it significantly reduced and delayed tumour growth, 
suppressed cell proliferation, protein expression of cyclinD1, D2, Cdk2, Bcl-2, and induced p21 
and PARP cleavage (Saleem et al., 2008). 
It increased the formation of dendrites in B16 2F2 melanoma cells and reduced the migration 
of human G361 melanoma and NB-1 neuroblastoma (Hata et al., 2005). 
It inhibited cell proliferation of human pancreatic adenocarcinoma cells AsPC-1 and induced 
apoptosis, together with the reduction of the expression of Ras and NF-kB activation, and 
modulation of the protein expression of signalling molecules involved in PKCα/ODC, PI3K/Akt 
and MAPKs pathways (Saleem et al., 2005a).    
The compound inhibited A431 human epidermoid  cancer cell proliferation with IC50 value of 75 
µM, induced apoptosis, caused cell cycle arrest at sub G1, inhibited Akt/PKB signaling pathway 
and NF-κB activation (Prasad et al., 2009). 
It inhibited cell proliferation, induced apoptosis and expression of Caspase3 and FADD, while 
suppressed the expression of Death receptor 3 (DR3) in hepatocellular carcinoma SMMC7721 
cell (Zhang et al., 2009).  
Lupeol inhibited cell proliferation of human prostate cancer cells LNCaP and CWR22Rv1 with 
IC50 values of 21 and 18.5 µM, respectively. It also induced PARP cleavage, expression of 
FADD, Fas receptor–mediated apoptotic pathway. It also reduced tumour growth in nude mice 






In vivo, 200 µg/kg BW 
i.p. 21 days, N/A  
Cell cultures, 0–500 μM, 
N/A 
Marmelin reduced the volume, size, weight, angiogenesis, microvessel density, and CD31 (an 
endothelial cell specific surface marker) of colon cancer cell induced xenograft tumours in nude 
mice compared to control group. In vitro, the compound at 50 μM significant inhibited the cell 
proliferation of HCT-116 colon and HEp-2 cells, while it did not show the effect in normal mouse 
embryo fibroblasts up to 500 μM. At 10 -25 μM, marmelin induced apoptosis, caspase 3 protein 
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Plants Traditional uses  
(from Khamphi Sappakhunya) 
Extracts/ active 
ingredients 
Model, doses, controls Chemopreventive effect 
expression, sub-G1/G0 cell cycle arrest, expressions of TNF-α, TNFR-1, TRADD and caspase-
8 in Hep-2 cells. At 125 nM, it suppressed Akt and Erk phosphorylation, NF-kB activation and 






Dried rhizome: treatment of 
diseases in oral cavity and 
neck, asthma, fix 
Uthankhamavata (see Figure 
1-6) that causes shaking and 
aching  
Ethanol extract Cell culture, 1.95 – 250 
μg/ml, 5-FU (pos) 
 
 
In vitro, N/A, N/A 
The extract showed promising cytotoxicity against CL-6 cholangiocarcinoma and Hep-2 human 
laryngeal carcinoma with IC50 values of 24 and 29 μg/ml, respectively, while the effect was 
moderate in HepG2 human hepatocarcinoma cells (IC50 = 77 μg/ml) and weak in normal human 
epithelial cell HRE (IC50 = 208 μg/ml) (Mahavorasirikul et al., 2010).  
The extract inhibited LPS-induced nitric oxide production in RAW 264.7 cells with IC50 values of 
9.7 μg/ml (Kakatum et al., 2012).  
Essential oil and 
hinesol 
Cell culture, 2.5 – 50 
µg/ml and 5 – 100 µM, 
N/A 
Essential oil and hinesol, inhibited the proliferation of HL-60 cell with IC50 values of 9.6 µg/ml 
and 4.9 µg/ml (= 22.1 µM), respectively. Hinesol induced apoptosis, activated JNK and ERK (at 
100 µM), but not p38 (Masuda et al., 2015).  
Prenylated 
dihydrobenzofur
an derivative (s) 
Cell culture, N/A, 10-
Hydroxycamptothecin 
(pos) 
Trans-2-Hydroxyisoxypropyl-3-hydroxy-7-isopentene-2,3-dihydrobenzofuran-5-carboxylic acid  
showed cytotoxicity against HCT-116 and MKN-45 cancer cells with IC50 values of 0.4 and 0.5 
µM, respectively (Duan et al., 2008).  
Phenol 
derivative (s) 
In vitro, N/A, NDGA 
(pos; 5-LOX) and 
indomethacin (pos; 
COX-1) 
2-[(2’E)-3’,7’-Dimethyl-2’,6’-octadienyl]-4-methoxy-6-methyl-phenol showed potent inhibitory 
activity against 5-LOX and COX-1 with IC50 values of 0.1 and 1.8 µM, respectively (Resch et 
al., 2001). 
β-eudesmol Cell culture, 2.5 – 50 
µg/ml, N/A 
Cell culture, 10 – 100 
µM, 0.1%DMSO (con) 
 
 
In vivo, 100 and 200 
mg/kg BW, 5-FU (pos) 
It inhibited the proliferation of HL-60 cell with IC50 value of 10.4 µg/ml (= 46.8 µM) (Masuda et 
al., 2015). 
It inhibited the proliferation of HL-60 cell with IC50 value of 35.1 µM, induced apoptosis via the 
mitochondrial apoptosis pathway, activated cleavage of caspase-3, caspase-9, and PARP, JNK 
signalling, downregulated of Bcl-2 expression; caused a release of cytochrome c, and 
suppressed MMP (Li et al., 2013b). 
Treatment with 100 mg/kg BW of β-eudesmol for 30 days reduced tumour growth to less than 
10% compared to the control group in CCA-xenografted mice. It also prolonged survival time 
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Cell culture, 10 – 100 
µM, 0.1%DMSO (con) 
In vivo, upto 300 µM, 
0.3%DMSO (con), 
thalidomide (pos) 
Cell culture, 10 – 180 
µM, nifuroxazide (pos) 
 
 
Cell culture, 10 – 100 
µM, 0.1%DMSO (con), 
cisplatin (pos) 
In vivo, 2.5 – 5 mg/kg 
BW, 0.5% CMC-Na 
containing 0.5% ethanol 
(con), thalidomide (pos)  
from 43 days in control group to 71 days, while 5-FU prolonged survival time to 54 days. In 
addition, it decreased metastasis from 90% to less than 5% of total lung mass (Plengsuriyakarn 
et al., 2015).  
It inhibited the proliferation of porcine brain microvascular endothelial cells and HUVEC, 
HUVEC migration, the phosphorylation of ERK 1/2. In mice, the compound inhibited 
angiogenesis in subcutaneously implanted Matrigel plugs in C57BL/6J mice and in adjuvant-
induced granuloma in ddY mice (Tsuneki et al., 2005).    
 
The compound showed weak cytotoxicity against (IC50 = 167 µM). At 180 µM, it suppressed 
2D cell migration, HMOX-1, P-STAT-1 and NF-kB protein expression in time-dependent 
manner (Mathema et al., 2017).  
 
The treatment inhibited HUVEC proliferation and CREB phosphorylation stimulated by VEGF 
and/ or basic fibroblast growth factor (bFGF), proliferation of cancer cell lines HeLa, SGC-
7901, and BEL-7402 cells. In mice implanted with H22 and S180 mice tumour cells, the 
treatment suppressed the tumour growth, and angiogenesis (Ma et al., 2008).    
 
n-Hexane 
extract and its 
isolated 
compounds 
In vitro, N/A, ethanol 
(con), indomethacin and 
nordihydroguaiaretic 
acid (pos) 
The crude extract and its isolated compound; atractylochromene and quinone, exhibited potent 
inhibitory activities against 5-LOX with IC50 values of 2.9 µg/ml, 0.6 µM, and 0.2 µM, 
respectively. Atractylon and osthol also showed moderate activity against 5-LOX with IC50 
values of 25 µM and 36 µM, respectively. Atractylochromene also showed strong effect against 
COX-1 (IC50 = 3.3 µM), while the crude extract and quinone showed less potent activity with 
IC50 values of 30 µg/ml and 64 µM, respectively. Other isolated compounds; atractylon, osthol, 
atractylenolide I – III, showed weak effect with IC50 values more than 200 µM (Resch et al., 






Root and stem: treatment of 
fever and fi (abscess) 
Water extract of 
the leaf and stem  
In vivo, 50 – 200 mg/kg 
BW, saline (con) and 
diclofenac (pos) 
All doses of both extracts reduced carrageenan-induced paw oedema in Wistar rats 
(Deshpande et al., 2011).   
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Resin from root: treatment of 
constipation, stomach pain, 
flatulence, achinarok 
(conditions caused by eating 
prohibited food), aid digestion, 
fix abnormal elements, cleanse 
semha and lom, nourish fire 
element, swelling  
Ethanol extract 
(unknown part) 
In vivo, 6.25 and 12.5 
mg/kg BW, 1 mM EDTA 
(con) 
All doses of extract reduced the effect of 1,2-dimethyl hydrazine (DMH) by increasing the level 
of GSH, FRAP, and GST and reducing level of CYPs, β-catenin, and ACF formation in DMH-




of resin and 
conferol 
Cell culture, N/A, 
doxorubicin (pos)  
The chloroform fraction exhibited promising cytoxicity in all cell lines tested with IC50 values less 
than 20 µg/ml. Conferol; a sesquiterpene coumarin, which was isolated from the fraction, 
showed potent cytotoxicity with IC50 values of 0.51, 2.6, and 3.4 µg/ml in HepG2, Hep3B, and 
MCF-7 cells, respectively (Lee et al., 2009).  
Farnesiferol C In vivo, 0.1 and 1 mg/kg 
BW daily i.p. for 2 days, 
PBS (con) 
In vitro, 10 – 40 µM, N/A 
 
In Lewis lung cancer cells (LLC)-inoculated C57BL/6 mice, the treatment reduced the tumour 
weight, microvessel density, and Ki67 index (proliferation index). In vitro, the compound 
countered the effect of VEGF-A in HUVECs cells by suppression of the induced proliferation 
(IC50 ~15 μM), induced tube formation (IC50 = 20 μM), induced 2D-migration (IC50 ~ 20 μM), 
induced invasion in Boyden chamber assay (IC50 < 20 μM), secretion of pro–MMP-2 (IC50 ~ 20 
μM), and induced vessel sprouting (IC50 ~ 10 μM). Its mechanisms on the VEGF-VEGFR 
signalling pathway involved with the inhibition of VEGF binding, VEGFR1 autophosphorylation, 
ERK1/2, p38, MAPK, and JNK (Lee et al., 2010).    
Umbelliprenin Cell culture, 25 – 100 
µM, 0.5% DMSO (con), 
staurosporine (pos)  
In vivo, 0.0025% in 
drinking water, curcumin 
(pos)     
Cell culture, 31 µM, 






The compound induced apoptosis in Jurkat and Raji leukemia cell lines, but not in PBMC. 
This effect was not inhibited by IL-4 (Ziai et al., 2012).            
 
Pre-treatment with water supplemented with umbelliprenin delayed the formation of papilloma 
and reduced the number of tumours in TPA-induced papilloma in SENCAR mice. The latter 
effect was similar to that of curcumin (Iranshahi et al., 2009).    
Using proteomics approach, treatment with umbelliprenin resulted in differential expression of 
45 proteins in QU-DB cells and 70 proteins in A549 cells. In QU-DB cells, downregulatory effect 
on some tumourigenic proteins, such as heat shock protein, and upregulatory effect on some 
anti-tumour proteins, such as Nipsnap1, suggested that the compound is a promising anti-
cancer agent. However, the downregulation of the tumourigenic proteins; cyclophilin and 
tumour suppressor MST, in A549 cells contradicted the results in QU-DB cells (Khaghanzadeh 
et al., 2016).   
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Galbanic acid Cell culture, 3.1 – 100 
µM, cisplatin (pos) 
The compound inhibited the proliferation of ZIPneo and Hras-F cells with IC50 values of 58 
and 16 µM, respectively. In enzyme-based assay, it inhibited FTase protein (the protein that 










Dried rhizome: treatment of 





In vitro, 0.32 – 250 
µg/ml, N/A 
The essential oil exhibited DPPH and ABTS scavenging activities with IC50 values ~ 8 and 1.6 
µg/ml, respectively. At 250 µg/ml, the extract protected against UVB-induced damage in mouse 
skin fibroblast cells NIH 3T3 by reduction of DNA migration, H2A.X phosphorylation, p21 protein 
expression, and restoration of cyclin D expression (Jeong et al., 2009). 
Supercritical 
fluid CO2 extract 
In vivo, 50, 100 
mg/kg/day orally, saline 
(con), vitamin E (pos) 
In vitro, 25 – 400 µg/ml, 
vitamin E (pos) 
The treatment countered the damages caused by D-galactose injection by reduction of elevated 
serum ALT, AST, BUN, CRE, hepatic and renal MDA level, increasing activity and gene 
expression of various antioxidant enzymes; Cu, Zn-SOD, CAT, GPx in liver and kidney, reversal 
of liver and kidney injury, and reduction of COX-2 and iNOS protein expressions in liver and 
kidney. However, the extract showed weak DPPH, ABTS, and oxide anion radicals scavenging 
activity with IC50 values of 353, 201, and 707 µg/ml, respectively, as well as weak reducing 




Cell culture, 1 – 100 
µg/ml, N/A 
Seven out of eight BPDs isolated from 95% ethanol extracts showed potent to moderate 
cytotoxicity with IC50 values ranging from 3 to 87 µg/ml in human large-cell lung cancer H460, 
human liver cancer SMMC7721, and human gastric cancer BGC823 cell lines. In SMMC7721 
cells, compound 5 (1.23 µg/ml) and 6 (0.4 µg/ml) reduced cell adhesion, migration, invasion, 
MMP-2 and MMP-9 expression (Hu et al., 2015).  
Levistolide A Cell culture, 0 – 200 µM, 
DMSO (con), 5-FU (pos) 
The compound inhibited the cell proliferation and induced apoptosis of both colon cancer 
HCT116 wild type and HCT116 p53-/- cells. At 50 and 100 µM, it induced caspase-3, PARP 
cleavage, ROS generation, the expression of ER stress-related proteins in HCT116 wild type. 
Therefore, anti-cancer effect in colon cancer cells of levistolide A involved with ROS-mediated 
ER stress pathway (Yang et al., 2017).    
Phyllanthus 
emblica L. 
Young fruit: nourish muscle and 
voice, treatment of constipation, 
worm in semha 
Fruit powder In vivo, 20 mg/kg BW 
orally, N/A 
In Dalton’s lymphoma ascites (DLA)-tumour bearing BALB/c mice, the treatment increased 
splenic NK cells activity, antibody dependent cellular cytotoxicity (ADCC), and mean survival 
time from 20 to 27 days after the tumour cells inoculation (Suresh and Vasudevan, 1994).  
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Mature fruit: treatment of fever 
Whole extract of 
the fruit 
In vivo, 100 mg/kg BW 
orally, 10% sucrose 
(con) 
Cell culture, 10 – 1000 
µg/ml, water (con) 
In vitro, the extract (300 μg/ml) induced autophagy by upregulation of the expression of 
autophagic proteins- beclin1 and LC3B-II in OVCAR3 and SW626 cells. It also downregulated 
angiogenesis-related genes in OVCAR cells; COL4A3, CXCL6, ECGF1, EFNB2, FGF2, IL-1β, 
PDGFB, TNFRSF12A, and HIF-1α, to less than 40% of the control. Addition of cisplatin to the 
extract treatment presented synergistic effects in autophagy induction and angiogenesis 
inhibition. In vivo, the treatment reduced the tumour growth and mass, and angiogenesis, and 
induced autophagy in OVCAR3-induced tumour in nude mice (De et al., 2013).      
Water extract of 
the fruit 




Cell culture, 6.25 – 400 
μg/ml, taxol (pos) 
In vivo, 1 – 4 mg/ 0.1 ml 






In vivo, 100 mg/kg BW 
orally, water (con) 
In vitro, 1 – 100 μg/ml, 









The extract inhibited AP-1 DNA binding activity by downregulating the protein expressions of 
AP-1 family members; c-Jun, JunB, JunD and c-Fos, cell proliferation, and induced apoptosis 
in two cervical cancer cell lines SiHa (HPV-16 positive) and HeLa (HPV-18 positive). Inhibition 
of AP-1 has been associated with reduced HPV transcription (Mahata et al., 2013).  
The extract showed moderate cytotoxicity in various human cancer cell lines; HepG2 (liver), 
HeLa (cervical), SW620 (colorectal), MDA-MB-231 (breast), and SKOV3 (ovarian) with IC50 
values between 46 – 106 μg/ml, but no cytotoxicity in normal lung fibroblast with IC50 values > 
400 μg/ml. At 50 - 200 μg/ml, the extract induced apoptosis in HeLa through extrinsic caspase-
8-dependent pathway, while it acted by activating the death receptor Fas/caspase-8-dependent 
apoptosis pathway in A549, HeLa and SKOV3 cells. In two-stage mouse skin tumourigenesis 
model using DMBA (initiator) and TPA (promoter), the treatment reduced more than 50% of 
tumour numbers and volumes over a 20-week period. At 25 – 50 μg/ml, the extract suppressed 
MDA-MB-231 cells invasion through Matrigel (Ngamkitidechakul et al., 2010).  
In vitro, the extract, at 1 and 25 μg/ml, showed stronger inhibition of O2
–, H2O2, NO activity 
than 100 M vitamin C. In DEN-treated rats, the extract reduced liver ROS level, bile O2
–, 
H2O2, NO production, plasma ALT, AST, and -GT levels (intragastric), infiltrated leukocytes in 
liver, oxidative stress. It also reversed the effect of DEN treatment by restoring MnSOD and 
catalase, and suppressing iNOS and CYP2E1 protein expressions in the liver. Moreover, the 
treatment of the extract after DEN induction suppressed Bax/Bcl-2 ratio, PARP, and Beclin-1 
expression which confirmed the ability of the extract in the inhibition of apoptosis and autophagy 
induced by DEN (Chen et al., 2011).    
At 50 and 100 μg/ml, the extract decreased the level of ROS and lipid hydroperoxides, while 
induced GSH, SOD, catalase, GPx, GR, GST and total antioxidant capacity (the ability of 
antioxidants in the cell lysate to inhibit ABTS+ formation) in HepG2 cells (Shivananjappa and 
Joshi, 2012).  
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In vivo, 100 mg/kg BW 
orally, water (con) 
In vivo, 500 mg/kg BW 
orally, water (con) 
 
The extract protected from t-BHP-induced cell death, with the concentration that gave 50% 
protection of 32.4 μg/ml, and inhibited AAPH-induced fluorescence in HepG2 cells. It exhibited 
ABTS and DPPH radical scavenging activities with IC50 values of 5 and 12 μg/ml, respectively 
(Hiraganahalli et al., 2012).   
The extract inhibited cell proliferation of HT1080 human fibrosarcoma cells at 24, 48, and 72 
with IC50 values of 48, 3.5, and 3 μg/ml, respectively. At 2 and 3 μg/ml, it down-regulated MMP2 
and MMP9 expression in the cells after 5 days-incubation. It also showed anti-migration and 
anti-invasion activity at high dose; IC50 values of 640 and 750 μg/ml, respectively, after 4 hour-
incubation (Yahayo et al., 2013). 
Administration of the extract decreased tumour incidence, yield, burden and cumulative number 
of papilloma in DMBA-induced papilloma in Swiss albino mice (Sancheti et al., 2005). 
The extract reversed arsenic-induced oxidative stress by reduction of serum SGOT, serum 
SGPT, liver lipid peroxidation, enhancing serum alkaline phosphatase, liver SOD, liver catalase, 
and liver GST in Swiss albino mice. It also reduced pathological alterations after sodium 
arsenite treatment (Sharma et al., 2009).  
Methanol extract 








of the fruit 
(defatted) 
In vivo, 50 – 200 mg/kg 
BW by gastric 
intubation, mineral oil 
(con)  
In vivo, 100 and 200 
mg/kg BW orally, saline 
(con) 
 
In vivo, 100 and 200 
mg/kg BW orally, saline 
(con) 
In DMBA-induced oral squamous carcinogenesis in hamsters, DMBA treatment caused a 
decrease in SOD, CAT and TBARS levels and increase in GSH, Vit E, and GPx in buccal pouch. 
In plasma, DMBA reduced SOD, CAT, GPx, Vit C, Vit E, GSH and elevated TBARS level. The 
effects were reversed after the extract treatment (Krishnaveni and Mirunalini, 2012).  
In hepatic carcinogenesis model in Wistar rats, the extract recovered the pathological 
manifestation, -GT-positive foci, elevated hepatic ODC activity, elevated GST, elevated -GT, 
and GSH level which were results from DEN initiation and 2-AAF promotion with partial 
hepatectomy (PH) (Sultana et al., 2008).  
Pre-treatment with the extract decreased thioacetamide-induced oxidative stress in Wistar rats 
by lowered elevated SGOT, SGPT and -GT in serum, elevated GST, GR, G6PD in liver, MDA 
formation, and recovered hepatic GSH and GPx, as well as inhibition of ornithine decarboxylase 
(ODC) (Sultana et al., 2004).  
Ethyl acetate 
fraction of 95% 
ethanol extract 
In vivo, 500 mg/kg BW 
orally, 2% gum acacia 
(con) 
Co-treatment with arsenic and the extract reduced the toxicity of arsenic by increasing thymus 
weight and cellularity, levels of GSH, activity of SOD, catalase, and cytochrome c oxidase, 
mitochondrial membrane depolarization, while decreasing lipid peroxidation, ROS generation, 
number of cells in sub G1 phase, and number of necrotic and apoptotic cells in thymus as 
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In vitro, 1 – 40 μg/ml, 
N/A 
compared to those treated with arsenic alone. In vitro, the extract inhibited DPPH radicals with 
IC50 value of 8.32 μg/ml (Singh et al., 2013). 
Polyphenol 
fraction 
In vivo, 60 mg/kg BW 
orally, N/A 
In vitro, 0 – 200 μg/ml, 
N/A  
The treatment reduced NDEA-induced liver tumour development, elevated levels of serum -
GT, ALP, GPT, bilirubin, hepatic GST, and GSH in rats. In vitro, the fraction induced apoptosis 
in Dalton's Lymphoma Ascites and CeHa cell lines. In addition, it scavenged superoxide and 





Fruit (peppercorn), leaf, root: 
nourish fire element, treatment 
of semha and wind element 
Black pepper In vivo, 0.5 – 2% in diet, 
N/A 
Diet containing 1 and 2% black pepper increased GST, -SH, cyt b5, and CYPs level, while 
inhibited MDA in Swiss albino mice (Singh and Rao, 1993). 
Dichloromethan
e extract of the 





extract of the 
fruit (piperine-
free)                                     
In vivo, 100 – 400 mg/kg 
BW orally, tween 80 
(con) 
In vitro, 7.45 μg/ml, N/A 
In vivo, 100 – 200 mg/kg 
BW orally , tween 80 
(con) 
In vitro, N/A, N/A 
All doses of extract reduced tumour volume, up-regulated p53, down-regulated estrogen 
receptor, E-cadherin, MMP-9, MMP-2, c-Myc, and VEGF levels in N-nitroso-N-methylurea 
(NMU)-induced mammary tumourigenesis rats. In human breast cancer cell lines MCF-7, the 
extract induced protein expression of E-cad, VEGF and c-Myc, but not p53 (Deng et al., 2016). 
Administration of the extract reduced tumour incidence (20%) and weight in NMU-induced 
mammary tumorigenesis in Sprague-Dawley rats. In vitro, the extract exhibited promising 
cytotoxicity in breast cancer cell lines; MCF-7, MDA-MB-468, and ZR-75-1, with IC50 value of 
7.5, 18, and 14 μg/ml, respectively, but weaker effect in other cell lines tested (IC50 > 20 μg/ml); 
including normal breast cells, neuroblastoma, colorectal carcinoma, lung carcinoma, and 
mouse fibrosarcoma. It induced apoptosis by upregulation of p53 and cyt C, while down-
regulation of topo II in the MCF-7 cells (Sriwiriyajan et al., 2016).  
Water extracts 
of the fruit 
Cell culture, 10 – 100 
μg/ml, vehicle, ConA,  
LPS (con)   
In splenocytes isolated from mice, the extract induced cell proliferation and IFN release, but 
suppressed the release of Th2 cytokines; IL-4 and IL-10, in the presence of ConA. It also 
promoted the cytotoxic activity of NK cells. In peritoneal macrophages, it increased the release 
of pro-inflammatory cytokines; IL-6 and TNF, and NO production in the presence of IFN 
(Majdalawieh and Carr, 2010).  
Piperine Cell culture, 10–150 M, 




The compound showed moderate and selective cytotoxicity to colon cancer cells; HT-29 (IC50 
= 53 M), Caco-2 (IC50 = 54 M), SW480 (IC50 = 126 M), HCT-116 (p53
+/+) (IC50 = 109 M), 
and HCT-116 (p53-/-) (IC50 = 118 M). The cytotoxic effect in HT-29 cells are associated with 
cell cycle arrest at G1 phase, suppression of cyclins D1 and D3 expression, cyclin-dependent 
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In vivo, 2.5 – 5 mg/kg 
BW, N/A  
Cell culture, 35 – 280 
M, N/A   
 
Cell culture, 10 – 200 
M, vehicle (con)  
 
 
Cell culture, 25 – 200 
M, N/A  
In vitro, 3.9 – 250 M, 
N/A 
In vivo, 50 mg/kg BW 







In vivo, 200 mol/kg BW 
i.p., N/A 
Cell culture, 10 – 100 
g/ml, N/A 
kinases 4 and 6, phosphorylation of the retinoblastoma protein, and promotion of p21/WAF1 
and p27/KIP1 expression. It induced apoptosis by induction of ROS generation, loss of 
mitochondrial membrane integrity, PARP cleavage, caspase activation, and the expression of 
endoplasmic reticulum stress-associated proteins, c-Jun N-terminal kinase and p38 mitogen-
activated protein kinase, as well as inhibition of the phosphorylation of Akt and surviving 
expression. It also suppressed colony formation and the growth of HT-29 spheroids (Yaffe et 
al., 2015). 
Injection of piperine into 4T1 tumour, which was inoculated into BALB/c mice, suppressed the 
tumour growth and lung metastasis. Piperine inhibited cell growth and migration, induced 
apoptosis, activated caspase 3, caused cell cycle arrest at G2/M phase with a reduction of 
cyclin B1 expression, and suppressed MMP-9 and MMP-13 expression in mouse mammary 
carcinoma 4T1 cells (Lai et al., 2012).  
Piperine inhibited cell proliferation, induced apoptosis in HER2-overexpressing breast cancer 
cells by activation of caspase-3 and PARP cleavage, downregulation of HER2 expression, 
suppression of cell migration by inhibition of MMP-9 expression, AP-1 and NF-kB activation, 
and interruption of ERK1/2, p38 MAPK, and Akt signalling pathways (Do et al., 2013). 
The compound inhibited proliferation, migration, invasion by suppressing MMP-2 and -9 
expression in human osteosarcoma cells HOS and U2OS cells (Zhang et al., 2015). 
At high concentration, piperine inhibited H.pylori growth (IC50 = 115 M) and adhesion to gastric 
epithelial cells (Tharmalingam et al., 2014).  
In B(a)P-induced lung carcinogenesis in Swiss albino mice, administration of piperine reversed 
the effect of tumour by increasing the activities of mitochondrial enzymes; isocitrate 
dehydrogenase (ICDH), ketoglutarate dehydrogenase (KDH), succinate dehydrogenase 
(SDH), and malate dehydrogenase (MDH), glutathione-metabolizing enzymes in lung and liver; 
GR, GPx, G6PD, and suppressing phase I enzymes in lung and liver; CYPs, cytochrome b5, 
NADPH-c reductase compared to benzo(a)pyrene-treated group (Selvendiran et al., 2005b). It 
also increased phase II enzymes; UDP-GT, QR and GST, and reduced DNA-damage in lung 
cancer-bearing mice (Selvendiran et al., 2005a).  
Piperine treatment remarkably increased survival rate, reduced number of lung nodules, lung 
metastatic markers; hydroxyl proline, uronic acid, and hexosaline, serum sialic acid (a marker 
for metastatic ability) and GT (a cell proliferation marker) of mice bearing lung metastasis 
induced by B16-F10 melanoma cells. In vitro, the compound inhibited B16-F10 melanoma cell 
proliferation (Pradeep and Kuttan, 2002).  
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In vitro and ex vivo, 10 – 
100 M, vehicle (con) 
 
In vitro, 5 – 100 M, 
0.1%DMSO (con) 
 




Cell culture, 2.5 - 10 
g/ml, N/A 
Cell culture, 10 - 10 M, 
N/A 
At 100 M, the compound reduced HUVECs migration, tubule formation, collagen-induced 
angiogenesis, and MDA-MB-231-induced angiogenesis in chick embryo chorioallantoic 
membrane (CAM) (Doucette et al., 2013).  
Piperine inhibited 2D-cell migration, MMP-9 expression, PMA-stimulated cell invasion, PMA-
stimulated NF-kB and AP-1 expression in fibrosarcoma HT-1080 cells, but not MMP-2 (Hwang 
et al., 2011).  
Piperine inhibited digoxin and cyclosporine A transport in Caco-2 cells and CYP3A4 in human 
liver microsomes (Bhardwaj et al., 2002).  
 
It inhibited the cell proliferation, invasion, proinflammatory cytokines; L-1, IL-6, TNF- and  
GM-CSF, and NF-kB in B16F-10 melanoma cells (Pradeep and Kuttan, 2004). 
The compound suppressed PMA-induced COX-2 expression by downregulating NF-kB, C/EBP, 













Root: treatment of semha 
problems, lom ammapruek 
(causes nausea, colic, loss of 
hearing, and faint) 
 
Methanol extract In vivo, 300 mg/kg BW 
orally, water (con) 
The extract exhibited hepatoprotective activity by attenuation the effect of deltamethrin (toxic 
pyrethroid insecticide) by reduction of serum ALT, AST, ALP, and GT, promotion of serum SH 
protein, GST, SOD, and CAT in albino rats (Alnahdi et al., 2016).  
Alantolactone  Cell culture, 0 – 15 M, 
N/A 








Cell culture, 1 – 10 M, 
N/A 
The compound suppressed both constitutive and inducible STAT3 activation and translocation 
in triple-negative breast cancer MDA-MB-231 cells (Chun et al., 2015). 
Alantolactone showed promising cytotoxic effect in human lung cancer SKMES-1 cells with IC50 
value of 40 M. It induced apoptosis, together with the induction of caspase-8,-9,-3 activation 
and inhibition of Bcl-2, caused cell cycle arrest at G1/G0 phase, and activated PARP (Zhao et 
al., 2015).  
The IC50 value for HepG2 cell proliferation inhibition was 33 M and induced apoptosis by GSH 
depletion, inhibition of STAT3 activation, induction of ROS generation, reduction of 
mitochondrial transmembrane potential, increasing of Bax/Bcl-2 ratio, and caspase-3 activation 
(Khan et al., 2013).  
This compound inhibited iNOS and COX-2 expression, NO, PGE2, TNF-α, NF-κB activation and 
MAPKs phophorylation (Chun et al., 2012). 
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In vivo, 25 – 100 mg/kg 
BW orally, N/A  
In vitro, 5 – 20 M, N/A 
 
 
Cell culture, 1- 10 M, 
N/A 
Cell culture, 1 – 50 M, 
N/A 
 
In C57BL/6 mice, alantolactone inhibited CYP3A4 and CYP2C19. In liver microsomes, the 
compound exhibited a potent inhibition of CYP3A4 (IC50 = 3.6 M), moderate inhibition of 
CYP2C19 (IC50 = 37 M), but no inhibition for CYP2A6, CYP2C9, and CYP2D6. It also 
suppressed gene expression of CYP3A1 and CYP2C39, but not CYP2A4, CYP2D22, and 
CYP2C37 (Qin et al., 2015).  
The treatment induced antioxidant enzymes; QR, GST, -GCS, GR, and HMOX-1, and Nrf2 
nuclear translocation in Hepa1c1c7 mouse hepatoma cells (Seo et al., 2008). 
The IC50 value for glioblastoma cells U87, U251, U118, and SH-SY5Y proliferation inhibition 
were 20, 16, 29, and 24 μM, respectively. It also suppressed cell migration, invasion, induced  
the expression of caspase-3, -9, Bax, PARP cleavage, while decreased Bcl-2 expression of 
U87 and U251 cells (Wang et al., 2017b).   
Isoalantolactone Cell culture, 1 – 10 M, 
tBHQ (pos) 
 
The treatment induced QR activity to almost two folds in Hepa1c1c7 and its mutant BPRc1 
cells. It also increased protein expressions of GR, -GCS, GST, and HMOX-1 (-tubulin was 
used as a loading control) and Nrf2 nuclear translocation in Hepa1c1c7 and BPRc1 cells (Seo 






Unripe fruit: treatment of blood 
problems 
Methanol extract 
of the fruit 
In vitro, 0.1 – 10 g/ml, 
baicalein and curcumin 
(pos) 
 
In vitro, 0 – 120 g/ml,  
In vivo, 50 – 200 mg/kg 
BW orally, saline (con), 
desirox (pos) 
The extract protected against OGD-R induced and H2O2-induced cell death, reduced lipid 
peroxidation in thiobarbutic assay in rat pheochromocytoma cells (PC12) cells. It also reduced 
LPS-induced cell death and NO production in BV2 cells and scavenged DPPH free radical 
(Gaire et al., 2013).  
It exhibited considerable iron chelation activity and DNA protection in vitro. In vivo, it reduced 
the elevated ALT, AST, alkaline phosphatase, and bilirubin caused by iron-dextran, as well as 
alleviated the decreased levels of liver SOD, CAT, GST, and non-enzymatic GSH in Swiss 
albino mice (Sarkar et al., 2012).  
Methanol 
fraction of the 
total extract 
In vivo, 25 and 50 mg/kg 
BW gavage, saline (con) 
 
 
In vivo, 25 and 50 mg/kg 
BW gavage, saline (con) 
The treatment protected from Fe-NTA-induced and DEN-induced renal carcinogenesis and 
oxidative damage in Wistar rats by restoration of the levels of GSH and cellular protective 
enzymes and reduction of MDA formation and hydrogen peroxide content. Moreover, it inhibited 
ornithine decarboxylase activity and DNA synthesis (Prasad et al., 2007). 
The pretreatment suppressed NiCl2-induced damage by reduction of the elevated GSH, GST, 
GR, LPO, H2O2 generation, BUN, serum creatinine, DNA synthesis, and ODC activity, as well 
as, the decreased GPx (Prasad et al., 2006).  
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Plants Traditional uses  
(from Khamphi Sappakhunya) 
Extracts/ active 
ingredients 
Model, doses, controls Chemopreventive effect 
Water extract of 
the fruit 










In vivo, 200 mg/kg BW 




After 5 hours-treatment in lymphoma Jurkat cells, the extract suppressed protein expressions 
of -tubulin, RCHY1, IGF1R, and HSP70, which may negatively affect lymphoma cells. IPA 
analysis also identified interacting proteins that were associated in the inhibition of NF-kB 
signalling by the extract (Das et al., 2012). This proteomic study confirmed the result from (Das 
et al., 2011) that reported NF-kB inhibitory activity of the extract.   
The extract showed strong DPPH radical scavenging activity with IC50 value of 1.52 g/ml and 
inhibited CuSO4-induced lipid peroxidation. In RAW 264.7 cells, NO production and expressions 
of iNOS and COX-2 induced by LPS were suppressed by the extract (from 50 g/ml). In 
vascular smooth muscle cells, the extract (from 50 g/ml) inhibited cell proliferation and 
migration induced by platelet-derived growth factor (PDGF-BB) (Lee et al., 2015b).   
The extract reduced mitochondrial lipid peroxidation, lipofuscin (LF), protein carbonyls (PCO), 
(xantine oxidase) XO in liver and kidney of both young rats and aged rats. In young rats, the 
treatment enhanced hepatic GST, G6PDH, GSH and renal GST and GSH. In old rats, it 
promoted MnSOD, GR, GST, G6PDH, GSH, vitamin C, and vitamin E in liver and kidney, while 
suppressed CAT and GPx in liver and kidney (Mahesh et al., 2009).  
Ethanol extract 
of the fruit 




In vitro, N/A, N/A 
Treatment with the extract protected isoproterenol-induced lipid peroxidation in plasma and 
heart tissue. Isoproterenol caused a reduction in serum GSH, ceruloplasmin, vitamin E, vitamin 
C, iron, PIBC, heart GSH, and antioxidant enzymes in heart tissues; GPx, GR, GST, SOD, and 
CAT in Wistar rats. The extract reversed these effects significantly (Suchalatha et al., 2005).  
IC50 values for COX-1 and COX-2 inhibition were 90 and 3.75 g/ml, respectively (Reddy et al., 
2009).  
Chebulic acid In vitro, 0.5 - 250 g/ml, 
N/A 
In  vitro, 1 – 100 g/ml, 
EGCG (pos)  
 
It showed strong DPPH radical scavenging activity with IC50 value of 1.1 g/ml and inhibited 
CuSO4-induced lipid peroxidation (Lee et al., 2015b). 
The compound showed a comparable ferric reducing antioxidant activity to EGCG. It decreased 
t-BHP-induced oxidative stress by reduction of %cell death, intracellular ROS, MDA formation, 
and GSSH/total glutathione ratio in primary rat hepatocytes (Lee et al., 2007).  
Chebulagic acid Cell culture, 0.001 – 100 
M, N/A 
 
In retinoblastoma cells Y79, IC50 value for cell proliferation inhibition was 50 M. At 50 M, the 
compound inhibited IkB, which results in the suppression of NF-kB nuclear translocation 
(Kumar et al., 2014).  
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Plants Traditional uses  
(from Khamphi Sappakhunya) 
Extracts/ active 
ingredients 
Model, doses, controls Chemopreventive effect 






In vitro, 1 – 50 M, N/A 
The compound exhibited promising cytoxicity towards various cancer cell lines; HCT-15 (colon), 
COLO-205 (colon), MDA-MB-231 (breast), DU-145 (prostate) and K562 (chronic myeloid 
leukemia) with IC50 values of 20, 18, 26, 28, and 30 M, respectively. It induced apoptosis and 
PARP cleavage in COLO-205 cells. It also strongly suppressed COX-2 and 5-LOX with IC50 
values of 0.92 and 2.1 M, respectively, and weaker inhibited COX-1 (IC50 = 15 M) (Reddy et 
al., 2009).   
The compound possessed antiangiogenic property by reduction of sprouting in rat aortic rings, 
downregulation of CD31 production, E-selection, and VEGF in HUVEC cells (Athira et al., 
2013). 
Note: con = control or vehicle, pos = positive control
 46 
Table 1-1 presents existing data for TTM drugs in the context of their use in cancer prevention. 
These medicinal plants exhibit promising activities to be developed to cancer prevention 
and/or chemopreventive agents, with garlic being the best example. The effects of the plants 
on antioxidant enzymes, apoptotic pathways, PARP (essential for DNA repairs), and NF-kB 
have been studied extensively. These targets are important for prevention of initiation, 
promotion, and progression of carcinogenesis.  
These botanical drugs could either be used in the traditional way (herbal combinations) or in 
newly developed preparations (e.g. capsules containing single plant powder). In general, TTM 
preparations usually contain between 3 to 70 botanical and other drugs. To translate results 
of a single plant to actual uses, we need to consider its use in a formulation, such as its ratio 
in the whole recipe and potential synergistic effects with other ingredients. If a single plant 
preparation were to be developed from a recipe, one should consider safety issues due to the 
higher amount than its traditional uses. Extracting methods used in the in vitro or in vivo 
studies need to be compared to traditional methods, which normally are decoction or ethanol-
water maceration, because phytochemical profiles would be different. In addition, some 
mechanisms have paradoxical effects, such as NF-kB inhibitors often suppress tumour 
necrosis factor (TNF) which could interfere immune response (Boik, 2001). Thus, it is 
necessary to see the effects in in vivo.   
TTM has potential to contribute to cancer prevention, not only because many plants have 
shown positive results before, but also the opportunities to perform research in the area are 
increasing. Firstly, TTM is widely accepted among Thai people for treating and preventing 
diseases. Secondly, herbal medicine used in TTM has a long history of use. Therefore, such 
usage could provide preliminary data on safety and effectiveness in order to choose high 
potential medicines for further exploration. Lastly, the Thai government has been keen to 
develop TTM and integrate it into the main health care system. In 2017, Thailand has had its 
first master plan for the development of Thai herbal medicine (Ministry of Public Health, 2017). 
This is a great opportunity to contribute to the sustainable development of Thai healthcare by 











A basic assumption of this study is that in order to prevent cancer, it is important to prevent 
cancer development at several mechanisms at the same time, as well as to maintain cell 
homeostasis. So holistic medicine like TTM which emphasizes maintaining the balance of the 
body and has been officially promoted in Thailand for health promotion fits well with the finding 
of natural sources for chemoprevention.      
This thesis aims to discover new extracts or compounds which could be useful in the 
prevention of cancer. An ethnopharmacological approach was used to investigate medicinal 
plants used in TTM. The project comprises two main parts; fieldwork and in vitro experiment. 
The specific objectives are as follows; 
1. To understand cancer prevention strategy from Thai traditional practitioners 
2. To document medicinal plants used by Thai traditional practitioners to prevent cancer 
3. To investigate chemopreventive properties of selected medicinal plant extracts in vitro 
using an ethnopharmacology approach 
4. To study the phytochemistry of selected species in order to identify bioactive 
metabolites responsible for the chemopreventive effects observed 
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Chapter 2 Thai traditional medicine concepts of 
cancer and approaches in cancer prevention:                                        
An ethnopharmacological field study 
‘Culture is at the heart of plant meaning’ 
Daniel E. Moerman & Ina Vandebroek,  
The Anthropology of Ethnopharmacology (Moerman and Vandebroek, 2015) 
2.1. Introduction  
In the past decades, Thai researchers have been excited about the number of ‘cancer therapy’ 
recorded in ancient texts. According to news published on 3rd of February 2014, Thawatchai 
Kamoltham, MD, Director General of Department of Thai Traditional and Alternative Medicine 
at the time announced “In our Thai traditional medicine database containing 12,428 herbal 
recipes for chronic diseases, there were 3,115 formulations used for treatment of cancer” 
(ASTV, 2014). This news aids to confirm that herbal medicine is a promising source to find 
cancer treatments. However, it also provokes the question ‘are they really for cancer?’. In 
global view, the vast majority of medicinal plants that are reported as cancer treatments in 
indigenous cultures are actually used for infectious conditions of the gastrointestinal tract, 
respiratory tract, and skin. For example, Heinrich et al. (1992) found that plants used to treat 
‘cancer’ referred by local people in Lowland Mixe, Mexico were actually used for chronic 
infectious skin conditions (Heinrich and Bremner, 2006). This calls for a systematic 
assessment of ‘what is cancer’ in the context of a traditional medical system and how this may 
be linked to experimental and preclinical research.  
Health care systems, both Biomedicine and traditional medicine, are considered cultural 
systems. Illness is presented as a combination of beliefs about disease causation, the 
experience of symptoms, specific patterns of illness behaviour, decisions regarding treatment 
options, actual therapeutic practices, and evaluations of treatment outcomes (Kleinman, 
1978). In folk medicine, medical concepts are usually complex and associated with social, 
cultural, historical, and linguistic aspects (Heinrich and Bremner, 2006). Moreover, they are 
often different from one society to another. For instance, the concept of benefits of bitter plants 
is different among cultures. A Dominican community believes that bitter plants ‘burn sugar in 
the blood’, therefore they are used for treatment of diabetes. Jamaican culture uses them for 
skin rashes and other skin problems because they believe that bitter plants could ‘cleanse the 
blood’ (Moerman and Vandebroek, 2015). In this project, one of our very first question was ‘Is 
cancer in TTM the same as cancer in biomedicine?’.  
2.1.1. Cross-cultural research and emic & etic concepts 
Ethnopharmacological research is cross-cultural as it is a combination of emic perceptions of 
local people and an etic perception of scientist-researchers and applied science methods. 
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Cross-cultural research scrutinizes local information and contrasts it with a global view. 
Therefore, this framework is useful in comparative studies aiming to find general patterns from 
different cultures and helps us to understand unique cultural characteristics. In addition, it may 
stand for transdisciplinary approaches that bridge knowledge from different cultural systems 
together and develop new perspectives based on an equal exchange (Heinrich and Jäger, 
2015). One example of cross-cultural studies is from Berger-González et al (2016) who 
studied Maya healers’ conception of cancer from five ethnolinguistic groups in Guatemala and 
compared with biomedicine. In Guatemala, most Maya people still rely on Maya healers and 
have poor compliance for Western medicine. This problem is partly caused by cultural 
disagreements with procedures used in hospitals. From the findings, the authors proposed 
that primary health care providers should understand the influence of Maya medicine 
(especially healing settings which normally comprise physical, spiritual, and social methods) 
on the behaviour of indigenous patients in order to improve compliance which leads to a more 
efficient and successful treatment, such as spiritual blessing of chemotherapy (Berger-
González et al., 2016).    
In Thai traditional medicine, as well as other traditional medical systems, diagnosis is based 
on observation and interpretation of patients’ symptoms, past history, causes, effects, and 
responses, mostly without objective information. On the other hand, in biomedicine, diagnosis 
relies on objective physical examinations together with patient's history and pathophysiology 
information obtained from laboratory. This results in cultural gaps between the two systems 
(Berger-González et al., 2016). To link information from TTM to experimental models in 
biomedicine, the ‘emic-etic concept’ has been applied. The terms emic and etic were originally 
coined in the context of anthropological research by Kenneth Pike in 1954. According to Pike 
“The etic viewpoint studies behaviour as from outside of a particular system, and as an 
essential initial approach to an alien system. The emic viewpoint results from studying 
behaviour as from inside the system.” (Pike, 1967). 
2.1.2. ‘Mareng’ - Cancer in Thai Traditional Medicine? 
In modern Thai, ‘mareng’ is the commonly used term for cancer. It is believed that the word is 
derived from ‘merengsa’ in Melayu which means untreatable ulcer. However, it is also used 
to refer to other diseases in TTM text books, which might or might not be cancer in a 
biomedical sense. In this study, the term ‘mareng’ was used when referring to a disease in 
TTM, which might or might not be the same with cancer. Cancer was used only when referring 
to biomedical diagnosis. 
The word ‘mareng’ was mentioned several times in Phaetthayasat Songkhro4. Each khamphi 
gives symptoms of illnesses, treatment options, and herbal remedy composition and its usage, 
which depends on the expertise of masters who wrote it  (Foundation for the promotion of Thai 
                                                     
4 A collection of ancient scripture (khamphi) which was published the first time in 1961. It is used 
nowadays as a manual for people studying Thai traditional medicine and pharmacy. 
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traditional medicine and Ayurved Thamrong School Center of applied Thai traditional 
medicine, 2007b). Among twenty manuscripts from the first volume, mareng was mentioned 
in five khamphi, namely Khamphi Chanthasat, Khamphi Maha Chotarat, Khamphi Chawadan, 
Khamphi Mutcha Pakkhantha, and Khamphi Takkasila.  
According to Khamphi Takkasila5, there are ten malignant sores (Fi Kan) which could occur 
along with toxic fevers, including Mareng Tamoi, Mareng Pakthum, and Mareng Pleo-fai-fa. It 
explains the symptoms of each as follows (the original text is shown in appendix I);    
 Mareng Tamoi – A nodule which has equal size to a thumb or a garden pea. The 
severe one has a white base and a black head. It causes shivering, watery eyes, or 
blurred vision. It occurs on the body, arms, or legs. The nodule must be treated as 
fast as possible, otherwise, a burst could cause death or develop into mareng.  
 Mareng Pakthum (or Mareng Thum) – A swollen nodule at the back, one side or 
both side. It has dark blue colour. If it is not cured, a burst could cause death or 
develop into Mareng Pak Mu. 
 Mareng Pleo-fai-fa (or Mareng Pleo-fai) – A nodule which has equal size to wong 
saba6. Its head is green. It causes a burning sensation. A burst causes death. 
Another one mentioned in the manuscript is Mareng Nakkharat which occurs on finger(s). Its 
size is varying, from a mung bean to a rock. It causes fever, shivering, watery eyes, blurred 
vision, headache, and a burning sensation. It also makes hands become black, and stops the 
heart beating. If hands and legs become black, patients will die. In Khamphi Maha Chotarat7, 
some postpartum complications8 are mentioned, such as obstruction of menstrual blood and 
menstrual blood clots, which might develop into internal Fi (nodule), such as Fi Mareng Suang 
Krasun.  
From the given examples, it can be seen that a dangerous nodule or later stage of some 
conditions are common symptoms of mareng. And this might be the reason why modern Thai 
physicians translated tumours “wounds that do not heal (Dvorak, 1986)” as mareng. There 
are also some conditions in the old texts that are similar to the symptoms of some forms of 
cancer. For instance, the symptoms of liver with impaired earth element include lower position 
of liver, nodules in liver, blood in the stool, abdominal pain, red eye, coughing, panting, and 
loss of appetite (Foundation for the promotion of Thai traditional medicine and Ayurved 
Thamrong School Center of applied Thai traditional medicine, 2007b), which are similar to 
those of liver cancer (American Cancer Society, 2014). According to Khamphi Roknithan, Ben-
                                                     
5 An ancient Thai medical manuscript about toxic fevers (unknown date). 
6 Fruits of Entada phaseoloides (L.) Merr.. Approximate size is 1 x 6 x 0.3 cm. 
7 An ancient Thai medical manuscript about female diseases (unknown date). 
8 After a woman gave birth, toxic blood occurring during the delivery should not be left in the body. If 
there are some remains, it becomes rotten. Rotten blood can circulate back into the heart and cause 
several symptoms, such as fever or madness.  
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cha-am-ma-rit9 is one of the remedies used for these conditions. Early 2014, this medicine 
was featured in local newspapers as a medicine that can be used to treat liver cancer (Variety 
team, 2014), resulting in a lot of liver cancer patients seeking for it. Although it helps in the 
relief of some symptoms, such as uncomfortable and swelling abdomen, the use of the drug 
alone caused a huge concern from many academics and health sectors, especially TTM 
practitioners. According to TTM, this remedy is used to remove waste from the body which is 
usually the very first step in any disease treatment. Moreover, it must be used together with 
other remedies to treat diseases and support the body (Temsiririkkul, 2014).  
Although there is a lack of scientific evidence to support the use of Thai traditional drugs in 
cancer, there have been many experiences and anecdotal evidence of their benefits towards 
cancer. Therefore, we believe that TTM is potentially a good source for cancer treatment and, 
more importantly, prevention. However, we need to understand its concept of cancer in order 
to use it properly. Such understanding will also provide a great potential to find novel treatment 
or prevention for cancer.   
2.1.3. Objectives 
The first objective of this field work is to understand Thai traditional practitioners’ perceptions 
of cancer in the definition, causes, diagnosis, treatment, and prevention, as no one ever 
systematically studied it before. The second goal is to document medicinal plants used to treat 
and prevent cancer in order to find potential plants for further pharmacological investigation. 
The ultimate aim is to provide a documentation that preserves the knowledge and offers an 
opportunity for TTM practitioners to discuss and improve it in the future. 
2.2. Methods  
2.2.1. Ethnopharmacological field survey 
Information from TTM practitioners living in different parts of Thailand was collected. The 
surveys were carried out during December 2013 – April 2014. The project has been approved 
by the UCL Research Ethics Committee, Project ID: 5068/001, and Siriraj Institutional Review 
Board (Thailand), Protocol number 779/2556(EC4). All data were collected and stored in 
accordance with the Data Protection Act 1998.    
2.2.1.1. Location of ethnopharmacological surveys 
The field work was conducted in five provinces in Thailand, namely Lamphun which is located 
in the north; Suratthani which is located in the south; Chanthaburi which is located in the east; 
and Bangkok Metropolitan Region (Bangkok and the five adjacent provinces of Nakhon 
Pathom, Pathum Thani, Nonthaburi, Samut Prakan, and Samut Sakhon) which is located in 
the centre (Figure 2-1). We chose the locations from different regions because the healing 
                                                     
9 Ingredients: mahahing (Ferula assa-foetida L.), yadam (dried latex from Aloe spp.), rongthong (resin 
from Garcinia hanburyi Hook.f.), tongtaek (Baliospermum solanifolium (Burm.) Suresh), di-kluea (epsom 
salt) 
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practice may be influenced by indigenous medicine, local culture, and religion, even though 
some influences from written sources may be of relevance. For instance, Northern Thailand 
was influenced by Lanna culture, some parts of Eastern Thailand were influenced by Khmer, 
and most parts of Southern Thailand were influenced by Islam. Each part of the country also 
has different food cultures. 
 
Figure 2-1 Interview locations in green colour. (Map modified from Wikimedia commons) 
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2.2.1.2. Data collection by interviews  
An interview guide (Table 2-1) was prepared in advance in English and Thai versions. The 
word ‘mareng’ was used in the guide (also in the interviews) as it is commonly used to refer 
to cancer in modern Thai. To validate the Thai version of the interview guide, other Thai 
students in the UCL School of Pharmacy who did not know about the project helped in the 
translation back from Thai to English. This English translation was then compared to the 
original English version.  
To recruit participants, we went to locations that are known to be home of the practitioners 
and visited them. To obtain their addresses, we asked our colleagues who work at Center of 
Applied Thai Traditional Medicine, Faculty of Medicine Siriraj Hospital (CATTM, Bangkok), 
Tharongchang Hospital (Suratthani) and Phrapokklao Hospital (Chantaburi), villagers, and 
local herbal dispensaries.  
Semi-structured, open-style interviews with 33 TTM practitioners were performed in an open-
style in informal settings, such as at practitioners’ houses. All interviews were performed in 
Thai language. Prior to each interview, the informants were informed about the aims of the 
project and were advised that they could withdraw at any point. Informed consent and a 
permission to record the conversation were also obtained.  
 
 




Table 2-1 Interview questions 





1.5. Expertise (eg. spiritual healers, herbalists, bone healers, or masseurs.) 
1.6. How long have you worked as a Thai traditional practitioner? How long have you been 
treating? 
1.7. What is the average number of patients per week or per month? 
2. What is the symptom that you treat most? 
3. Please list herbs that most important to you or that you frequently use. 
4. Is there anything to eat to protect from diseases? 
5. Please describe ‘mareng’: 
5.1. What is ‘mareng’? 
5.2. What is the cause of ‘mareng’? 
5.3. How do you know that somebody has ‘mareng’? 
5.4. How often that you treat patients with ‘mareng’? 
5.5. Please tell me about ‘mareng’ that you have experience with. 
5.5.1. Please describe how did you diagnose or identify it?  
5.5.2. What were the main symptoms? 
5.5.3. What plants did you use to treat it? 
5.5.4. What was the dosage regimen?  
5.5.5. How long did the remedy take to make patients feel better? 
5.6. What is the theory or treatment concept of ‘mareng’? 
5.7. Can ‘mareng’ be prevented? How? 
6. How do you select the plants or medicines for each patient? 
7. How have you learned about the use of this medicine/ plants? 
8. How do you obtain the plants? Buy, grow, collect? 
9. Can you give or show me the plants? 
 
2.2.1.3. Plant sample collections and identifications 
After each interview, the informant was asked to show the mentioned plants. Then the living 
plant samples were photographed and collected, with the informants’ permission, into plastic 
bags with some water inside. All possible parts of the plants were collected, including roots, 
stems, twigs, leaves, fruits, and flowers. However, in many cases roots, flowers, and fruits 
were not available. For these cases a description of the flowers and fruits was obtained in 
order to help with the identification. The voucher specimens were labeled with local name, 
common name, date of collection, locality, habitat, and other notes, such as height, presence 
of saps (‘rubber’), bark feature, smell, and colour of fresh fruits and flowers. When the living 
plants were not available, especially for introduced species, dried crude drugs were 
photographed and collected instead. In addition, some specimens were collected from local 
botanical gardens, including Chanthaburi botanical garden (Chanthaburi), Siri Ruckkhachati 
Nature Park (Salaya Campus, Mahidol University), and Suan Chalerm Phrakiat (Faculty of 
Medicine Siriraj Hospital). 
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Figure 2-3 Plant voucher specimens collection 
 
Identification of voucher specimens was done by comparison with books, monographs, or 
authentic specimens from botanical gardens with help from experienced TTM practitioners 
from CATTM. Imported crude drugs were identified by comparing macroscopic features and 
thin layer chromatography fingerprints with authentic materials obtained from Sun Ten 
Pharmaceutical Co., Ltd. (provided by Dr. Anthony Booker). Some common food plants, such 
as ginger, garlic, shallot, and mung bean were not collected. Plant voucher specimens were 
deposited at Faculty of Pharmacy, Mahidol University, Bangkok, Thailand. 
In addition, some informants were re-visited or called to get more information, such as the 
colour of flowers, in order to confirm or help in identification of the plant species. During the 
re-visits, we asked them to look at plant samples or pictures from textbooks/monographs and 
tell us the plant names. We also asked them to prepare some crude drugs for us to buy.   
2.2.1.4. Analysis of qualitative data 
All interviews were recorded, transcribed, and translated into English with the help from 
CATTM. The medical terms used in this report were translated to English in two steps; from 
Thai traditional medical terms to modern Thai, and then from modern Thai to English. Data 
grouping and association was used for the qualitative analysis of the data. Medicinal plants 
were ranked according to the frequency of citation (FC) (so called ‘number of use-reports’) as 
it is recommended as a tool to select candidates for further bioactivity investigation (Heinrich 
and Jäger, 2015). FC of specie A is calculated by counting the number of informants who 
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mentioned that A is useful. Relative Frequency of Citation (RFC) was calculated by dividing 
FC with the total number of informants participating in the study. The use of RFC is to give the 
information of relative importance of each species (Tardío and Pardo-de-Santayana, 2008).   
2.2.2. Plants selection for pharmacological and phytochemical studies  
The selection strategy of species for further bioactivity investigation is shown in Figure 2-4. 
The first step was to include all the plants mentioned by the informants. The second step was 
to separate only the plants used in cancer/disease prevention as this is the focus of this thesis. 
Then some criteria were applied to obtain samples to be investigated. 
 
Figure 2-4 Selection strategy of plant samples for further bioactivity investigations. The selection 
criteria in the third steps were 1) the plants are not endangered species AND 2) the plants can be 
sustainably supplied by local people AND 3) the plants were mentioned by at least two informants. 
AND 4) the plants have not been studied extensively with regards to their chemopreventive activities. 
 
2.3. Results and discussion  
2.3.1. Informants’ characteristics 
Thirty-three informants were interviewed independently. Each interview lasted about 1-3 
hours. Informants’ general characteristics are shown in Table 2-2. Most of them were male 
(73%). This might be a result of a local belief in some locations that healers should have been 
in a monkhood before. Thirty informants out of thirty-three treat at home or private clinics and 
three of them work in public hospitals. Most of them learned their practice from family 
members. Herbal medicine was the main treatment in general. Physical methods, such as 
massage, and spiritual approaches, such as ritual blessing, are used together with herbal 
medicine in some cases.  
 
Medicinal plants mentioned by the informants





Table 2-2 Informants’ characteristics 
Parameters  Results 
Gender (N) Female 9 
 Male 24 
Age (years) Min 31 
 Max 96 
 Average+SD 64.3 +14.7 
Treatment experience (years) 1 - 20 14 
 21 – 40 11 
 41 – 60 6 
 61 - 80 2 
Types of expertise (N) Herbal medicine 31 
 Physical methods 8 
 Spiritual approach 5 
Major source of knowledge 
about therapeutic practice 
Family 19 
 
Masters (not from the family) 6 
 TTM school 5 
 Scriptures/ textbooks 2 
 Buddhist temple 1 
 
Figure 2-5 The house of an informant was full of dried herbs, ready to prescribe to patients. Each jar 
contains one herb, labelled with its local name. Herbs were mainly from the informant’s own garden or 
herbal shops in the area.  
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Figure 2-6 One informant and his assistant were repelling ‘phi’ (a ghost or bad spirit) from a patient. 
The assistant (left, standing) was spitting holy water onto the forehead of the patient. 
 
2.3.2. Informants’ cancer experiences  
Twenty-nine out of thirty-three informants (87.87%) have had experience in cancer treatment. 
Three practitioners (9.10%) have been visited by cancer patients but the practitioners refused 
to give the treatment, instead, they referred those patients to another practitioner in the same 
area because they are better than them in cancer care. One informant (3.03%) has never 
been visited by any cancer patients before the interview. In general, cancer patients who have 
visited the informants were those with cancer of the lung, uterus, liver, breast, colon, neck, 
bone, cervix, trachea, pancreas, nose, blood, prostate, skin, and lymphoma. The most 
common types were liver, uterine, lung, and breast cancer.    
Cancer patients who have visited the informants commonly come at an advanced stage or 
because they do not want to have surgery to remove tumours, or have been rejected or 
discontinued cancer treatments in hospitals due to the treatment guidelines that give priority 
to palliative care in incurable cases.  
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Figure 2-7 Medical records. An informant has monthly medical records (A) and medical records for 
each patient (B) in some cases. In this figure, (B) shows a medical record for a neck cancer patient. 
 
2.3.3. Local concept of cancer and causes 
‘Mareng’ is commonly used to refer to cancer in modern Thai. However, it is also used to refer 
to other diseases in old TTM text books, which might or might not be cancer in a biomedical 
sense. It is believed that the word is derived from ‘merengsa’ in Melayu which means 
untreatable ulcer. In this study, the term ‘mareng’ was used when referring to a disease in 
TTM, which might or might not be the same with cancer. Cancer was used only when referring 
to biomedical diagnosis.  
As the informants had various views on mareng, case studies were found to be the best way 
to represent their knowledge on causes, diagnosis, treatment, and prevention of mareng. The 
following case studies contain both informants’ existing knowledge about mareng and some 
examples of their passed/current cases. A short detailed portrait of each informant was also 
included. These case studies represent perception of TTM practitioners on causes, diagnosis, 
treatment, and prevention of mareng. Summary of the main concept of mareng of each 
informant was also given.  
2.3.3.1. Case studies 
Informant A – Mareng is linked with inflammation, blood circulation, chronic conditions, 
microorganisms, and chemicals 
Informant A studied TTM from a TTM school and graduated with a Bachelor in TTM. Later 
she also studied Thai traditional massage. She has had experience in TTM for around 
10 years. Before running her own clinic, she used to work for a clinic in which she said 
‘cancer patients were the majority because the place was famous in cancer care’. She 
takes care of herbal medicine production by herself and she got the formulations from 
ancient Thai medical textbooks. Her father is also a TTM practitioner.   
A B 
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“In general, mareng is caused by internal inflammation (kan aksep) and microorganisms. 
These microorganisms cause wounds or abscesses in the lungs or the liver. When the 
body cannot fix it or we intake toxins, the wounds will be bigger and distribute to lymph 
nodes, and then to other organs. In summary, if we have a chronic condition and our 
body cannot fix it, that condition will become mareng. 
Mareng in the breast is caused by an obstruction of blood and lom. In the early stage, we 
would find hard lumps, pain in the arms, and headaches. Once there is the obstruction 
of blood, phangphued (fibrosis) would develop and grow bigger if we don’t treat it. If the 
obstruction continues, waste will accumulate locally. When microorganisms or chemicals 
get inside, mareng will develop. For the treatment, I use herbal remedies which help 
improving blood circulation, eliminate the phangphued, and detoxify the chemicals and 
microorganisms. The recipe for phangphued comprises thaowanpriang, khokhlan, 
phimsen (borneol camphor), and karabun (camphor). The patients will defecate every 
day to remove the waste. Normally after a month, the lumps will be softer and smaller, 
and will eventually disappear. 
I’ve also treated a case with lung cancer. The patient has received chemotherapy 14 
times already before starting TTM therapy with me. I’ve prescribed a detoxifying remedy 
for the first seven days to wash away chemotherapy. It can be noticed that the patient’s 
face was brighter and he was less tired, could eat, and had less chest pain. Then I 
prescribed medicine to treat lung diseases and kill mareng.  
For mareng in the colon, patients will start with detoxifying remedy for three days. Then 
they will be prescribed mareng remedy together with ulcer treatment. I also have to treat 
other symptoms, such as diarrhoea, indigestion, flatulence, constipation, and bulging 
stomach which are common co-symptoms of mareng in the colon.  
In general, mareng patients must take medicines that adjust the elements and remove 
waste, together with mareng remedy. Herbs for mareng cannot be hot, but it also depends 
on the type of abnormal elements. I have only one mareng remedy for which the main 
ingredients are kammathandaeng (arsenic disulphide), kammathanlueang (sulphur), 
khaoyennuea, khaoyentai, khanthongphayabat, horathaosunak, khanunsampalo, and 
makhampom. I will add other related remedies, such as liver remedies for patients with 
mareng in the liver. Moreover, I will also add massage to facilitate the blood circulation 
which benefits the treatment because it pushes the medicine and immunity into tumours. 
The most important thing is to remove accumulated toxins and waste.  
To prevent mareng, we have to remove toxins daily because we intake them with food. 
Mareng prevention can also be personalized. For instance, patients with chronic gastric 
ulcer should take a herbal medicine that heals wounds in the stomach and intestine and 
detoxifies. Detoxification is the most important step. Also we have to eat properly; like eat 
five, and avoid food that cause mareng, such as internal organs, processed food, eg. 
sausages, and bamboo shoots.” 
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Informant B – Mareng is linked to the imbalance of elements and chronic conditions (krasai)  
Informant B learned the practice from his aunt. The knowledge has been passed down 
from generations to generations in his family. He became his aunt’s successor in the 
family’s Thai traditional medical clinic. He has helped his aunt since he was a child in 
their pharmacy. Before he took his aunt’s place, he studied the clinical practice beside 
his aunt for many years. Now he has been treating patients for more than 10 years. 
“In TTM, a disease happens because of abnormal tridosha. To treat a disease, we have 
to re-balance tridosha and then the earth element will become normal. Every disease is 
treated like this, including mareng. 
Mareng is a familial condition that makes a person have an abnormal organ from the 
beginning. So this kind of disease cannot be prevented because it is already in the blood. 
However, we could suppress its emergence by preventing krasai. A person can develop 
krasai when he/she has a chronic condition. A general method to prevent krasai is to eat 
green mung beans boiled with rangchued, triphala10, and sugar. This is a gentle way to 
wash away poisons to prevent krasai with the aim to prevent mareng. 
An example of mareng diagnosis: a patient visited me last week with creamy white 
vaginal discharge during the menstrual cycle. I performed an examination (touching) and 
could feel lumps in her cervix. Together with other symptoms, I suspected mareng in the 
uterus. So I asked this patient to check up with the hospital (at the time of the interview 
we did not know the result yet). The most important symptom which leads to mareng 
diagnosis in this case was the history that the patient has had abnormal vaginal discharge 
during the menstrual cycle and dysmenorrhea for a long time. I did not tell her that I 
suspected mareng because she would not believe me. 
A case where I have suggested mareng prevention is a friend of mine who has a familial 
history of liver diseases. His parent had liver cancer and his brother died because of a 
liver disease. I knew that he would develop a liver disease in the future. So I 
recommended him to take care of the liver by having a diet that good for the liver and 
taking a liver remedy every 2 weeks. I also check the signs of liver diseases, such as 
tiredness, feeling sleepy, not eating, flatulence, and white tongue. If he has these signs, 
liver remedy will be prescribed immediately. For the food, he should not eat spicy food 
and try to eat bitter food more. He also had to take a remedy to wash away poisons in 
blood every three months to prevent precipitation in blood and namlueang. Furthermore, 
he has to take ‘Ya-klom-nang-non’ to nourish the liver for one week every month.   
For lung cancer treatment, I start with detoxification of the lung. The medicinal plants 
have to be those that get into the lungs, such as yamornoi and bird nests. When I treat 
                                                     
10 A mixture of the fruits from Phyllanthus emblica L. (Phyllanthaceae), Terminalia bellirica (Gaertn.) 
Roxb. (Combretaceae), and Terminalia chebula Retz. (Combretaceae) 
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cancer patients, I always tell them to use my prescribed herbal medicines together with 
conventional treatment, but do not tell their doctors otherwise they will be asked to stop 
herbal remedies. I prefer to use both together because each has its advantages. Herbal 
medicine only might not be fast enough to kill the tumours. Conventional treatment is very 
fast. For patients who are taking chemotherapy, I have to prescribe nourishment because 
their bodies will be very weak.” 
Informant C – Mareng is linked with inflammation, fire element, abnormal namlueang, and 
chronic bruises 
Informant C has practiced TTM for 28 years. When she was young, she always went with 
her uncle, who was a TTM practitioner, to treat patients. She decided to become a TTM 
practitioner when she was 16 years old. 
“Mareng is caused by a severe inflammation. The fire element is fully activated. There 
are two conditions that cause mareng. One is from abnormal namlueang which is caused 
by over-activated fire element. The second one is from a chronic bruise. A blood clot that 
has deposited for a long time could develop to mareng. 
I have experience in treating mareng in the breast. The remedy comprises drugs for 
namlueang conditions, including khaoyen (means khaoyennuea and khaoyentai), 
haoyang, nontaiyak, kammathanlueang, and a charcoal. Patients have to stop using this 
medicine once they have recovered because this drug affects neurological system. Some 
patients took three pots and they recovered.   
Mareng could be prevented by changing habits; no stress. Fruits and vegetables which 
have cooling effects (they have ‘cold taste’ in TTM) can help because mareng is related 
to fire element.” 
Informant D – Mareng is linked with chemicals and chronic mahok.  
Informant D is a Lanna healer. Lanna medicine is practiced widely by TTM practitioners 
in the North of Thailand. He obtained the knowledge from his ancestors and also from a 
famous master in the area. He has had his license for TTM practice for more than 20 
years. 
“Mareng is caused by lom saan or lom khaan. My master said that smoking causes khaan 
to eat liver and lung. Mareng in the liver is caused by khaan eating liver. The cause of 
mareng is food, such as vegetables contaminated with chemicals. Long term mahok 
could develop into mareng. Patients who have lom khaan will have pains. There are 
several khaan; some cause pale faces or yellow or thin. 
Patients with mareng in the liver have yellow skin and vomit after eating. I treat them by 
asking them to drink nammon (holy water) and rangchued drink or phakkhaotong drink 
or a decoction of kasalong, oidam, and yapakkhwai. 
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Patients with mareng in the intestine have stomach pain, twisted intestine, gas, and 
flatulence, which are similar to mahok in the intestine. The treatment is drinking holy 
water and a decoction of kasalong, sugar cane, and yapakkhwai. 
To prevent from a disease, we could drink a decoction from boiled rangchued with rice, 
or kasalong-sugar cane-yapakkhwai, or have an herbal steam bath.” 
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Table 2-3 Summary of informants’ perception of cancer and causes 




BK1 1) Mareng is caused by internal inflammation and microorganisms*. These microorganisms cause wound or abscess in lung or 
liver. When the body cannot fix it or we intake toxins, the wounds will be bigger and distribute to lymph nodes, and then to other 
organs.  
2) Chronic conditions.  
3) Mareng in the breast is caused by an obstruction of blood and wind.  
4) Difference in defected elements cause different type of mareng. 
5) External mareng is caused by blood and lymph. 
6) Internal mareng is caused by the microorganisms that get to lung and liver. 




They could be 
bacteria or viruses or 
fungi or worms.  
BK2 Mareng is a familial condition. We could suppress its emergence by preventing krasai. A person can develop krasai when he/she has 
a chronic condition. For instance, a diabetic patient would develop krasai in the kidney. 
 
BK3 Mareng is caused by the imbalance of the four elements (dhātu si phikan). The imbalance starts with fire or wind or water element 
and then finally affect the earth element. Mareng patients have problems with their luead/ namlueang system. According to old texts, 
such as Takkasila and Wat Pho, it might be a type of skin disease.  
 
CH1 It is caused by food (especially meat), chemicals, and toxicants. 
Mareng Fai – caused by bad blood and lymph or got bitten by ticks 
Mareng Rai – caused by mites that carry mareng* 
*From the 
explanation, mareng 
is transferable like 
bacteria or viruses or 
worms.  
CH2 Mareng medluead (blood cancer) is caused by the imbalance of blood cells. They eat each other. It’s from genetics. Very difficult to 
prevent.  
 
CH3 Mareng is caused by an obstruction of toxic luead or namlueang in each part of the body.  
CH4 It is caused by a severe inflammation. The fire element is fully activated. There are two conditions that cause mareng. One is from 
abnormal namlueang which is caused by over-activated fire element. The second one is from a chronic bruise. A blood clot that has 






CH5 Mareng is caused by chronic bruises. Mareng in the colon is caused by food. Mareng in the uterus is caused by bruises of the uterus. 
When the uterus moves for a long term (eg. by jumping), the inflammation occurs and it becomes swollen. Chronic bruises form 
discharge which then turn into sticky rubber. When eat something which causes non-stop bleeding (eg shallot, garlic), the blood will 
mix together with the sticky liquid and form a clot. Chronic clots suppress fire element, which results in indigestion of food. Then wind 
element will ascend. After giving birth to two children, uterus will become very bruising and that when mareng develops.  
 
CH6 Mareng is a cell that grows abnormally. It is caused by namlueang. We have more than 3,000 lymph nodes. If the lymph nodes are 
good, we will not get allergy easily. Some symptoms like urticaria, rash, or diarrhea are symptoms of mareng. It distributes fast because 
it eats white blood cells, so patients don’t have immunity to fight it. 
 
CH7 Tua developed within the four elements causes an inflammation by an interaction with toxic food that we eat. When there is an 
imbalance of the elements cancer would develop. It can be treated when it just newly developed. 
 
CH8 Mareng is caused by eating food contaminated with germs.  
CH9 An abscess that is difficult to cure or chronic shingles can develop to mareng. The cause is an accumulation of microorganisms or 
chemicals. 
 
LA1 Bruises and shingles are mareng. We call it ‘ma-eng’ which is external mareng.  
LA2 Mareng is saan in Northern Thai dialect. Saan is something that cause an abnormality of the body, such as shingles is mareng in the 
skin. Some saan cannot be seen, such as mareng in the intestine and mareng in the uterus. The causes of saan are many, such as 
poisons, abnormal secretion from the body, food, or genetics. 
 
LA3 Mareng is caused by lom saan or lom khaan. My master said that smoking causes khaan to eat liver and lung. Mareng in the liver is 
caused by khaan eating liver. The cause of mareng is food, such as vegetables contaminated with chemicals. Long term mahok* 
could develop to mareng. 
*Mahok is a disease 
which causes 
different symptoms 
depending on the 
affected area of the 
body, such as mahok 
in the intestine have 
similar symptom with 






LA4 Mareng is involved with allergy.   
LA5 We don’t know what cause mareng. It is developed from wind. This wind distributes throughout the body and causes pain. When it 
stops, it causes daan* and fi. Nowadays all fi are called mareng. 
*Daan (ดาน) = a lump 
LA6 Mareng is caused by sunlight and phayat* *Phayat (พยาธิ) in 
modern Thai refers to 
a worm. In TTM, it 
means illness. 
LA7 Mareng in the intestine is from khaan in the stomach that invade to the intestine.  
LA8 Mareng is saan. It might be caused by beef and catfishes.  
LA9 Mareng is poisonous lom*. It is caused by genetics and food.  *Lom is literally 
translated as wind. 
But in this context it 
should mean wind in 
the body, which could 
involve with wind 
element.   
SU1 Merang is a type of phayat. Sometimes they are visible but sometimes not. They are in the environment. Mareng in the breast is 
caused by inflammation of breast.   
 
SU2 Mareng is any disease, which progresses very fast. The cause of the disease is unknown.   
SU3 Mareng is from abscess.   
SU5 Chronic wound would develop to mareng. When a wound expose with fungi or chemicals, it would become untreatable and distribute.  





SU7 Mareng is caused by bad immune system. Therefore, wounds or abscess can progress.  
SU8 Mareng is caused by something in the spinal cord.  
SU9 Mareng is caused by improper eating habit, such as rotten food, black cooking oil, preserved food   
 
Table 2-4 Summary of cancer diagnosis by Thai traditional practitioners 




BK1 Beside from looking at the symptoms, I ask about their habits, such as what did they eat, what they smelled, as well as cancer history in 
the family because the disease passes through genetics. 
 
BK2 For example, a patient visited me last week with creamy white vaginal discharge during the menstrual cycle. I performed an examination 
(touching) and could feel lumps in her cervix. Together with other symptoms, I suspected mareng in the uterus. So I asked this patient to 
check up with the hospital (at the time of the interview we did not know the results yet). The most important symptom which leads to the 
diagnosis of mareng in this case was the history that the patient has had abnormal vaginal discharge during the menstrual cycle and 
dysmenorrhea for a long time. I did not tell her that I suspected mareng because she would not believe me. 
 
BK3 I’ve never diagnosed mareng myself, normally patients came already with the diagnosis. I just use TTM to help them. However, I still 
examine them with TTM methods to see which elements are defective and correct those elements. 
 
CH1 The symptoms of some mareng are described below; 
Mareng Kam Chang – open wounds with black edges in oral cavity and painful 
Mareng Fai – it is a skin condition with blackened skin (like burnt wound). Hot and painful. 
Mareng Rai – open wounds which distribute very fast (like in a day), itching, thick edges together with rotten flesh. If not treated, it will 






Mareng Pak Moo – chronic wounds (years), 2-3 cm deep, hot and painful, not itching 
Mareng Lamsen – occurs internally, local swollen tendon or ligaments,  the whole body aches regardless the affected location  
Every mareng wound is hot and painful, and bloody because the blood was bad.  
CH2 I use a spiritual method called Pheng Kasin (เพ่งกษิณ) where the patient’s spirit is invited to give information about the illness.  
CH3 Most cancer patients have been diagnosed with cancer already from the hospital.  
CH4 I check symptoms. For instance, patients who have mareng in the breast have several small nodules which will be bigger one year later. 
The nodules do not move. If they move, they are not mareng, they are cysts.  
 
CH5 I check symptoms. However, cancer patients who came here always came in a critical condition.   
CH8 The main symptoms are lumps and bleedings.  
LA1 The symptoms are feeling hot and cannot eat. I will also ask what they ate. If they’ve eaten prohibited food, they got mareng.  
LA2 We could see rashes or lumps in some types of mareng, but for mareng inside we cannot see. In the latter cases, patients have to be 
diagnosed with cancer from the hospital.  
 
LA3 Patients who have lom khaan will have pains. There are several khaan; some cause pale face or yellow or thin. Patients with mareng in 
the liver have yellow skin and vomit after eating. Patients with mareng in the intestine have stomach pain, twisted intestine, gas, and 
flatulence, which are similar with mahok in the intestine.  
 
LA4 Mareng produces a lot of heat. For instance, patients with mareng in the skin have nodules with heat which is different from a skin 
disease. In general, the symptoms of mareng are pain, heat, and fever.  
 
LA5 Stomach ache and have daan.  





LA7 We call it saan. Pain is the symptom of saan lom. Western doctors call it tumour. We could see saan. But for saan inside the body, we 
could not see. We would know it after a diagnosis from the hospital. 
Lom = wind 
LA9 Patients with mareng have hot flushes and difficulties in excretion.  
SU1 We can know that someone has mareng when they have a condition, which does not respond to any treatment.   
SU2 I’m not an expert in mareng treatment. The symptoms of mareng patients that I know are that they are thin, have muscle pain, internal 
abscess, and cough with blood.    
 
SU3 Stomach pain is an important symptom of patients with mareng in the liver. We also have to know the colour of urine and feces.  
SU4 Chronic pain in stomach for more than a year. Chronic abnormal menstruation can develop mareng.    
SU5 Check symptoms, eg. patients with mareng in the uterus will feel itching and pain when urinate and have seeds in cervix.  
SU6 Yellow skin, thin, inside heat, tired, having difficulties in eating, dizzy, pain around cancer area  
SU7 Pain like being stabbed by needles, but not so often, around cancer area; tired, lack of appetite  
SU8 Common symptoms are tiredness and difficulty in eating and sleeping. I also check the pulse because cancer patients have a very fast 
pulse. 
 







Table 2-5 Summary of cancer treatment 
The questions used were ‘how often that you treat patients with mareng?/ what plants did you use to treat it?/ what was the dosage regimens?/ how long did the remedy take to 




BK1 In general, mareng patients must take medicines that adjust the elements and remove waste, together with mareng remedy. Herbs 
for mareng cannot be hot, but it also depends on which elements that are abnormal. Massage helps to facilitate the blood circulation 
which benefits the treatment because it pushes the medicine and immunity into tumours. The most important thing is to remove 
accumulated toxins and waste.  
 
BK2 We have to re-balance the elements. Start with tridosha* first and then earth element. Every disease is treated like this. For mareng, 
detoxification is the first step. We have to use herbs that go to the affected organ.  
*Tridosha means Pitta 
(fire), Vata (wind), and 
Semha (water). 
BK3 The treatment strategy is still the same with other diseases which are to nourish affected organs and relieve symptoms. I will prescribe 
herbal medicine and patients have to control the diet. Herbs that I use are for treatment of bad luead and namlueang. In general, I 
would use Yaharak, element adjustment remedy, intoxicated taste remedy, and blood nourishment remedy.  
 
CH1 - External mareng – we must catch mareng by putting cotton pads with coconut oil over the affected area and leave for 10-15 minutes. 
Then burn the pads. 
- For external mareng – make ashes from some herbal materials. Then mix with coconut oil and poultice. 
- Washing solution – break some herbal materials and soak in water. Wash the wound. Use freshly prepared solution. 
- Decoction: root of nontaiyak (properties: repel namlueang and mareng), heartwood of thao-khui-daeng (property: relief of mareng), 
khoi (properties: repel bad lymph, laxative) 
-Mareng patients must not receive massages because massages could cause bruises in that area and would make mareng worse. 
- Some food items are prohibited for cancer patients, such as Chinese kale, eggs, some fish, pineapples, corns, poultry, prawns, 
shrimps, and crabs.   
- Main treatment is a decoction. If patients feel better during the first three days, the same remedy will be given continuously for 1-3 







CH2 The first step of blood cancer treatment is to enhance the immunity by taking a powdered mixture of young fruits or vines from 
marakhinok, leaves from khlu, and camphor until the patients stop feeling tired, mostly within one month. Then I will add a blood tonic 
which contains fang, wankeeprat, and kritsana. The patients can take these remedies until they are better. The most important things 
in mareng treatment is to stop the degeneration of the body.  
 
CH3 I use a decoction as mareng remedy.  
CH4 A treatment for mareng in breast comprises drugs that are used for lymph conditions, including khaoyen, haoyang, nontaiyak, 
kammathanlueang, and a type of charcoal. Patients have to stop using this medicine once they are recovered because this drug 
affects neurological system. Some patients took 3 pots and they recovered.   
 
CH5 There are different herbal remedies for different people because they have different blood group. Before prescribing a treatment, I 
will check the strength of patients. If they are very weak, I cannot give a very strong medicine. For mareng therapy, mix a herbal 
powder with water. Dosage depends on patients’ sizes. We can see that they are better or not in 1-2 days. Chicken and squids are 
prohibited for cancer patients.  
 
CH6 When I treat mareng, I also give a tonic recipe for that organ and blood tonic (because the patients have less blood). For instance, I 
give liver tonic recipe together with the treatment for mareng in liver. My medicines are in the form of capsules or poultice.  
 
CH7 I’ve succeeded in many cases of mareng in lymph nodes and breast. It is difficult for mareng in stomach, but it is very rare anyway. 
Mareng dies because of intoxicated* drugs. To treat mareng, I start with a pot of cleansing remedy to cleanse the body, and then 
prescribe ya-lu-thong (mean laxative). After that I start fi treatment and monitor the patients for another 3 days. Then I apply some 
medication and cast a spell.  
*In TTM, drugs are 
categorized according 
to their tastes. 
Intoxicated taste is one 
of the nine tastes. 
CH8 I have treated mareng in neck and breast the most often. For internal mareng, I use decoction. One pot of a decoction would last for 
10 days. For external one, I use ‘Soon Poon’ until the lumps are gone. 
Soon poon = to apply 
Poon (a product from 
ground cockle shells 
mixed with water and 
turmeric water) on the 
skin 





LA3 Mareng treatment composes of the use of herbal medicine, holy water, pao kra mom*, and avoiding prohibited food items. Example 
of prohibited food items are preserved food, catfishes, sausages, and some mushrooms.  
*Pao kra mom is a ritual 
performance where a 
healer casts spells and 
blows air onto a 
patient’s forehead. It is a 
belief that forehead is 
the centre of the body.    
LA4 In general, mareng patients will take a detoxification remedy, such as a decoction rangcheud. Then they will be prescribed medicine 
according to their conditions. 
 
LA5 I use herbal medicine to wash saan-phit which is composed of rangcheud, kasalong, and rangjang.  
LA6 Herbal medicine used for mareng treatment must not be hot. We have to use ‘cold medicine’. I also perform ritual blessing. The 
patients have to avoid drinking alcoholic drinks. 
 
LA7 Herbal medicine capsules/ decoctions, and also for bathing and external application.  
LA8 I use ritual blessing and spitting herbal medicine on patients. I also use herbal medicine.  
LA9 I have treated the patients with herbal medicine, such as yanang or buabok, together with their conventional treatment.      
SU1 Herbal medicine and massage. Use an oral remedy to expel phayat from inside the body and then use a topical remedy to kill the 
phayat. Massage will be used to treat pain. 
 
SU2 Use herbs with intoxicated taste, such as kangplakhao, kangpladaeng, maiyarab, to treat poisons and abscess inside the body.  
SU3 I use several herbal medicine depends on the type of mareng. The informant showed 
us notebooks with 






SU4 Decoction to dissolve menstruation and make it become normal. Spit herbal medicine on patients and perform ritual blessing. Some 
food items are prohibited. 
 
SU5 I use a decoction and ointment from a combination of sabadeang, wa, and several mushrooms.   
SU6 Capsules contain khaoyennuea, khaoyentai, huaroiru, and sabulueat. Patients who have taken this medicine could live up to 6-7 
years. They could take it with conventional treatment, but in a reduced dose of the herbal medicine. They will take this recipe together 
with a decoction that helps in eating, sleeping, cleansing of bad blood, and excretion.  
 
SU7 Decoction, according to symptoms, to expel internal wounds. Once the wounds come out, they will be treated with topical remedies. 
Herbal medicine will be spiritually processed before giving to patients.  
 
SU8 I use herbal medicine to treat mareng  
SU9 I have several herbal remedies  
 
Table 2-6 Summary of cancer prevention by Thai traditional practitioners 




BK1 We have to remove toxins daily because we intake them with food. Prevention of mareng can be personalized. For instance, patients 
with chronic gastric ulcer should take herbal medicine that heals wound inside the stomach and intestine, as well as detoxify. 
Detoxification in the most important step. Also we have to eat properly, such as eat five and avoid food that cause mareng e.g. internal 
organs, processed food, sausages, and bamboo shoots etc. 
 
BK2 By preventing krasai by using triphala. And we could prevent mareng personally as well. For instance, I have suggested a man, which 
his parent and elder brother passed away because of mareng in liver, to take care of his liver by taking food and medicine that nourish 






BK3 Any disease can be prevented, according to TTM, because we can know the signs, so we prevent before it gets worse. By keeping the 
balance of the four elements, eating normally, sleeping well, having good blood circulation, and having normal excretion, mareng could 
be prevented. 
 
CH1 By eating a lot of vegetables to help in regular excretion.  
CH2 Green vegetables, such as okra.  
CH3 It is very difficult to prevent cancer but we could prevent bad luead or namlueang by using a blood tonic recipe.  
CH4 Yes. By changing habits; no stress. Fruits and vegetables which have cooling effects can help because mareng is related to fire element.  
CH5 It’s very difficult to prevent mareng. We have to maintain the balance of the four elements and prevent the development of bruises to 
mareng. 
 
CH6 We can prevent mareng by nourish namlueang. Bruises can develop to mareng, so if we get one, we must treat it right away. We can 
also take benjakool to maintain the balance of the four elements, at least once a year. 
 
CH7 We could take Ya-lu-thong which is composed by ten drugs.  
CH8 I have herbal tablets and decoction for cancer prevention. We could also drink the water from fang and thonglang soaked in lime water.  
CH9 No. But we can prevent the development of shingles to cancer. The remedy called ’12 roots’.  
LA1 This preventive remedy composes of katangbai, thaowanprieng, thaowandaeng, and huayang.   
LA2 Yes, we have to take care of our health by eating and living properly. I don’t recommend to take too much medicine to prevent for any 
diseases. 
 
LA3 Boil rangchued with rice. Drink the decoction as water. It is a universal detoxifier. There is another detoxifier which composes of 






LA4 I think mareng could be prevented by our immunity. To prevent it, we have to avoid habits that cause it. For some people who get ill 
easily, they should take remedies that help them to eat well, sleep well, and excrete well. The main ingredient is benchakool combined 
with herbs which nourish blood or the four elements. 
 
LA5 We can use an antidote against poisons.  
LA6 There is no preventive remedy for any diseases.  
LA7 I think we could take saan remedy. If it could cure the disease, why not prevent.  
LA8 Yatatrak should work. Rak = root. Yatatrak 
is the very last 
remedy for treating 
mareng. 
LA9 Food in very important. I suggested eating local vegetables and avoiding meat. We could take a preventive food recipe composes of 
pakwanpa, pakwanban, and mon to prevent from any diseases and keep healthy. 
 
SU1 I have herbal medicine which can be used to prevent from mareng.  
SU2 To prevent any disease, use a decoction composed of thaowanprieng, kamphaengjedchan, and five types of kod.  
SU3 Mareng cannot be prevented.  
SU5 Lingzhi and Thai medicine used for cleansing stomach, such as roots of toeilamchiak and yakha mix with other ingredients.  
SU6 Triphala can suppress mareng. It can be used as prevention as well.  
SU7 Drinking a decoction from fresh ginger and salt daily could prevent mareng. 






SU8 Use a decoction that contains three ingredients which are leaves from phaiseesuk (a type of bamboos), turtle shells, and chicken 
feathers. 
 
SU9 It is difficult to prevent from any disease. We have to exercise and eat properly.  
 




CH2 In old Thai medical textbooks, there are some abscesses which might be cancer, such as Fi Kanthasut and Fi nai pod. The first condition 
is an internal abscess in colon similar to haemorrhoid, with pus. The latter one is abscess in lung, nowadays called lung cancer. 
Skin cancer is a type of skin disease in Thai traditional medicine. 
 
CH3 There is a type of Fi (abscess) which is very similar to cancer. A western doctor often diagnoses this to be cancer. It is a big lump inside 
stomach. This is the most aggressive Fi and can develop into mareng. 
 
CH4 The common symptoms of mareng in colon are frequent defecation and bloody, smelly, and black feces. In TTM, this condition is not 
mareng but a kind of haemorrhoid, which the treatment is different from that of colon cancer. While we use intoxicated* drugs for mareng, 
but we use hot-taste and astringent-taste herbs for this condition to increase blood and wind flow, and heal the wounds. 
*In TTM, drugs are 
categorized 
according to their 
tastes. Intoxicated 
taste is one of the 
nine tastes. 
CH7 In TTM, there is only one mareng. But in Western medicine, there are many mareng according to the location, such as mareng in the 
liver, mareng of the skin etc.  
 







SU2 Some skin cancers are psoriasis, not mareng. We have to see how deep the condition is. If it goes under the skin, it is skin cancer  
SU3 Mareng develops from chronic fi. However not all fi are mareng. For example, fi in liver is not mareng but krasai linkrabue. Exploded 
internal fi will distribute throughout the body. 
 
SU5 Most of the time invasive wounds were diagnosed to be cancer from the hospital. In TTM, they are not mareng. We treat those using 
wound-healing remedies.    
 
SU9 Sometimes I examined patients who were diagnosed with cancer from the hospital and found that they don’t have mareng, such as 
breast cancer. I could not find the cancer pulse. 
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2.3.3.2. Disease explanation of cancer and causes in Thai traditional medicine 
Explanation of mareng and causal factors from each informant are summarized in Table 2-3. 
Generally, mareng is a disease which develops when there is chronic fi (abscess), untreated 
chronic conditions, spoiled luead and namlueang, serious inflammation, or chronic bruise. 
Some informants also stated that mareng is any fast progressive diseases or body/organ 
degeneration. This is similar to the definition of cancer from traditional healers in Malaysia 
which defined cancer as a prolonged sickness or accumulation of abscesses (Al Naggar et 
al., 2012) and from Maya healers which stated that cancer is a disease that is difficult to treat 
(Berger-González et al., 2016). Traditional healers in Nigeria also associated cancer with an 
ulcer that does not heal easily (Nwoga, 1994). This agreement is obviously not relevant to the 
location or religion. However, it might be because one common characteristic of traditional 
medical systems is that traditional practitioners have no modern equipment for physical 
examination. As a result, abscesses and wounds are among the symptoms that can be seen 
and can be compared to ancient texts (please see the introduction; mareng-cancer in Thai 
traditional medicine?).  
How TTM practitioners diagnose mareng is shown in Table 2-4. Since the practitioners do not 
have any tools that help in a diagnosis or confirmation of cancerous cells, the diagnosis relies 
on patients’ symptoms and their history, especially history of cancer in family, jobs, and eating 
habits. The practitioners recognized that cancer is a disease in Western medicine. Since most 
patients were already diagnosed with cancer prior to the visits, the practitioners did not have 
to diagnose them again. However, the informants just check other information related to the 
treatment consideration i.e. symptoms and dhātu. Sometimes they compared the symptoms, 
mostly nodules and fi, with old texts. One informant uses spiritual diagnosis called Pheng 
Kasin, in which he would invite the patient’s spirit to come and give the information about the 
sickness. Two informants check the pulse as they said cancer patients have a very fast pulse 
with a specific pattern (Figure 2-8) as they also have knowledge in Traditional Chinese 
medicine (TCM). They use both Chinese herbs and Thai herbs. TCM and traditional Indian 
healers in Malaysia also use the pulse checking to check for cancer (Al Naggar et al., 2012).  
 
Figure 2-8 Pulse checking demonstration by a Thai traditional practitioner. 
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Based on the informants’ responses, causes of mareng can be divided into internal and 
external factors. External factors are factors that a person is exposed to in the environment 
which include food, chemicals, phayat, tua, tobacco, and sunlight. Tua is generally used to 
classify ‘living things with legs’ and phayat means illness or parasites. Thai people use these 
words to refer to living things, so we could say that some informants view mareng as a living 
entity (Bamber, 1987). Interestingly, this is similar to Maya healers who stated that cancer is 
moving within the body (Berger-González et al., 2016). In essence these are emic concepts, 
and some perceived causes are in agreement with current knowledge that smoking, fried food, 
red meat, sunlight, and pollutants cause cancer (Anand et al., 2008).  
Internal factors are now labelled as being linked to modern concepts like genetics and 
conditions that develop within the body, which include chronic abscesses, serious 
inflammations, degeneration of body or organs, and an unhealthy immune system.  
2.3.3.3. Linking explanatory models of cancer in Thai traditional medicine with biomedical 
concepts 
Understanding characteristics of mareng from an etic perspective helps in a better 
understanding of the actions of mareng treatments in TTM. The case studies above were 
representative of different perceptions of mareng from the informants which covered five main 
characteristics of mareng (Figure 2-9). These characteristics; waste accumulation, 
krasai/chronic illnesses, kan aksep (inflammation), bad luead and namlueang, and imbalance 
between elements, were found to be common in patients who suffered from mareng and the 
treatments were based on them. The main characteristics here are our interpretations from 
the interviews of 33 Thai traditional practitioners (our etic perspective). They were mainly from 
the description of mareng, causes of mareng, and the treatment and prevention (see Table 
2-3, Table 2-4, Table 2-5, and Table 2-6). In some topics, evidence on species used (this is 
etic perspective) was given to provide examples for the better understanding (Table 2-8). 
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Figure 2-9 Main characteristics of cancer from Thai traditional practitioners. The arrows show the 
relationships between each characteristic. Kan aksep (inflammation) and accumulative waste cause 
krasai. Bad luead or namlueang causes the imbalance of dhātu si (the four elements). Outer circle 
shows matching Western medicine concept to each characteristic. 
 
Luead sia (bad blood) and Namlueang sia (bad lymph) 
Eight informants mentioned that luead sia (bad blood) and namlueang sia (bad lymph) resulted 
in mareng development. The definition of luead and namlueang in TTM is not clear. Luead is 
recognized as the basic fluid of the body. So blood is accepted to describe luead. Namlueang 
is recognized as a specific fluid and is referred to as watery secretions. Luead and namlueang 
can be in different states, such as normal or bad. Some reports or books might detail their 
conditions to be spoiled or rotten or poisonous, but we used ‘bad’ (especially for namlueang) 
to describe abnormal states, as this needs to be investigated further in order to characterize 
them. Our findings that bad luead and namlueang could cause mareng correspond to the 
description of Brun and Schumacher (Brun and Schumacher, 1994) and Maya healers 
(Berger-González et al., 2016). Similarly, Hausa/Fulani folk healers in Northern Nigeria stated 
that cancer of male and female gonads and inflammation are caused by excessive production 
and deposition of fluids and phlegm (Abubakar et al., 2007).    
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Luead and namlueang are also involved with other causes of mareng which are the imbalance 
of the four elements and fi (abscesses). According to Khamphi Maha Chotarat (a scripture 
that describes the symptoms and herbal remedies for abnormal menstrual blood and 
menstruation), rotten or toxic blood could develop to fi (Foundation for the promotion of Thai 
traditional medicine and Ayurved Thamrong School Center of applied Thai traditional 
medicine, 2007b).  
Medicinal plants used for namlueang problems are important ingredients in mareng therapy. 
Khaoyennuea and khaoyentai (Table 2-8) are well-known medicines for cancer treatment in 
Thailand (Itharat et al., 2004) They are used traditionally for namlueang problems. Informant 
C used them to make a decoction for patients with mareng in the breast. Extracts from 
rhizomes of Smilax glabra Roxb. (Smilacaceae), which is a major source for khaoyentai, 
showed significant growth inhibition to cancer cells of colon, gastric, lung, bladder, breast, 
liver, prostate, cervix, and human leukemia cells in vitro, while exhibiting low cytotoxicity to 
human umbilical vein endothelial cells and normal gastric epithelial cell line GES-1. 
Mechanistically, this has been linked to cell cycle arrest at S phase, apoptosis induction, and 
autophagy induction via redox-dependent ERK1/2 pathway (She et al., 2015b).  
Nowadays namlueang in TTM is often associated with the immune system. Medicinal plants 
that are good for namlueang might be good for immune system and this can be used as a 
model to test their pharmacological properties. Water extract from S. glabra exhibited 
immunomodulatory activities by down-regulation of over-activated macrophages, up-
regulation of the dysfunctional T lymphocytes in adjuvant-induced rats (Jiang et al., 2013), 
promotion of macrophage phagocytosis, and increasing macrophage-derived biological 
factors, including nitric oxide (NO), interleukin-6 (IL-6), tumour necrosis factor-α (TNF-α) and 
interleukin-1β (IL-1β) secretion (Wang et al., 2017a). Derris scandens (Roxb.) contains 
flavonoids that exhibited specific cytotoxicity against several breast cancer cells in in vitro 
(Tedasen et al., 2016) and its extract also increased lymphocyte proliferation and NK cells 
functions (Table 2-8) (Sriwanthana and Chavalittumrong, 2001).  
Moreover, informant C stated that abnormal namlueang causes inflammation by over-
activation of the fire element. Informant A also stated that the obstruction of blood resulted in 
an accumulation of waste. These show that bad luead and namlueang are not only directly 
involved in mareng development, but also facilitate other characteristics.  
Kan aksep (inflammation) 
Five informants mentioned that kan aksep (inflammation) was related to mareng development. 
Inflammation can be caused by over-activation of the fire element, or external factors, such 
as food and microorganisms; or constant impact on an organ. According to informant C, 
inflammation was a result of an abnormality of namlueang. The concept of inflammation and 
mareng was similar to the Ayurvedic concept of cancer, which describes cancer as being of 
two types; inflammatory and non-inflammatory swelling   (Balachandran and Govindarajan, 
2005). Thus, this might be due to the influence of Traditional Indian medicine onto TTM 
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(Chokevivat and Chuthaputti, 2005). It is also in agreement with the current knowledge that 
chronic inflammation is a risk factor in cancer development (Candido and Hagemann, 2013). 
Inflammation is a defence mechanism of the body to infections and some conditions, such as 
trauma and toxins. Chronic inflammation is known to be associated with tumourigenesis and 
progression. It assists cancer cells to acquire hallmark capabilities, such as sustaining 
proliferation, limiting cell death, facilitating angiogenesis and metastasis. Nowadays 
inflammation is accepted as an enabling characteristic of cancer (Hanahan and Weinberg, 
2011).  
Chronic illnesses/krasai 
Every informant said that mareng is very difficult to treat. Five informants mentioned 
specifically that chronic bruises and wounds would develop into mareng. According to the 
informants, chronic conditions can be used to differentiate mareng from another disease. For 
instance, vaginal discharge can result from a problem of the urinary system and dysmenorrhea 
can result from menstrual blood (ra-du) problems. However, informant B suspected mareng 
in the uterus of a patient because this patient had the symptoms for a long time. When a 
person has an illness for a long time, krasai would develop. According to the official Thai 
dictionary, krasai is characterised by  emaciation, yellow skin, and cold feet and results in a 
deterioration of the body (Royal Society of Thailand, 2011). It is also defined as a condition 
with symptoms generally located in the lower abdominal area, including symptoms recognized 
in biomedicine as hernia, uro-genital afflictions, ulcers, and possibly gallbladder illness 
(Bamber, 1987); and a deterioration of the four elements or a decline of the body (Foundation 
for the promotion of Thai traditional medicine and Ayurved Thamrong School Center of applied 
Thai traditional medicine, 2007b). Consequently, krasai can be described as a degeneration 
of the body or an organ. As such it is a type of degenerative disease in TTM. 
The relationship between degeneration and cancer is generally linked to mitochondrial 
dysfunction. Mitochondrial DNA (mtDNA) plays a crucial role in maintaining normal functions 
of organelles. The accumulation of mtDNA mutations or decreased mtDNA copy number have 
an effect on energy production, cell survival, and increase ROS generation. These have been 
linked to aging, age-related diseases, and cancer (Hsu et al., 2016b). 
Accumulation of khong sia (waste) 
One of the key therapeutic strategies to tackle mareng is to remove khong sia (waste). Khong 
sia is a very broad term, including body waste, such as urine, excrement, and sweat; as well 
as accumulated blood clots in a womb and unexcreted food in the intestines. According to 
Khamphi Maha Chotarat, blood clots in a womb are very dangerous since they cause pain 
and death. To treat the clots, one should take medicines that nourish the fire element to re-
balance the four elements, followed by a blood tonic (Foundation for the promotion of Thai 
traditional medicine and Ayurved Thamrong School Center of applied Thai traditional 
medicine, 2007b). Poonthananiwatkul et al. (2015) reported that medicinal plants used for 
detoxification have been taken widely by cancer patients in Thailand and they produced some 
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benefits, such as laxative effect and improved blood test results and breathing in patients  
(Poonthananiwatkul et al., 2015). Accumulated waste also causes krasai (Figure 2-9), so 
removal of waste also helps to prevent it.  
A Thai medicinal plant that is the best known for its detoxifying properties is rangchued 
(Thunbergia laurifolia Lindl.) (Table 2-8). Its decoction was mentioned by eight informants to 
be used in mareng treatment and prevention. It also has been reported for anti-cancer, anti-
inflammatory, and protective effects (Junsi and Siripongvutikorn, 2016, Jetawattana et al., 
2015, Rocejanasaroj et al., 2014, Wonkchalee et al., 2012).  
Imbalance of dhātu si (four basic elements); earth, water, wind, and fire 
Three informants mentioned that the imbalance of dhātu si (the four basic elements) is a cause 
of mareng. The imbalance of body’s basic elements causing mareng is also an important 
explanatory model in Ayurvedic medicine. Cancer is seen as a result of a loss of coordination 
between three main system in the body, which are air, fire, and water elements (Balachandran 
and Govindarajan, 2005). The balance of elements is the main focus of TTM, as well as in 
other traditional medical systems. It maintains normal functions of the body and keeps one 
healthy. Every herbal remedy has to contribute to maintaining or re-balancing health.  
To link the balance of the elements to pharmacological models, we propose here that such 
preparations could be involved in homeostasis. Homeostasis is a state of balance within the 
body or cells. This state maintains normal function and structure of the body or cells. Losing 
homeostasis plays an important role in tumourigenesis. For example, the production of cell 
proliferative signals is carefully controlled in normal tissues to ensure a suitable number of 
cells and to maintain tissue homeostasis. Cancer cells can avoid this regulation and continue 
to proliferate, grow, and invade nearby tissues and form tumours (Hanahan and Weinberg, 
2011).   
Triphala (Table 2-8) is a well-known herbal medicine used widely in the treatment of many 
diseases and their prevention. It is said to balance the elements, nourish blood, and clean the 
body. A large body of evidence supports that the medicine is beneficial in cancer and 
inflammation treatment. It also exhibited immunomodulatory and protective effects (Takauji et 
al., 2016, Kalaiselvan and Rasool, 2016, Varma et al., 2016, Chandran et al., 2015). 
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Table 2-8 List of plants/ingredients mentioned in the case studies, their traditional uses, and published relevant pharmacological properties 
Local names Part used Scientific names Voucher number Traditional uses Relevant pharmacological properties 
Thaowanprian
g 
stem Derris scandens 
(Roxb.) Benth. 
(Fabaceae) 
PBM05189 To fix en11 
problems, 
treatment of 
cough, cold, and 
Krasai, diuretic 
Anti-cancer activities 
- Methanol extract/ flavonols exhibited anti-cancer activity 
against MDA-MB-231 and MCF-7 breast cancer cells and 
Topoisomerase II poison activity in yeast cells (Tedasen et 
al., 2016, Sangmalee et al., 2016, Ausawasamrit et al., 2015). 
Anti-inflammatory activity 
- In vitro, water extract/ ethanol extract/ genistein inhibited 
inflammatory substances; including myeloperoxide and 
eicosanoids (Laupattarakasem et al., 2003, Laupattarakasem 
et al., 2004) 
- In the rat hind paw edema test, the water extract reduced the 
edema when given intraperitoneally, but not when given orally 
(Laupattarakasem et al., 2003). 
Immunomodulatory activity 
- The ethanol extract enhanced lymphocyte proliferation and 
NK cell activity of normal individuals and induced NK cell 
activity of HIV-infected participants. It also increased IL-2 
secretion from normal PBMC, but not IL-4 (Sriwanthana and 
Chavalittumrong, 2001).  
Anti-oxidant activities 
- Its hexane and chloroform extracts showed moderate free 




                                                     
11 Tendon or ligament 
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Local names Part used Scientific names Voucher number Traditional uses Relevant pharmacological properties 
Khokhlan stem Mallotus repandus 
(Willd.) Müll. Arg. 
(Euphorbiaceae)  






tonic, treatment of 
internal poisons  
Anti-inflammatory activity 
- Water extract of the stems exhibited anti-inflammatory activity 
in paw edema induced by carrageenan model (Lin et al., 
1992). 
Anti-oxidant activity 
- The ethyl acetate fraction of its ethanol extract exhibited 
strong superoxide radical scavenging activity and the n-
hexane fraction showed strong hydroxyl radical scavenging 
activity (Lin et al., 1995). 
Khaoyennuea root Smilax corbularia 
Kunth. (Smilacaceae) 


















pus, inhibition of 
poisons in bones. 




- Its ethanol extract inhibited TNF-α and NO production. Three 
flavonols isolated from the ethanol extract; engeletin, astilbin 
and quercetin, inhibited PGE2 release (Ruangnoo et al., 
2012). 
Antioxidant activity 
- The ethanolic extract and its isolated compounds; astilbin and 
engeletin, exhibited antioxidant activity in DPPH assay and 






                                                     
12 A condition in TTM with fever and itching rash 
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Local names Part used Scientific names Voucher number Traditional uses Relevant pharmacological properties 
Khaoyentai  root Smilax glabra Roxb. 


















pus, inhibition of 
poisons in bones. 




- Its extracts possessed anti-cancer activity on cancer cell lines 
of gastric, lung, colon, bladder, breast, liver, prostate, and 
cervix origins, and human leukemia cells, with little 
cytotoxicity to HUVECs and normal gastric epithelial cell line 
GES-1 (She et al., 2015a, She et al., 2015b, Hao et al., 
2016b, Li et al., 2015).  
- In vivo, supernatant of the water-soluble extract (SW) reduced 
the growth of tumour in xenograft mice (She et al., 2015a) 
and inhibited the  metastasis of MDA-MB-231 (She et al., 
2015b). 
Anti-inflammatory activity 
- In vitro, ethanol extract showed 5-LOX inhibition property 
(Zhao et al., 2016). Its polysaccharide fractions and phenolic-
enriched extract inhibited LPS-induced production of TNF-α, 
IL-6, and NO in RAW  264.7 cells (Wei et al., 2015).  
Immunomodulatory effect 
- The water extract/ heteropolysaccharide showed 
immunomodulatory effects in macrophages and dysfunctional 
T lymphocytes (Jiang and Xu, 2003, Wang et al., 2017a). 
Protective effects and anti-oxidant activity 
- Ethanol extract/ flavonoid-rich fraction exhibited protective 
effects against CCl4-induced and lead-induced toxicity and 
reversed hepatic damage caused by CCl4 in rats (Xia et al., 




Local names Part used Scientific names Voucher number Traditional uses Relevant pharmacological properties 
Khanthongpha
yabat 















- The hexane extract and helioscopinolide A inhibited NO 
production, PGE2 production, and iNOS and COX-2 mRNA 
expressions in RAW264.7 cells (Tewtrakul et al., 2011). 
Horathaosuna
k  
Dried stem Balanophora 
abbreviata Blume 
(Balanophoraceae)  
NL-0025 Anti-asthma Anti-inflammatory activity 
- Lignans from its extract showed moderate to potent inhibitory 
activity on LPS-induced iNOS expression in RAW 264.7 cells 
(Hosokawa et al., 2004). 
Khanunsampa
lo, sake 










- Diethyl ether extract/ methanol extracts/ partially purified 
fraction/ geranyl dihydrochalcone showed anti-cancer activity 
in in T47D breast cancer and DU145 prostate cancer cells, as 
well as suppressed tumour growth in DU145 xenograft 
initiation model (Jeon et al., 2015, Arung et al., 2009). 
Protective effects 
- The water and ethanol extracts reduced serum AST, ALT and 
ALP levels in CCl4-treated rats and restored total protein and 
albumin to near normal levels. It also suppressed TBARS and 
increased glutathione level (Sairam et al., 2016).   
Activities related to blood and lymph 
- Intravenous administration of the water extract of the leaves 
caused significant hypotensive and bradycardiac responses 
(Nwokocha et al., 2012). 
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Local names Part used Scientific names Voucher number Traditional uses Relevant pharmacological properties 
- Ethanol extract of the leaves showed ACE-inhibitory activity 
with an IC50 value of 54.08 + 0.29 µg/mL (Siddesha et al., 
2011). 
Makhampom Root, fruit Phyllanthus emblica 
L. (Phyllanthaceae)  





worm in semha 
Mature fruit: 
treatment of fever 
Anti-cancer activity 
- Water extract/ geraniin/ isocorilagin showed cytotoxic effects 
against MCF-7 cells, HELF cells, and HT1080 and down-
regulated MMP2 and MMP9 gene expressions in human 
fibrosarcoma cells HT1080 (Liu et al., 2012, Yahayo et al., 
2013) 
Anti-inflammatory activity 
- Ethanol extract of the branch suppressed the expression of 
LPS-induced pro-inflammatory genes (COX-2, iNOS, TNF-
alpha, IL-16 and IL-6) in RAW 264.7 and also suppressed the 
carrageenan-induced paw edema in rats (Sripanidkulchai and 
Junlatat, 2014). 
Protective effects  
- Administration of the fruits/ methanol extract of the leaves/ 
compounds isolated from the fruits showed protective effects 
against cognitive deficits, biochemical abnormalities, 
apoptosis induced by aluminum chloride, and tau 
hyperphosphorylation (Thenmozhi et al., 2016), cadmium-
induced neurotoxicity in mice (Chatterjee et al., 2016), CCl4-
induced oxidative injuries and tissue damage of lungs of rats 
(Tahir et al., 2016), H2O2-induced injury in PC12 cells (Zhang 
et al., 2016), and chemical-induced liver injuries in several 
animal models (Variya et al., 2016).  
Immunomodulatory activity  
- The fruit extract reversed the immunosuppressive effect of  Cr 
(VI), enhanced white blood cell count and % lymphocyte  
distribution  in mice, and also activated macrophages  
(Belapurkar et al., 2014) and the isolated compounds, 
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Local names Part used Scientific names Voucher number Traditional uses Relevant pharmacological properties 
geraniin and isocorilagin, stimulated splenocyte proliferation 
(Liu et al., 2012). 
Activities related to blood and lymph 
- Water extract decreased haemolytic activity in red blood cells 
of human subjects receiving chronic alcohol and cigarette 




dried seed Vigna radiata (L.) 
R.Wilczek 
(Fabaceae) 




Anti-inflammatory activity  
- In vivo, water extract/ ethanol extract showed potent anti-
inflammatory and antinociceptive activities (Ali et al., 2014, 
Venkateshwarlu et al., 2016).  
- In vitro, water extract/ methanol extract/ ethanol extract 
inhibited NO, COX-2, and exhibited membrane stabilization 
activity and protein denaturation activity (Ali et al., 2014, 
Venkateshwarlu et al., 2016, Zia-Ul-Haq et al., 2013).   
Immunomodulatory activity  
- Polysaccharide sub-fractions; MAP-1 and MAP-2, from alkali-
extractable polysaccharides from the seeds enhanced the 
production of NO, TNF-α, and IL-6 in RAW 264.7 cells (Yao et 
al., 2016). 
Protective effects  
- C. militaris-fermented mung beans protected DNA damage 
(Xiao et al., 2015).  
- Mung bean coat extracts attenuated LPS-induced release of 
HMGB1 and several chemokines in macrophage cultures. It 





Local names Part used Scientific names Voucher number Traditional uses Relevant pharmacological properties 












of toxin from the 
liver 
Protective effects  
- In vitro, water extract/ ethanol extract/ acetone extract 
showed protective effects against oxidative stress in HepG2 
cells  (Rocejanasaroj et al., 2014), increased QR activity in 
Hepa1C1C7 cells and showed antimutagenic activity in 
Salmonella typhimurium TA 98 (Oonsivilai et al., 2007), 
ethanol-induced cell death of primary rat hepatocytes 
(Pramyothin et al., 2005). 
- In vivo, leaves/ water extract/ ethanol extract had protective 
effects against cadmium toxicity in rats (Ruangyuttikarn et al., 
2013), inflammation-induced by O. viverrini infection or with 
NDMA administration (Wonkchalee et al., 2012), and 
Pb(NO3)2 treated Oreochromis niloticus (Palipoch et al., 
2011), ethanol-induced liver injury (Pramyothin et al., 2005). 
Anti-inflammatory activity  
- Rosmarinic acid isolated from the leaves exhibited 
antinociceptive activity in the hot-plate test, reduced acetic 
acid-induced writhing, suppressed formalin-induced pain in 
the early and late phases, reduced carrageenan-induced and 
PGE2-induced paw edema, and inhibited cotton pellet-
induced granuloma formation in mice (Boonyarikpunchai et 
al., 2014).  
- The powder showed anti-inflammatory properties in O. 
viverrini and NDMA-treated Syrian hamsters by reducing the 
aggregation of inflammatory cells surrounding the hepatic bile 
ducts and reversed serum ALT, ALP, BUN and creatinine 
levels to normal (Wonkchalee et al., 2012). 






- Balance the 
elements, tonic, 
nourish water 
element so this 
improves blood 
circulation, 
Anti-cancer activity  
- Methanol extract/ chebulinic inhibited proliferation and 
induced apoptosis in human colon cancer stem cells (Vadde 
et al., 2015) and suppressed VEGF- induced angiogenesis 
(Lu et al., 2012). 
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in the intestine 
Anti-inflammatory activity 
- A randomized controlled clinical trial in 90 volunteers with 
chronic gingivitis showed that the effectiveness of Triphala 
mouthwash in the treatment of gingivitis was comparable to 
that of chlorhexidine mouthwash  (Pradeep et al., 2016).  
- Water extract inhibited LPS-induced inflammatory responses 
in RAW 264.7 cells and adjuvant-induced arthritic rats by 
inhibition of NF-κB pathway (Kalaiselvan and Rasool, 2016).  
- Triphala recipe (4 mg/ear) showed an inhibitory effect on the 
ear edema formation in rats induced by ethyl 
phenylpropiolate, but not by arachidonic acid. Furthermore, It 
also decreased carrageenan-induced hind paw edema and 
showed antinociceptive effect in formalin-treated mice 
(Sireeratawong et al., 2013). 
Immunomodulatory effects  
- Administration of Triphala showed immunomodulatory effects 
on neutrophil functions, IL‑2, IFN‑γ levels, 
CD4+/CD8+lymphocyte  phenotype, mitogen‑induced T-
lymphocyte proliferation, as well as increased phargocytic 
functions in mice (Belapurkar et al., 2014).  
- In a clinical trial phase I, volunteers who administered 
Triphala 3 capsules/ day for 2 weeks showed increase activity 
of cytotoxic T cells (CD3−CD8+) and natural killer cells 
(CD16+CD56+) compared to control group (Phetkate et al., 
2012). 
Protective effects  
- Water extract/ ethanol extract exhibited protective effects 
against X-radiation and bleomycin-induced DNA breaks and 
suppressed ROS generation in HeLa cells (Takauji et al., 
2016), H2O2-induced damage in fibroblasts or HaCaT cells, 
and decreased the mRNA levels of tyrosinase in B16F10 cells 
(Varma et al., 2016). 
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Local names Part used Scientific names Voucher number Traditional uses Relevant pharmacological properties 
Yamornoi, 
Yadokkhao 












and cleanse the 
lung  
Anti-cancer activity  
- In vitro, dichloromethane fraction of the ethanol extract/ 
vernolide-A exhibited anti-cancer activity against HeLa, A549, 
MCF-7, Caco-2 (Beeran et al., 2014) and B16F-10 melanoma 
cells (Pratheeshkumar and Kuttan, 2011e, Pratheeshkumar 
and Kuttan, 2011d). 
- In vivo, methanol extract/ vernolide-A reduced lung tumour 
formation, metastasis, elevated level of serum IL-1β, IL-6, 
TNF-α, and GM-CSF, and VEGF induced by angiogenesis, 
and increased life span of C57BL/6 mice (Pratheeshkumar 
and Kuttan, 2011e, Pratheeshkumar and Kuttan, 2011c).  
Anti-inflammatory activity  
- In vitro, sesquiterpene lactones isolated from hexane extract 
of the flower suppressed TNF-α-induced NF-κB activity and 
NO production in LPS-stimulated RAW 264.7 cells (Youn et 
al., 2012). 
- In vivo, Intraperitoneal administration of methanol extract 
inhibited the PMA-induced superoxide generation in mice 
peritoneal macrophages,  increased the levels of catalase, 
superoxide dismutase, glutathione, glutathione peroxidase 
and glutathione-S transferase in blood and liver, decreased 
lipid peroxidation, and inhibited carrageenan-induced 
inflammation in BALB/c mice (Kumar et al., 2009). 
Immunomodulatory activity  
- Methanol extract and vernolide-A stimulated cytotoxic T 
lymphocyte, NK cell, antibody-dependent cellular cytotoxicity, 
and antibody-dependent complement-mediated cytotoxicity 
through enhanced secretion of IL-2 and IFN-γ in in vivo and in 
vitro (Pratheeshkumar and Kuttan, 2012).  
- Vernolide-A increased the production of IL-2 and IFN-γ in 
metastatic tumour-bearing mice. It downregulated the serum 
levels of IL-1β, IL-6, TNF-α, and granulocyte–macrophage 
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colony-stimulating factor (GM-CSF) during metastasis in 
C57BL/6 mice (Pratheeshkumar and Kuttan, 2011a).  
Protective effects  
- Intraperitoneal administration of the methanol extract 
exhibited protective effects against gamma radiation-induced 
immunosuppression and oxidative stress in BALB/c mice, 
while it did not compromise the effectiveness of the 
radiotherapy (Pratheeshkumar and Kuttan, 2011b).  
Nontaiyak  root Stemona tuberosa 
Lour. (Stemonaceae) 




piles, mareng in 
liver, kill worms, 
use externally for 
skin diseases, kill 
scabies and louse 
Anti-inflammatory activity  
- In vivo, water extract/ Tuberostemonine N showed anti-
inflammatory activity against cigarette smoke-induced sub-
acute lung inflammation in mice (Lim et al., 2015, Lee et al., 
2014, Jung et al., 2016).   
- In vitro, water extract/ methanol extract and its eight alkaloids/ 
methyl ferulate exhibited anti-inflammatory activity in murine 
BV2 microglial cells and RAW264.7 cells; such as inhibition of 
LPS-induced NO production, COX-2 expressions, inducible 
nitric oxide synthase (Lee et al., 2016, Lim et al., 2015, 
Phuong et al., 2014).  
Immunomodulatory activity  
- Tuberostemonine O suppressed IL-2 production and IL-2-




Whole plant Houttuynia cordata 
Thunb. 
(Saururaceae) 









Anti-cancer activity  
- Its extracts/ fractions exhibited anti-cancer activity against 
nasopharyngeal carcinoma cells (Chen et al., 2016), lung 
cancer A549 cells (Chen et al., 2013), and human leukemic 
Molt-4 cells (Prommaban et al., 2012). 
- Fermentation products suppressed the growth of HeLa, 
HCT116, HT29 cells, human leukemic HL-60 and Molt-4 cell, 
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khuttharat   
and HepG2 cells (Senawong et al., 2014, Banjerdpongchai 
and Kongtawelert, 2011).  
Anti-inflammatory activity  
- Ethanol extract from Houttuynia cordata poultice exhibited 
anti-bacterial effects and anti-biofilm against methicillin-
resistant Staphylococcus aureus (MRSA), inhibition effect of 
S. aureus lipoteichoic acid (LTA)-induced IL-8 and CCL20 
production in human keratinocyte without any cytotoxicity 
(Sekita et al., 2016).  
- Volatile compounds/ polysaccharides/ flavonoids exhibited 
anti-inflammatory effects in in vivo (Chen et al., 2014, Li et al., 
2013a, Lee et al., 2015c, Xu et al., 2015, Park et al., 2013).  
- Ethanol extract/ ethyl acetate fraction/ volatile oil suppressed 
the production of inflammatory markers/ cytokines in LPS-
stimulated RAW 264.7, LPS-stimulated mouse peritoneal 
macrophages, and HMC‑1 human mast cells (Chun et al., 
2014, Li et al., 2013a, Lee et al., 2013, Li et al., 2011).  
- Hexane extract inhibited prostaglandin synthase in in 
vitro(Bauer et al., 1996). 
Immunomodulatory activity  
- Water extract/ ethanol extract/ polysaccharides possessed 
immunomodulatory effects on the vaginal mucosa (Satthakarn 
et al., 2015), PBMCs(Cheng et al., 2014), LPS-activated 
macrophages (Kim et al., 2009), mouse splenic lymphocytes 
(Lau et al., 2008), Jurkat T cells and HMC-1 human mast cell 
line (Lee et al., 2008), mast cell-mediated anaphylactic 
responses (Li et al., 2005). 
Protective effects  
- Ethyl acetate extract exhibited hepatoprotective effect in CCl4-
induced hepatotoxicity in mice (Kang and Koppula, 2014)   
- Water extract showed protective effect against high saturated 
fat diet-induced obesity and oxidative and inflammatory injury 
in mice (Lin et al., 2013), prevent lung injury from LPS 
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stimulation in rats (Cai et al., 2013), cardiac and renal injury 
and oxidative stress under diabetic condition in mice (Hsu et 
al., 2016a), and ethanol extract also reduced atherogenic risk 
and hepatic oxidative damage induced by high saturated fat 






NL-0027 Treatment of 
gallstones, cough, 
thirst, fever, 
wounds, diuretic  
Anti-cancer activity 
- Ethyl acetate extract/ tricin derivatives exhibited cytotoxicity in 
concentrations in human cancer cell lines; glioma (U521), 
breast (MCF-7), resistant ovary (NCI/ADR-RES), kidney (786-
0), lung (NCI-H460), prostate (PC-3), ovary (OVCAR-3), and 
colon (HT29), and human keratinocyte HaCat cell lines (Alves 
et al., 2016, Duarte Almeida et al., 2007). 
- Its phytocystatin, CaneCPI-4, exhibited a strong inhibitory 
activity against cathepsins B and L, which are important for 
cancer cells invasion, in breast cancer cells (Carmona et al., 
2008).  
Anti-inflammatory activity  
- A mixture of fatty acids from wax oil reduced zymozan-
induced β-glucuronidase, cellular infiltration, synovial 
hyperplasia, and synovitis in mice (Ledon et al., 2007).  
Protective effects  
- In vivo, sugar cane extracts/ high molecular weight primary 
acids from sugar cane wax showed protective effects against 
CCl4-induced and paracetamol-induced hepatic injury in rats 
(Mendoza et al., 2003, Noa et al., 2002), LPS-induced liver 
injury (Motobu et al., 2006), LPS-induced endotoxin shock 
(Hikosaka et al., 2006),  
- Water extracts exhibited protective effect against radiation-
induced DNA damage in pBR322 plasmid DNA and 
Escherishia coli cultures and also antioxidant properties 
(Kadam et al., 2008).  
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Immunomodulatory effects  
- Sugar cane extracts and polyphenol-rich fraction stimulated 
immune responses in chicken by affecting peripheral blood 
leukocytes, intestinal leukocytes and splenocytes, and 
delayed-type hypersensitivity responses to human γ globulin 







PBM05202 Nourishment of 
lung, treatment of 
tuberculosis and 
lung problems 
Anti-cancer activity  
- Water extract and its fraction inhibited cell proliferation and 
induced apoptosis in RKO colon cancer cells (Tansuwanwong 
et al., 2009). 
Antimutagenic activity  
- Hispidulin and hortensin showed antimutagenic activity 
against 2–aminoanthracene, aflatoxin Bl, and 
dimethylnitrosamine, while showed no mutagenicity and no 
cytotoxicity toward S. typhimurium strains TA98 and TA100 
(Chulasiri et al., 1992). 
Anti-inflammatory activity  
- Hispidulin inhibited 5-LOX in in vitro (Moongkarndi et al., 
1991). 
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2.3.4. Treatment of mareng 
The practitioners combine several methods to treat mareng patients, such as herbal medicine, 
or herbal medicines combined with massage, or herbal medicine combined with spiritual 
methods (such as ritual blessings) (Table 2-5). For herbal medicine, the practitioners received 
formulation from their ancestors in the form of notebooks or verbal instruction or khamphi, 
well-known khamphi (eg. Phaetthayasat Songkhro and Tamrayaklangbaan), or from some 
famous traditional practitioners (Figure 2-10).  
 
Figure 2-10 (A) Samud khoi is very difficult to find and mostly passed on only among family members.  
(B) A version of Phaetthayasat Songkhro owned by an informant. (C) Tamrayaklangbaan is a very 
popular textbook published in 1995. It contains more than 500 herbal formulae for many symptoms 
from many important practitioners, including secret recipes from famous familes. 
 
Prescriptions depend on patients’ condition and stages of mareng. At the beginning of the 
treatment, the informants evaluate the suitability of the first therapy in the initial 3-7 days to 
see the compatibility with the patient’s body and good signs for the efficacy. If it does not 
improve any of the patient’s conditions, they will change to the next herbal remedy until they 
find the right one. The duration of the treatment depends on the disease progress. For 
instance, an informant recalled a patient with advanced liver cancer who lived up to one year, 
while in another case with colorectal cancer the person has been on the treatment since four 
years and still continues the therapy (the interview was performed in April 2013).  
 
Figure 2-11 (A) Herbal recipe to make a decoction for mareng  
(B) Ingredients in yatatrak with drug preparation and dosage regimen  
A B C 
A B 
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Apart from killing mareng, there are also other important steps in treating mareng. The first 
one is detoxification as it is believed that accumulated waste in the body could cause mareng. 
Another one is enhancing immunity. Some practitioners also prescribe “Yatatrak” (a remedy 
that kills the ‘root’ of mareng) to prevent the recurrence (Figure 2-11 B). As mentioned 
previously, some TTM practitioners see mareng as a living entity and it has roots. Even though 
the patients have recovered, mareng will grow again if they don’t kill the roots.  
During and after the treatment, the patients have to avoid some food items which are believed 
to worsen the condition. Some prohibited food items are catfish, Indo-Pacific mackerel, 
prawns, shrimps, shellfish, crabs, beef, poultry, sausages, eggs, pineapples, corns, Chinese 
kale, cucumbers, oyster mushroom (specific to some types of mareng), and pickled food. Food 
restriction is common knowledge in traditional medicine, such as in Mayan medicine (Berger-
González et al., 2016). In Thailand, catfish, mackerel, shellfish, shrimps, crabs, chicken meat, 
beef, and pickled food are general food prohibitions which are not specific to a disease. 
Patients just have to avoid them after they start to have health problems. In Northern Thailand, 
eggs are restricted in some diseases, such as khaan lidsaduan (lesions of gums/ mouth/ nose/ 
eyes/ throat/ skin), bahen (a group of skin diseases), and saan (tumour). Traditional 
practitioners in Northern Thailand also prohibit some food items which have shapes similar to 
tumours, such as everything with a head or round fruits or fingers, food that grows by root 
sprouts, also food with sap because it could make tumours become ripe and pus might 
develop (Brun and Schumacher, 1994).  
2.3.5. Cancer prevention  
Twenty-nine informants suggested preventive methods for mareng (Table 2-6). Four 
informants believed that diseases cannot be prevented. They also believed that unnecessary 
taking of medicine is dangerous. The best way is to seek treatment as early as possible. There 
are three methods for mareng prevention which are herbal medicine, food items, and life style 
modification. Herbal medicines are multi-herbal preparations or single herbs. In addition, some 
informants suggested taking herbal products that nourish or adjust the balance of the four 
elements regularly or at least one course per year. Another preventive method is eating some 
specific food items which mostly are local fresh vegetables. Lifestyle modifications are mostly 
dealing with eating habits, such as avoiding some food items. It also involvs avoiding the 
causal factors specified by western medicine including smoking, fried foods, red meat, alcohol, 
sunlight exposure, pollutants, infections, stress, obesity, and physical inactivity in order to 
prevent cancer (Anand et al., 2008). This agreement might be due to the result of the national 
cancer control program by Ministry of Public Health since 1997 (Ministry of Public Health, 
2013) or health information provided by media, especially television program.  
In addition, it is suggested that people with an increased risk, such as industrial workers who 
are exposed to lead or mercury or farmers who use a lot of insecticides, should take herbal 
medicine that helps in detoxification because chemical exposure leads to toxic blood and 
could cause mareng. This belief coincides with the uses of chemoprevention in high risk 
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populations, such as the use of raloxifene in prevention of estrogen-receptor-positive invasive 
breast cancer (Anand et al., 2008). The data suggest that TTM practitioners could have an 
important role in cancer or other disease prevention in the local community, together with 
primary health care sectors, because local people still seek help from them, especially in 
untreatable diseases. However, knowledge sharing and learning from each other (TTM 
practitioners and health care sector) must be initiated.   
Preventive approach from the external causal factors (eg. chemicals, food, smoke) can be 
achieved by avoiding them or removing them by detoxification. For internal causal factors, the 
informants suggested some approaches as follows; 
 Removal of waste from the body (detoxification) 
 Maintaining the balance of the four elements  
 Nourishment of luead and namlueang 
 Prevention of krasai 
 Prevention of liver abnormality because liver is among the most important organs of 
the body. If the liver becomes abnormal, diseases, including mareng, could show up 
in many organs, such as liver itself, breast, uterus, ovary, or prostate gland.  
These approaches help to form our strategy for pharmacological assays in the next steps. 
2.3.6. Herbal remedies used in cancer/ mareng management 
The informants mentioned 113 herbal remedies used in cancer patients and for 
cancer/mareng prevention. The purposes of them are shown in Table 2-9. Our results are in 
agreement with the findings from a previous study that reported herbal products used by 
cancer patients in Thailand. Herbal products; single herbs and formulae, were used for directly 
or indirectly treating of cancer, such as to manage side effects from chemotherapy (eg. 
aphthous ulcers and fever), detoxification, and enhancement of immunity (Poonthananiwatkul 
et al., 2015). The routes of administrations are shown in Table 2-10. About half of all remedies 
are used as a decoction (Table 2-11). Forty-one herbal remedies fall into preventive 
categories, which are maintain good health, prevention of mareng, and prevention of 








Table 2-9 Summary of purposes of herbal products mentioned by the informants 
No Purposes Number of remedies 
1 Treatment of cancer/mareng 65 
2 Maintain good health 22 
3 Prevention of mareng 14 
4 Supplement to cancer treatment   4 
5 Prevention of development of mareng from some conditions 3 
6 Treatment of a disease that is sometime diagnosed to be a cancer 3 
7 Treatment and prevention of cancer/ mareng 2 
 Total 113 
 
Table 2-10 Directions to use 
Directions Number of remedies 
Orally consume 100 
Cover on affected area 7 
Apply to affected area 3 
Spit on affected area 2 
Wash the affected area 1 
 
Table 2-11 Methods of preparation of all herbal remedies 
Methods of preparation Number of remedies 
Decoction  54 
Capsules  13 
Consume as food  13 
Pounding 7 
Mixing with oil 6 
Powder 6 
Alcoholic maceration 4 
Freshly press 3 
Scratching plants with a stone and water  3 
Water/ lime water maceration 3 
Pills  1 
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2.3.7. Plants used in cancer/mareng prevention in Thai traditional medicine  
There were 346 crude drugs mentioned to be used in cancer/mareng management. The crude 
drugs included 316 plant-derived materials, 15 animal-derived materials, 10 
minerals/chemicals, and 4 mushrooms. Thirty-nine plants and three mushrooms could not be 
collected to verify their correct taxonomic identity (all species listed in Appendix).  
Since this project focuses on cancer prevention, only herbal remedies and food plants related 
to prevention of cancer/mareng, including maintaining good health, prevention of mareng, and 
prevention of development of cancer/mareng from some conditions, were studied further. A 
total of 119 plants belonging to 56 families were mentioned by TTM practitioners for their use 
in cancer/mareng prevention (Table 2-12). Five plants could not be verified scientifically. 
Fabaceae and Zingiberaceae had the highest percentage of medical plant species with 10% 
and 8%, respectively.  
Table 2-12 Medicinal plants used in to maintain good health and prevent from cancer/mareng 
No Local name (other 
name) 
Part used Scientific name Family Frequency 
(FC) 
1 Boraphet (putarwali) stem Tinospora crispa(L.) Hook. f. 
& Thomson 
Menispermaceae 2 
2 Buabok (Asiatic 
pennyworth, gotu kola) 
leaf Centella asiatica (L.) Urb. Apiaceae 1 




4 Chaemthet (licorice) root Glycyrrhiza glabra L. Fabaceae 2 
5 Chan (nutmeg tree) flower, fruit Myristica fragrans Houtt.  Myristicaceae 2 




Senegalia pennata (L.) 
Maslin 
Leguminosae 1 
7 Chaphlu (wild betel) leave, 
whole 
plant 
Piper sarmentosum Roxb. Piperaceae 3 
8 Cheng-chu-chai (white 
mugwort Guizhou 
group) 
aerial part Artemisia lactiflora Wall. ex 
DC. 
Asteraceae 1 
9 Chetphangkhi root Cladogynos orientalis Zipp. 





root Plumbaco indica L. Plumbaginaceae 3 
11 Chingchi, saemathalai root Capparis micracantha DC. Capparaceae 2 
12 Dipli (long pepper) fruit Piper retrofractum Vahl Piperaceae 2 
13 Dongdueng (climbing 
lily) 
root Gloriosa superba L. Colchicaceae 1 
14 Fang (sappan tree) wood Caesalpinia sappan L. Fabaceae 1 
15 Haewmu (nutgrass) rhizome  Cyperus rotundus L. Cyperaceae 1 
16 Hangnokyung daeng 
(red flower) 
root Caesalpinia pulcherrima (L.) 
Sw. 
Fabaceae 1 
17 Hangnokyung lueang 
(yellow flower) 




No Local name (other 
name) 
Part used Scientific name Family Frequency 
(FC) 
18 Hanumanprasankai leaf Schefflera leucantha R.Vig. Araliaceae 1 
19 Homdaeng (shallot) young 
shoot 
Allium ascalonicum L.  Amaryllidaceae 2 
20 Huayang, thaowanyang 
(kumarika)  
stem Smilax ovalifolia Roxb. ex 
D.Don 
Smilacaceae 1 
21 Kamphaengchetchan wood Salacia chinensis L. Celastraceae 1 
22 Kanphlu (clove) flower Syzygium aromaticum (L.) 
Merr. & L.M.Perry 
Myrtaceae 1 
23 Kaprao (holy basil) leaf Ocimum tenuiflorum L. Lamiaceae 1 
24 Kasalong (Indian cork 
tree) 
stem bark Millingtonia hortensis L.f. Bignoniaceae 2 
25 Katangbai (bandicoot 
berry) 
leaf Leea indica (Burm. f.) Merr. Vitaceae 1 
26 Kha (galangal, Thai 
ginger) 
rhizome  Alpinia galanga (L.) Willd. Zingiberaceae 1 
27 Khamfoi (safflower) flower Carthamus tinctorius L.  Asteraceae 1 
28 Khaminkhruea, nae 
khruea (yellow-fruit 
moonseed) 
root Arcangelisia flava (L.) Merr. Menispermaceae 1 
29 Khanghuamu  N/A N/A N/A 1 




Houttuynia cordata Thunb. Saururaceae 1 
31 Khaoyennuea rhizome  Smilax spp. Smilacaceae 2 
32 Khaoyentai rhizome  Smilax spp. Smilacaceae 2 
33 Khaton root, wood Cinnamomum ilicioides 
A.Chev. 
Lauraceae 1 
34 Khing (ginger) rhizome  Zingiber officinale Roscoe  Zingiberaceae 5 
35 Khoklan wood Mallotus repandus (Rottler) 
Müll. Arg. 
Euphorbiaceae 1 
36 Khontha root Harrisonia perforata 
(Blanco) Merr. 
Simaroubaceae 1 
37 Kloi tuber Dioscorea hispida Dennst. Dioscoreaceae 2 
38 Kothuabua, (Szechwan 
lovage rhizome, Chuan 
Xiong) 






Atractylodes lancea (Thunb.) 
DC. 
Asteraceae 2 
40 Kotkraduk (costus root, 
Mu Xiang) 
dried root Saussurea costus (Falc.) 
Lipsch.  
Asteraceae 2 
41 Kotphungpla, Samothai 
(terminalia gall, 
myrobalan gall) 
fruit Terminalia chebula Retz. Combretaceae 4 
42 Krachai (fingerroot) rhizome  Boesenbergia rotunda (L.) 
Mansf. 
Zingiberaceae 1 
43 Kradaddaeng (red giant 
taro) 
rhizome  Alocasia macrorrhizos (L.) 
G.Don 
Araceae 1 
44 Kradadkhao (white 
giant taro) 
rhizome  Alocasia macrorrhizos (L.) 
G.Don 
Araceae 1 
45 Kradon (slow match 
tree) 
young leaf Careya arborea Roxb. Lecythidaceae 1 
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46 Kradukkaidam leaf Justicia fragilis Wall. Acanthacaea 1 
47 Krathiam (garlic) young 
shoot 
Allium sativum  Linn. Amaryllidaceae 3 
48 Krawan (Siam 
cardamom) 
fruit Amomum compactum Sol. 
ex Maton 
Zingiberaceae 1 
49 Lamchiak, toei-ta-le 
(umbrella tree) 
root Pandanus odorifer (Forssk.) 
Kuntze 
Pandanaceae 1 
50 Maduea chumpon 
(cluster fig) 
root Ficus racemosa L.  Moraceae 1 
51 Maduk root Siphonodon celastrineus 
Griff.  
Celastraceae 1 
52 Mafai (Burmese grape) heartwood, 
root, bark 
Baccaurea ramiflora Lour. Phyllanthaceae 1 




Averrhoa carambola L. Oxalidaceae 1 
54 Magrud (kaffir lime) leaf Citrus hystrix DC. Rutaceae 2 
55 Mahahing (asafoetida, 




 Ferula assa-foetida L.  Apiaceae 3 
56 Mahuad stem bark Lepisanthes rubiginosa 
(Roxb.) Leenh. 
Sapindaceae 1 
57 Makham (tamarind) leaf Tamarindus indica L. Fabaceae 1 
58 Makhamkai leaf Putranjiva roxburghii  Wall. Putranjivaceae 1 
59 Makhampom (emblic 
myrobalan) 
fruit Phyllanthus emblica L. Phyllanthaceae 3 
60 Maklamtanu (crab's eye 
vine, American pea) 
sap wood Abrus precatorius L. Fabaceae 1 
61 Maliwanpa root N/A N/A 1 
62 Manao (lime) leaf, juice 
from fruits 
Citrus × aurantiifolia 
(Christm.) Swingle 
Rutaceae 2 
63 Maprang (marian plum, 
gandaria, plum mango) 
heartwood, 
root, bark 
Bouea macrophylla Griff. Anacardiaceae 1 




Bouea oppositifolia (Roxb.) 
Adelb.  
Anacardiaceae 1 
65 Marum (horseradish 
tree, drumstick tree) 
leaf Moringa oleifera Lam. Moringaceae 2 
66 Matum (bael, golden 
apple) 
fruit Aegle marmelos (L.) Corrêa Rutaceae 2 
67 Muakdaeng stem Wrightia coccinea (Roxb. ex 
Hornem.) Sims 
Apocynaceae 1 





leaf Acanthus ilicifolius L. Acanthaceae 1 
70 Nontaiyak root tuber Stemona tuberosa Lour. Stemonaceae 1 
71 Oi-dam (sugar cane) stem Saccharum officinarum L. Poaceae 1 
72 Phakbungdaeng 
(morning glory) 










No Local name (other 
name) 




young leaf Acmella caulirhiza Delile Compositae 1 
75 Phakpaewdaeng whole 
plant 
Iresine diffusa f. herbstii 
(Hook.) Pedersen 
Amaranthaceae 1 
76 Phaktaew leaf Cratoxylum formosum (Jack) 
Benth. & Hook.f. ex Dyer 
Hypericaceae 1 
77 Phakwanban leaf Sauropus androgynus (L.) 
Mer.  
Phyllanthaceae 1 
78 Phakwanpa leaf Melientha suavis Pierre Opiliaceae 1 
79 Phitsanad root Sophora exigua Craib Fabaceae 1 
80 Phrikpa, Phriknaiphran N/A N/A N/A 1 
81 Phrikthai, black pepper fruit Piper nigrum L. Piperaceae 2 
82 Pua-ki-nai (Huang Qin, 
Baikal skullcap) 
root Scutellaria baicalensis 
Georgi 
Lamiaceae 1 
83 Rangchued (laurel 
clock vine, blue trumpet 
vine) 
stem, root Thunbergia laurifolia Lindl. Acanthaceae 6 
84 Reonoi fruit Amomum villosum Lour. Zingiberaceae 1 
85 Rhubarb rhizome  Rheum Palmatum L.  Or R. 
officinale Bail. Or R. 
tanguticum (Maxim. Ex 
Regel) Maxim. Ex Balf. 
Polygonaceae 1 
86 Rong, rongthong 
(gamboge) 
resin Garcinia hanburyi Hook.f. Clusiaceae 1 
87 Sakhan stem Piper aff. pendulispicum 
C.DC. 
Piperaceae 2 
88 Samodingu fruit Terminalia citrina (Gaertn.) 
Roxb. ex Flem 
Combretaceae 1 
89 Samophiphek, naeton 
(beleric myrobalan) 
fruit Terminalia bellirica (Gaertn.) 
Roxb.  
Combretaceae 3 
90 Samothet fruit Terminalia spp. Combretaceae 1 
91 Sankham (Chinese 
albizia, silk tree) 
twig Albizia chinensis (Osbeck) 
Merr. 
Fabaceae 2 
92 San-ngoen, insi 
(copperpod, golden 
flamboyant) 
twig Peltophorum pterocarpum  
(DC.) Backer ex K.Heyne 
Fabaceae 2 
93 Somchin (mandarin 
orange) 
root Citrus × aurantium L. Rutaceae 1 
94 Sompoi (soap pod) leaf, pod Senegalia rugata (Lam.) 
Britton & Rose 
Fabaceae 2 
95 Ta-khlai (lemongrass) rhizome  Cymbopogon citratus (DC.) 
Stapf 
Poaceae 1 
96 Tamlueng (ivy gourd) whole 
plant 
Coccinia grandis (L.) Voigt Cucurbitaceae 2 
97 Thao-en-on stem Cryptolepis dubia (Burm.f.) 
M.R.Almeida 
Asclepiadaceae 1 
98 Thaowandaeng stem Ventilago denticulata Willd. Rhamnaceae 1 
99 Thaowanpriang (jewel 
vine) 
stem Derris scandens (Roxb.) 
Benth. 
Fabaceae 3 
100 Thaoyaimom root Clerodendrum indicum (L.) 
Kuntze 
Lamiaceae 1 
101 Thiandam (fennel 
flower, black caraway) 
seed Nigella sativa L. Ranunculaceae 1 
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102 Thiankao (cumin) fruit Cuminum cyminum L. Apiaceae 1 
103 Thua-phu (winged 
bean) 
root Psophocarpus 
tetragonolobus (L.) DC. 
Fabaceae 1 
104 Wan hokmokkhasak root N/A N/A 1 
105 Wan khothongkae rhizome  Curcuma sp. Zingiberaceae 2 
106 Wan nakkharat, Wan 
hangnak (Ceylon 
bowstring hemp, devil's 
tongue) 
rhizome  Sanseviera zeylanica (L.) 
Willd. 
Asparagaceae 1 
107 Wan thonmokkhasak rhizome  Kaempferia sp.  Zingiberaceae 1 
108 Wanmahakan root Gynura hispida Thwaites Compositae 1 
109 Wanphetchahueng 





110 Wanphetchaklab rhizome  Boesenbergia thorelii 
(Gagnep.) Loes  
Zingiberaceae 1 




N/A N/A 1 












Heteropogon contortus (L.) 
P.Beauv. ex Roem. & 
Schult. 
Poaceae 1 
114 Ya tudma whole 
plant 
Paederia pilifera Hook. f. Rubiaceae 1 
115 Yadam dried latex  Aloe spp. Xanthorrhoeaceae 2 
116 Yakha (blady grass, 
cogon grass) 
root Imperata cylindrica (L.) 
P.Beauv. 
Poaceae 2 
117 Yanang root, stem Tiliacora triandra (Colebr.) 
Diels 
Menispermaceae 3 







119 Yo (Indian mulberry) fruit Morinda citrifolia L. Rubiaceae 2 
 
Table 2-13 shows frequency of citation (FC) and relative frequency of citation (RFC) of 
preventive plants that were mentioned by at least two informants. The species were ranked 
according to their total FC values. The first species in the ranking is rangchued (Thunbergia 
laurifolia) which was cited by six out of thirty-three informants. It was used as a single herb 
and in combination. However, it was mentioned by informants from two locations only, which 
were Lamphun (RFC = 0.44) and Bangkok Metropolitan Region (RFC = 0.33). Even though 
the total RFC is low, 0.18, its RFC values for each area show the spread of knowledge about 
the usefulness of the plant in each area. The second species in the ranking is khing (Zingiber 
officinale or ginger) which was mentioned by five informants from all locations. This might be 
because it is a food item and very easy to find. It was used in combination with other 
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ingredients. While rangchued is not recorded in Khamphi Sappakhunya13, khing appears in 
this famous textbook in several important herbal formulae, such as benchakool14 and trikatuk15 
(Foundation for the promotion of Thai traditional medicine and Ayurved Thamrong School 
Center of applied Thai traditional medicine, 2007a). The third in the ranking is samothai 
(Terminalia chebula) which was mentioned by four informants from Bangkok Metropolitan 
Region. Its RFC value is quite high showing that most TTM practitioners in Bangkok 
Metropolitan Region have an agreement in its usefulness in mareng prevention. It was used 
only in combination with other raw materials. Samothai is recorded in Khamphi Sappakhunya 
as an ingredient in the popular herbal medicine, triphala, and many others (Foundation for the 
promotion of Thai traditional medicine and Ayurved Thamrong School Center of applied Thai 
traditional medicine, 2007a). 
It is acceptable to state that the cultural importance of a plant depends on the number of 
informants who cited its usefulness (FC) and the number of uses. Plants that are easy to use 
and can be adapted for many uses are more widespread and would have higher FC (Tardío 
and Pardo-de-Santayana, 2008). Rangchued is easy to use because it can be used as a 
single herb or in a combination. It is also easy to find and grow. Khing is used in benchakool 
which is used to re-balance the four elements. Maintain such balance is the key strategy in 
TTM.  
Figure 2-12 shows the steps of potential plants selection for further pharmacological study. 
Table 2-14 shows the list of plants used in the in vitro screening in Chapter 3.  
                                                     
13 A famous textbook about uses of medicinal plants and many herbal formulae. It is in Phaetthasat 
songkhro.  
14 Benchakool which comprises dipli, chettamunploeng, sakhan, chaphlu, and khing is used to fix the 
four element abnormality. 
15 Trikatuk which comprises phrikthai, khing, and dipli is used especially in rainy season to fix abnormality 
of fire or wind or water element. 
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Figure 2-12 Selection of plants for further study. Seven plants were excluded from the study. Curcuma 
spp. was excluded due to the problem in identity and supply of the plants by local herbal dispensaries. 
A. marmelos, P. emblica, P. nigrum, S. glabra, T. chebula, and Z. officinale were excluded because 
there were many reports about their chemopreventive properties.
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Table 2-13 FC and RFC of plants used in prevention of cancer/ mareng by the informants in each province 
No Scientific name Family 
Local name  
(english/ other name) 
Part used 
FC RFC 
SU CH LA BK Total SU CH LA BK Total 
1 Thunbergia laurifolia Lindl. Acanthaceae Rangchued (laurel clock vine, 
blue trumpet vine) 
leaf, stem, 
root 
0 0 4 2 6 0.00 0.00 0.44 0.33 0.18 
2 Zingiber officinale Roscoe  Zingiberaceae Khing (ginger) rhizome  2 1 1 1 5 0.22 0.11 0.11 0.17 0.15 
3 Terminalia chebula Retz. Combretaceae Kotphungpla, samothai 
(terminalia gall, myrobalan gall) 
fruit 0 0 0 4 4 0.00 0.00 0.00 0.67 0.12 
4 Allium sativum  L. Amaryllidaceae Krathiam (garlic) young shoot 0 2 1 0 3 0.00 0.22 0.11 0.00 0.09 
5  Ferula assa-foetida L.  Apiaceae Mahahing (asafoetida, stinking 
gum, devil’s dung) 
oleo-gum-
resin 
0 1 0 2 3 0.00 0.11 0.00 0.33 0.09 
6 Cladogynos orientalis Zipp. ex 
Span.  
Euphorbiaceae Chetphangkhi root 0 0 2 1 3 0.00 0.00 0.22 0.17 0.09 
7 Derris scandens (Roxb.) Benth. Fabaceae Thaowanpriang (Jewel vine) stem 1 0 1 1 3 0.11 0.00 0.11 0.17 0.09 
8 Tiliacora triandra (Colebr.) Diels Menispermaceae Yanang root, stem 0 1 0 2 3 0.00 0.11 0.00 0.33 0.09 
9 Phyllanthus emblica L. Phyllanthaceae Makhampom  
(emblic myrobalan) 
fruit 1 0 0 2 3 0.11 0.00 0.00 0.33 0.09 
10 Piper sarmentosum Roxb. Piperaceae Chaphlu (wild betel) leave, whole 
plant 
0 1 1 1 3 0.00 0.11 0.11 0.17 0.09 
11 Plumbaco indica L. Plumbaginaceae Chettamunploengdaeng  
(rose-coloured leadwort) 
root 0 1 1 1 3 0.00 0.11 0.11 0.17 0.09 
12 Allium ascalonicum L.  Amaryllidaceae Homdaeng (shallot) young shoot 0 2 0 0 2 0.00 0.22 0.00 0.00 0.06 
13 Ligusticum striatum DC. Apiaceae Kothuabua (Szechwan lovage 
rhizome, Chuan Xiong) 
rhizome  1 0 0 1 2 0.11 0.00 0.00 0.17 0.06 
14 Atractylodes lancea (Thunb.) DC. Asteraceae Kotkamao  
(atractylodes, Cang Zhu) 
dried 
rhizome 
1 0 0 1 2 0.11 0.00 0.00 0.17 0.06 
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No Scientific name Family 
Local name  
(english/ other name) 
Part used 
FC RFC 
SU CH LA BK Total SU CH LA BK Total 
15 Saussurea costus (Falc.) Lipsch.  Asteraceae Kotkraduk  
(costus root, Mu Xiang) 
dried root 0 0 0 2 2 0.00 0.00 0.00 0.33 0.06 
16 Millingtonia hortensis L.f. Bignoniaceae Kasalong (Indian cork tree) stem bark 0 0 2 0 2 0.00 0.00 0.22 0.00 0.06 
17 Capparis micracantha DC. Capparaceae Chingchi, Saemathalai root 0 1 0 1 2 0.00 0.11 0.00 0.17 0.06 
18 Terminalia bellirica (Gaertn.) Roxb.  Combretaceae Samophiphek, Naeton (beleric 
myrobalan) 
fruit 1 0 0 1 2 0.11 0.00 0.00 0.17 0.06 
19 Coccinia grandis (L.) Voigt Cucurbitaceae Tamlueng (ivy gourd) whole plant 0 0 0 2 2 0.00 0.00 0.00 0.33 0.06 
20 Dioscorea hispida Dennst. Dioscoreaceae Kloi tuber 0 0 0 2 2 0.00 0.00 0.00 0.33 0.06 
21 Senegalia rugata (Lam.) Britton & 
Rose 
Fabaceae Sompoi (soap pod) leaf, pod 1 0 1 0 2 0.11 0.00 0.11 0.00 0.06 
22 Peltophorum pterocarpum  (DC.) 
Backer ex K.Heyne 
Fabaceae San-ngoen, insi (copperpod, 
golden flamboyant) 
twig 0 0 2 0 2 0.00 0.00 0.22 0.00 0.06 
23 Albizia chinensis (Osbeck) Merr. Fabaceae Sankham (Chinese albizia, silk 
tree) 
twig 0 0 2 0 2 0.00 0.00 0.22 0.00 0.06 
24 Tinospora crispa(L.) Hook. f. & 
Thomson 
Menispermaceae Boraphet (putarwali) stem 0 0 1 1 2 0.00 0.00 0.11 0.17 0.06 
25 Piper retrofractum Vahl Piperaceae Dipli (long pepper) fruit 0 1 1 0 2 0.00 0.11 0.11 0.00 0.06 
26 Piper nigrum L. Piperaceae Phrikthai (black pepper) fruit 0 0 0 2 2 0.00 0.00 0.00 0.33 0.06 
27  Piper ribesioides Wall.  Piperaceae Sakhan stem 0 1 1 0 2 0.00 0.11 0.11 0.00 0.06 
28 Aegle marmelos (L.) Corrêa Rutaceae Matum (bael, golden apple) fruit 0 1 0 1 2 0.00 0.11 0.00 0.17 0.06 
29 Smilax spp. Smilacaceae Khaoyennuea rhizome  1 0 1 0 2 0.11 0.00 0.11 0.00 0.06 
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No Scientific name Family 
Local name  
(english/ other name) 
Part used 
FC RFC 
SU CH LA BK Total SU CH LA BK Total 
30 Smilax spp. Smilacaceae Khaoyentai rhizome  1 0 1 0 2 0.11 0.00 0.11 0.00 0.06 
31 Aloe spp. Xanthorrhoeaceae Yadam dried latex  0 1 0 1 2 0.00 0.11 0.00 0.17 0.06 
32 Curcuma sp. Zingiberaceae Wan khothongkae rhizome  0 0 0 2 2 0.00 0.00 0.00 0.33 0.06 
SU = Suratthani, CH = Chanthaburi, LA = Lamphun, BK = Bangkok Metropolitan Region 
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Table 2-14 Total samples to be studied 
No Scientific name Family  Local name Part used Abbr. Voucher 
number* 
1 Allium ascalonicum  Alliaceae Homdaeng young shoot AA - 
2 Allium sativum   Alliaceae Krathiam young shoot AS - 
3 Aloe spp. Asphoderaceae Yadam processed resin 
from leaf 
AL NL-0028 
4 Atractylodes lancea  Asteraceae Kotkamao dried rhizome AT NL-0029 
5 Capparis 
micracantha  
Capparidaceae Chingchi root CM PBM05194 
6 Citrus hystrix Rutaceae Magrud leave CH NL-0030 
7 Cladogynos 
orientalis   
Euphorbiaceae Chetphangkhi root CO PBM05196 
8 Coccinia grandis  Cucurbitaceae Tamlueng Whole plant CG PBM05195 
9 Derris scandens  Fabaceae Thaowanpriang stem DS PBM05189 
10 Ferula assa-foetida  Apiaceae Mahahing resin from root FA NL-0031 
11 Imperata cylindrica Poaceae Yakha root IC NL-0032 
12 Ligusticum striatum 
DC. 
Apiaceae Kothuabua dried rhizome LS NL-0033 
13 Peltophorum 
pterocarpum   
Fabaceae San-ngoen, Nonsi twig PP NL-0034 
14 Piper sp. Piperaceae Sakhan stem PA PBM05190 
15 Piper retrofractum  Piperaceae Dipli dried mature 
unripe fruit 
PR PBM05191 
16 Piper sarmentosum  Piperaceae Chaphlu whole plant  PS1 NL-0035 
17 Piper sarmentosum  Piperaceae Chaphlu leaf PS2 NL-0035 
18 Plumbaco indica Plumbaginaceae Chettamunploengdaeng root PI PBM05192 
19 Saussurea costus Asteraceae Kotkraduk dried root AU NL-0036 
20 Senegalia rugata Leguminosae Sompoi leaf SR1 NL-0037 
21 Senegalia rugata  Leguminosae Sompoi pod SR2 NL-0037 
22 Smilax spp.  Smilacaceae Khaoyennuea root SM NL-0038 
23 Terminalia bellirica   Combretaceae Samophiphek, Naeton fruit TB PBM05198 
24 Thunbergia laurifolia  Acanthaceae Rangchued leave TL PBM05178 
25 Tiliacora triandra Menispermaceae Yanang stem TT PBM05193 
26 Tinospora crispa  Menispermaceae Boraphet stem TC PBM05197 
*PBM – voucher specimens deposited at Faculty of Pharmacy, Mahidol University, Bangkok, Thailand. 
NL – collector’s number for materials purchased from the market without fruits / flowers for taxonomic 
identification. The verification of scientific name was performed by comparison with authentic materials. 




Mareng is commonly used to refer to cancer by Thai people nowadays. In TTM scriptures, it 
also refers to other diseases, mainly skin problems. Herbal medicines used in TTM, especially 
the ones for mareng, have been used to treat cancer. However, there was no study comparing 
mareng and cancer before. In this study, TTM’s emic concept of cancer was analyzed, 
compared to biomedicine and, for the first time, the main characteristics of mareng are 
proposed. Four characteristics; waste accumulation, chronic illnesses, inflammation, and bad 
luead and namlueang, are useful in planning pharmacological assays to investigate 
bioactivities of herbal medicines. Cancer/mareng is thought to be preventable by herbal 
medicine, of which the use should be based on individuals’ risk. Herbal formulae and medicinal 
plants used in cancer management were documented. Plants frequently cited to have benefits 
in cancer/ mareng prevention were common and easy to find. Then twenty-four potential 
plants were selected for further pharmacological investigation. 
This study provides a useful resource for identifying promising plants for the development of 
chemopreventive agents. Pharmacological and phytochemical evaluations of these medicinal 
plants were carried out in the next steps. Furthermore, the information could be beneficial for 
the integration of TTM in cancer care because the link between TTM and biomedicine was 
reported, thus, provide a better understanding of TTM to main health care providers. 
2.5. Study limitations and future work 
There were some limitations of this study that need to be highlighted. Clearly, there is no 
clinical evidence for any of the treatments, and this is beyond the scope of this contribution. 
Instead it demonstrates plausible mechanisms which can be investigated further.  
The number of participants (33) is sufficiently large to understand the basic concepts but it is 
too small to conclude that the data obtained represented an overall perspective of TTM 
practitioners’ knowledge. However, we interviewed informants from different parts of the 
country to make sure that the overall views, as well as influences of local culture, herbal 
medicine resources and the indigenous medical knowledge on the healing practice, are 
covered. Secondly, there was no clinical evidence to confirm practitioners’ diagnosis of 
cancer/mareng. The informants knew that their patients have cancer because the patients 
informed them so. Thirdly, we did not observe any real diagnosis or consults or treatment 
intervention as these were not included in the ethical approval.  
For future studies, a larger number of informants should be included to ascertain the findings. 
Clinical observational studies and studies combining the treatments of TTM practitioners and 
mainstream medical doctors would be an ideal next step as part of a strategy to better 
understand treatment outcomes for a set of diseases which is both devastating and of great 
importance both in TTM and in biomedicine. 
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Chapter 3. Screening for chemopreventive properties 
of plant extracts: cytotoxicity, protective effect 
against oxidative stress, and effects on glutathione 
and NQO1 
3.1. Introduction 
Previously in chapter 2, five characteristics of cancer in TTM were presented and compared 
to Western medicine concepts. Together with the information on the uses of herbal remedies 
for mareng prevention from the informants, a TTM cancer prevention strategy was proposed. 
Furthermore, related models for pharmacological activities investigation were also suggested 
(Figure 3-1). In this thesis, three topics, which were removal of waste from the body, liver 
protection, and prevention from krasai, were the main focus. Therefore, in vitro screening 
assays were dealing with antioxidant enzymes, which have roles in the removal of toxic 
substances or carcinogens from cells, and oxidative stress.  
 
 
Figure 3-1 Cancer prevention strategy from Thai traditional medicine and its possible pharmacological 
models. Bioassay models for the four strategies; protection of liver, prevention from krasai, 
nourishment of leaud & namlueang, and removal of waste, can be suggested. The balance of dhātu si 
is unclear in biomedical sense. It is possible to involve with the cell homeostasis. 
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3.1.1. Oxidative stress and carcinogenesis 
Yoshikawa and Naito (2002) defined oxidative stress as “a state where oxidative forces 
exceed the antioxidant systems due to loss of the balance between them”. Oxidative stress is 
well-known for the associated risk because of the damages that reactive oxygen species 
(ROS) and free radicals produce to biological molecules, such as DNA, lipids, and proteins. It 
is associated with the causation and development of many diseases, including 
atherosclerosis, hypertension, diabetes mellitus, ischemic diseases, and cancer. However, 
oxidative stress is useful in some events, such as triggering apoptosis to prepare the birth 
canal for delivery and strengthening the defence mechanisms during appropriate physical 
exercise and ischemia. In normal conditions, ROS are produced during the utilisation process 
of oxygen and are removed by antioxidant systems in the body. Under some circumstances 
ROS or free radicals are excessive and cause the loss of the balance between production and 
elimination, resulting in oxidative stress. Consequently, ROS and free radicals can attack 
biological molecules and cause DNA damage, lipid peroxidation, and lead to many diseases 
(Yoshikawa and Naito, 2002). It is important to note that ROS and free radicals are not 
synonymous. Table 3-1 shows major ROS and indicates which one is a free radical.  
Table 3-1 Major reactive oxygen species (Source: Yoshikawa and Naito, 2002) 
Reactive oxygen species Remarks 
O2 (Singlet oxygen) - 
H2O2 (Hydrogen peroxide) - 
LOOH (Alkylhydroperoxide) - 
CIO- (Hypochlorite ion) - 
Fe4+O (Ferryl ion) - 
Fe5+O (Periferryl ion) - 
O2 (Superoxide radical) A free radical 
HO  (Hydroxyl radical) A free radical 
HOO (Hydroperoxyl radical) A free radical 
LOO (Alkylperoxyl radical) A free radical 
LO (Alkoxyl radical) A free radical 
NO  (Nitric oxide) A free radical 
 
Oxidative stress has been proved to be associated with many of the hallmarks of cancer 
(Hanahan and Weinberg, 2011). It has an important role in cancer initiation and progression. 
Elevated ROS levels can initiate DNA damage. ROS also helps cancer cells to acquire 
proliferative signals and resist apoptosis, which result in uncontrolled cell growth. They also 
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promote the invasion and metastasis by activation of metalloproteinase (MMP) and epithelial 
mesenchymal transition, as well as angiogenesis (Fiaschi and Chiarugi, 2012). Many 
promising cancer chemopreventive natural products, such as (−)-epigallocatechin-3-gallate 
(EGCG) from tea, resveratrol from grapes and its analogs, genistein from soy, and curcumin, 
have been reported to possess abilities in ROS scavenging and protection against oxidative 
damage (Darvesh and Bishayee, 2013, Acharya and Ghaskadbi, 2013, Kim et al., 2015, Zhu 
et al., 2004, Gibellini et al., 2011).   
3.1.2. Krasai: degenerative conditions in Thai traditional medicine and correlation with 
oxidative stress 
Chronic illnesses/krasai is among the main characteristics of cancer recognised in TTM. 
According to the official Thai dictionary, krasai is characterised by emaciation, yellow skin, 
and cold feet and results in deterioration of the body (Royal Society of Thailand, 2011). It is 
also defined as a condition with symptoms generally located in the lower abdominal area 
including symptoms recognised in biomedicine as hernia, urino-genital afflictions, ulcers, and 
possibly gallbladder illness (Bamber, 1987). However, the most widely accepted definition 
among Thai traditional practitioners is the deterioration of the four elements or a decline of the 
body (Foundation for the promotion of Thai traditional medicine and Ayurved Thamrong 
School Center of applied Thai traditional medicine, 2007b). As such in TTM it can be 
interpreted as a type of degenerative diseases. 
Degenerative diseases are non-infectious diseases whose incidence increases with age. This 
type of diseases develops as a result of the continuous degeneration of cells and tissues 
which later affects organs. Oxidative stress has been linked to the pathogenesis of many 
common degenerative diseases, such as cardiovascular diseases, diabetes mellitus, and 
rheumatoid arthritis (Islam et al., 2016). Denham Harman proposed that an accumulation of 
free radical damage was one factor in aging (Harman, 1956). Later, scientific evidence 
revealed that oxidative stress causes cell apoptosis, necrosis, and an accumulation of DNA 
and mitochondrial DNA (mtDNA) mutations, as well as showed the correlation between ROS 
and degenerative diseases. Therefore, it is now accepted that oxidative damage plays an 
important role in the loss of physiological functions (Kadenbach et al., 2009). 
There are several reasons why krasai was considered as degenerative diseases. Firstly, the 
incidence of krasai increases with age because it takes a long time to develop the condition. 
Secondly, a patient will be diagnosed with krasai when an effect in an organ can be observed. 
Thirdly, patients with chronic illnesses would develop krasai eventually because it is at a 
terminal stage. Lastly, it is a result of the continuous degeneration of the body. Based on the 
link between krasai, degeneration, and cancer, in vitro assays using oxidative stress as an 
important marker were used in this project  
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3.1.3. Oxidative stress models in in vitro 
Protective effect against oxidative stress-induced cell death was used to screen for potential 
extracts as it allows to screen many samples using a microplate format. Two chemicals widely 
used in oxidative stress assays in living cells are hydrogen peroxide (H2O2) and tert-butyl 
hydroperoxide (t-BHP) (Figure 3-2). H2O2 and t-BHP induce cell death by damaging DNA by 
a free radical/peroxidation mechanism, depletion of glutathione, and activation of calcium-
dependent endonucleases. While H2O2 forms hydroxyl radicals which cause damage to DNA, 
lipids, and proteins, t-BHP causes little damage to DNA but mainly causes damage to the cell 
membrane by superoxide or superoxide-like radical formation. However, the mechanisms of 
t-BHP damage also involve lactate dehydrogenase (LDH) leakage, mitochondrial damage, the 
release of cytochrome c, the loss of calcium homeostasis, the induction of arachidonic acid 
release from membrane phospholipids, and malondialdehyde formation (Slamenova et al., 
2013). T-BHP is also widely used in cytoprotective effect evaluation models. Therefore, t-BHP 
was used in this project to induce cell death/damage due to the fact that it attacks cells via 
several mechanisms. 
 
Figure 3-2 Tert-butyl hydroperoxide (t-BHP) 
 
Based on the fieldwork, we selected detoxification and prevention of degeneration (oxidative 
stress) to be our focus to explore chemopreventive properties of the samples because it is 
difficult to avoid carcinogens and oxidative stress. Protection from oxidative damage caused 
by free radicals is one of blocking agents’ mechanisms. This activity of such agents can be 
tested in vitro by assessment of the ability to induce detoxifying enzymes and glutathione. The 
activation of phase II enzymes facilitates the clearance of toxicants and is among main 
mechanisms of chemopreventive agents (De Flora and Ferguson, 2005).  
3.1.3.1. NAD(P)H:quinone oxidoreductase 1 (NQO1) 
NAD(P)H:quinone oxidoreductase 1 (NQO1) is a key enzyme involved in the defence against 
the toxicity and carcinogenicity of quinones and inhibition of neoplasia. Quinones are 
widespread in our environment and human are exposed to them extensively. Many quinones 
have been reported to be carcinogens, such as dioxins (NTP (National Toxicology Program), 
2016), tetrachloro-1, 4-benzoquinone (TCBQ) (Zhu et al., 2010),  and quinone metabolites 
from polycyclic aromatic hydrocarbons (PAHs) in the air (Ran et al., 2008) (Figure 3-3). NQO1 
also reacts to other reactive species, such as methylene blue, dichlorophenolindolphenol, azo, 
and nitro compounds (Atia et al., 2014). Therefore, it shows ability in chemoprotection. 
117 
 
Figure 3-3 (A) TCDD (2,3,7,8-Tetrachlorodibenzo-p-dioxin), also known as dioxins, a well-known 
human carcinogen which is a contaminant in herbicides that were widely used in 1960s and 1970s to 
control weeds and as a defoliant during the Vietnam War. (B) Tetrachloro-1,4-benzoquinone (TCBQ) is 
one of the major carcinogenic quinoid metabolites of the widely used wood preservative 
pentachlorophenol (PCP). (C) O-quinone metabolite of benz[a]anthracene, a polycyclic aromatic 
hydrocarbon. 
NQO1 is induced under the oxidative stress conditions which results in the prevention of 
carcinogenesis by several activities. Firstly, the catalytic activity of NQO1 in the complete 
reduction and detoxification of highly reactive quinones allows the protection against DNA and 
other cellular macromolecules damage (Figure 3-4). Secondly, NQO1 maintains the 
endogenous lipid-soluble antioxidants (co-enzyme Q and α-tocopherol-quinone) in their 
reduced and active forms. The active forms of such lipid-soluble antioxidants protect against 
lipid peroxidation and damage to the plasma membrane. Thirdly, NQO1 is required for the 
stabilisation of p53 protein in response to DNA-damaging stimuli (Nioi and Hayes, 2004). 
 
 
Figure 3-4 A hypothetical scheme for the carcinogenicity of a quinone. Simple quinones can undergo 
single-electron reduction and produces highly reactive semiquinone intermediates with an unpaired 
electron. Semiquinones can form adducts directly with cellular macromolecules including DNA and 
proteins, and may lead to carcinogenesis. NQO1 protects against toxicity and carcinogenicity of 
quinones by bypassing the semiquinone intermediates (modified from (Nioi and Hayes, 2004)). 
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3.1.3.2. Glutathione 
Glutathione (L-gamma-glutamyl-L-cysteinglycine) has several functions in the body, including 
detoxification of reactive metabolites which mostly are toxic or carcinogenic, thiol-disulfide 
exchange which is involved in certain metabolic pathways, and acts as main plasma and 
tissue storage and transfer of cysteine because simple cysteine would auto-oxidize to its toxic 
form. In normal condition, glutathione reductase will rapidly reduce oxidized form of 
glutathione (GSSG) to its reduced form (GSH). Therefore, 98% of intracellular glutathione is 
GSH. GSH detoxifies toxic electrophiles by random conjugation or via a reaction catalysed by 
glutathione-S-transferase (GST). Then GSH conjugates, which are more water soluble, are 
metabolized to mercapturic acid and then excreted via the bile. GSH also has roles in the 
defence against oxidative stress which is a consequence of aerobic metabolism. Superoxide 
and hydrogen peroxide formed during the metabolism are reduced by GSH (DeLeve and 
Kaplowitz, 1991, Melino et al., 2011). 
3.1.4. Objectives 
The objectives of this chapter are to investigate cytotoxicity, protective effect against oxidative 
stress, and effects on glutathione and NQO1 enzyme activities of extracts from the selected 
plants used for cancer/mareng prevention in cell cultures. 
3.2. Materials and methods  
3.2.1. Materials 
AlamarBlue and PrestoBlue were bought from Abd Serotec. Primary rat hepatocytes from 
Sprague-Dawley rats (RTCP10, Lot number RS874), Dulbecco's Modified Eagle Medium 
(DMEM), Foetal Bovine Serum (FBS), PBS, Penicillin-Streptomycin (10,000 U/mL), Williams 
E Medium, dexamethasone, human recombinant insulin, GlutaMAXTM, and HEPES were 
purchased from Life technologies. HepG2 cells (ACC No 85011430, Lot 11C013), (-)-
Epigallocatechin gallate (EGCG) (E4268), paclitaxel (T1912), Albumin from bovine serum 
(A2058), β-Nicotinamide adenine dinucleotide 2′-phosphate reduced tetrasodium salt hydrate 
(NADPH) (N1630), L-Glutathione reduced (G4251), 5-5'-dithiobis (2-nitrobenzoic acid) 
(DTNB) (D218200), thiazolyl blue tetrazolium bromide (MTT) (M5655), glutathione reductase 
from baker's yeast (S. cerevisiae) (G3664), 5-Sulfosalicylic acid (SSA) (S2130), DMSO, 
Complete Mini protease inhibitor cocktail (11836170001), and other reagents were from 
Sigma Aldrich. NADP monosodium salt (sc-202724) and dicoumarol (sc-205647A) were 
purchased from Santa Cruz Biotechnology. Glucose 6-phosphate disodium salt was from Bio 
Basic Canada Inc. Yeast glucose 6-phosphate dehydrogenase (J61181) and flavin adenine 
dinucleotide disodium salt (FAD) (A14495) were from Alfa Aesar. RIPA lysis buffer 10X was 
from Merck Millipore. DC Protein Assay kit (500-0116) was from Bio-Rad Laboratories, Inc. 
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3.2.2. Plant extracts preparation 
Plant materials were washed with deionized water, oven-dried between 40-60 oC, and ground. 
Water extracts were prepared according to Thai traditional methods for decoctions. Briefly, 60 
g of herbal powder was boiled with 600 ml of water until the volume reached about 200 ml. 
The decoction was filtered through No.1 and No.4 filter paper (Whatman®) and the water was 
then removed by freeze drying. To prepare a 70% ethanolic extract, 60 g of herbal powder 
was added into a glass bottle. Then 70% ethanol was added until it covered the powder 
surface. The bottle was shaken for 15 minutes to mix the sample powder with the solvent. 
Later, the bottle was wrapped with aluminium foil to protect from light and allowed to stand for 
7 days with a 15-minutes shake every day. After 7 days, the extract was filtered through No.1 
and No.4 filter paper (Whatman®) and the solvent was then removed using a rotary evaporator 
and a freeze dryer. The dry extracts were stored in a cool, dry place and protected from light 
until use. Prior to cell-based assays, the extracts were prepared into stock solutions in water 
or DMSO. The water stock solution was then filtered through 0.22 μM syringe filter. All stock 
solutions were kept at -20 oC until use. 
3.2.3. Cells 
It is impractical to prevent specific forms of cancer, unless in increased risk population. 
Therefore, liver cells are selected based on some informants’ cancer prevention concept that 
many forms of cancer could be prevented by liver protection. The HepG2 (human 
hepatocellular carcinoma) cell line has been used in many studies investigating 
chemopreventive properties of plant extracts. The advantages of HepG2 cell line are many. It 
is easy to maintain and immortal, so it provides an unlimited number of cell divisions. The cell 
line has morphology similar to that of liver parenchymal cells and secretes many proteins 
which resemble normal human liver cells, especially phase I and phase II enzymes which are 
important in the activation/detoxification of procarcinogens, which reflect the metabolism of 
xenobiotics in the human body (Knasmüller et al., 2004). Rat hepatocytes have been used as 
an alternative to whole rats in the assessment of genotoxic potential and cytotoxicity 
mechanism (Muakkassah Kelly et al., 1988), as well as other in vitro studies of liver physiology 
and pathophysiology (Arterburn et al., 1995). The advantages of normal hepatocytes are that 
they express in vivo-like enzyme and show in vivo-like sensitivity to apoptosis, unlike liver 
cancer cell lines which acquired high resistance against apoptosis (Vinken et al., 2014).  
HepG2 cells were maintained in DMEM supplemented by 10% FBS and 1% 
Penicillin/Streptomycin in 75 cm3 cell culture flasks at 37 oC in 5% CO2/95% air. Fresh 
complete medium was changed every 3 days. The cells were discarded after 15th subculturing. 
Primary rat hepatocytes were thawed and maintained in collagen I-coated 96 well plates. The 
thawing and plating medium was Williams E Medium supplemented with 5% FBS, 1 μM 
Dexamethasone, 1% Penicillin/Streptomycin, 4 μg/ml Human Recombinant Insulin, 2 mM 
GlutaMAXTM, and 15 mM HEPES, pH 7.4. The serum-free medium was refreshed every 24 
hours to maintain the hepatocytes. The hepatocytes were discarded after five days. 
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3.2.4. Cytotoxicity of plant extracts in HepG2 cells 
AlamarBlue is a dye that fluoresces and changes its colour due to oxidation and reduction. It 
is very stable, water soluble, and has low toxicity. The AlamarBlue assay is a resazurin-based 
cell proliferation and viability assay which relies on the mitochondrial activity to reduce non-
fluorescent resazurin to pink fluorescent compound, resorufin. Therefore, the mitochondrial 
damage results in the decrease of the fluorescence. The reduction of AlamarBlue dye may be 
related to mitochondrial enzymes, such as flavin mononucleotide dehydrogenase, flavin 
adenin nucleotide dehydrogenase, nicotinamide adenine dinucleotide dehydrogenase, 
nicotinamide adenine phosphate dehydrogenase, and cytochromes (Miret et al., 2006). The 
reduction of resazurin depends on the cellular metabolism and this varies among different 
type of cells (Nakayama et al., 1997). Therefore, the experimental parameters, such as the 
cell density and the incubation time with the dye must be optimized. Based on the results from 
the method optimization, the cell density of 5,000 cells/ well and 2 hour-incubation was used. 
HepG2 cells were seeded at the density of 5,000 cells/well in 96-well black microplates and 
allowed to attach for 24 hours. The extracts (3.125 – 100 or 6.25 – 200 µg/ml), or paclitaxel 
(0.001 nM – 10 µM) or EGCG (50 – 400 µM) as positive control, or fresh medium as control 
were then added. After 48 hours, 100 µl of diluted AlamarBlue solution (1:10 in complete 
medium) was replaced and incubated for 2 hours at 37 oC. After that, the fluorescence intensity 
was measured at 560 nm excitation and 590 nm emission using a microtiter plate reader 
(Infinite M200, Tecan). The percentage difference between treated and control cell was 
calculated as follows;  
 
3.2.5. Protective effect against oxidative stress-induced cell death 
Prior to the experiment with plant extracts, suitable concentration and incubation time of t-
BHP were optimized. After the viability of HepG2 cells after different incubation time with 
various concentrations of t-BHP were tested, incubation with 0.5 mM t-BHP for 3 hours was 
used. 
HepG2 cells were seeded in 96-well black plate at the density of 10,000 cells/well. After 24 
hours, the medium was replaced with fresh complete medium as control, positive control 
(EGCG 50 µM), and plant extracts at maximum non-toxic concentration (MNTC). After 
incubation with the treatment for 24 hours, the medium was discarded and cell death was 
induced by addition of 200 µl of 0.5 mM t-BHP to each well. After 3 hours, AlamarBlue assay 
was performed to determine the cell viability. 
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3.2.6. NQO1 activity assay 
NQO1 activity was measured following (Fahey et al., 2004). The principle of the assay is 
shown in Figure 3-5.  
 
Figure 3-5 NQO1 assay principle. Glucose 6-phosphate and glucose-6-phosphate dehydrogenase 
(G6PDH) generate NADPH continually. NADPH is used by NQO1 (quinone reductase, QR) to transfer 
electrons to menadione and from menadiol. Then menadiol reduces MTT to the purple formazan which 
can be measured between 490 to 640 nm. Both NADPH and menadione are regenerated, which 
obviates problems encountered  with substrate depletion (Prochaska and Santamaria, 1988). 
 
The cells were seeded at the density of 10,000 cells per well in 96-well transparent plate and 
allowed to attach for one night. Then the cells were incubated with extracts at MNTC or DMSO 
or menadione (positive control) or dicoumarol (negative control). After the incubation, the cells 
were washed twice with PBS. Then the cells were lysed with 30 µl of RIPA buffer 
supplemented with 1 mM PMSF and shaken on a plate shaker for 20 minutes. Five µl of the 
cell lysate was transferred to a new plate for quantification of total protein. Just before the 
addition, 1 ml of reaction mixture was mixed with 1 μl of 50 mM menadione. Then 200 μl of 
the complete reaction mixture was added to each well. The absorbance of the product was 
measured immediately at 610 nm and every one minute up to five minutes with a microtiter 
plate reader (Infinite M200, Tecan). The reaction mixture was made according to Table 3-2 
and kept at 2-8 oC not exceeding 4 days to ensure the stability of MTT. NQO1 specific activity 
of treated cells were reported as percentage of the control (Prochaska, 1994). Optimum 
incubation time was optimized by incubating HepG2 cells with various concentrations of 
menadione and dicoumarol for 24, 48, and 72 hours. 72-hours incubation was used throughout 




Table 3-2 Composition of NQO1 assay reaction mixture 
 Reagents Amount/volume per 10 ml of reaction mixture 
1 0.5 M Tris-Cl (pH 7.4) 500 μl 
2 Bovine serum albumin 6.67 mg 
3 1.5% Tween-20 67 μl 
4 7.5 mM FAD 6.7 μl 
5 150 mM glucose 6-phosphate 67 μl 
6 50 mM NADP 6 μl 
7 Yeast glucose 6-phosphate 
dehydrogenase 
20 units 
8 MTT 3 mg 
9 Distilled water to10 ml 
 
3.2.7. Intracellular GSH assay 
Glutathione measurement is based on the enzymatic recycling method (Figure 3-6) which was 
modified from (Allen et al., 2001).  
 
Figure 3-6 Enzymatic recycling method for GSH measurement. Reduced form of glutathione (GSH) 
reacts with DTNB and produce 2-nitro-5-thiobenzoic acid (TNB) and oxidized form of glutathione 
(GSSG). In the present of NADPH, GSSG is then reduced by glutathione reductase and form GSH and 
TNB. TNB absorbance is measured at 405 nm. The absorbance is proportional to GSH amount in the 
sample (Shaik and Mehvar, 2006). 
 
The cells were seeded at the density of 6 x 105 cells per well in 6-well transparent plate and 
allowed to attach for one night. Then the cells were incubated with extracts at MNTC or DMSO. 
After 24-hour incubation, the cells were treated with 0.7 mM t-BHP for 4 hours. To prepare the 
cell lysate, the cells were washed twice with ice-cold PBS. After the addition of 150 µl of ice-
cold RIPA buffer containing cOmplete Mini tablets (150 µl of 7X cOmplete tablet stock solution 
was added to every 900 µl of RIPA buffer) to each well, the cells were scraped off quickly and 
transferred to 1.5 ml reaction tubes and incubated in ice for 30 minutes. Then the tubes were 
ultrasonicated for 10 seconds and kept in ice for 10 seconds to help lysing the cells completely. 









reaction tubes after centrifugation at 8000 x g for 10 minutes at 4 oC. The cell lysate was 
diluted with 5% SSA at 1:2 or 1:5 to precipitate proteins and to inhibit  γ-glutamyl  transferase, 
which  leads to the loss of GSH (Rahman et al., 2007). After centrifugation at 10,000 rpm for 
10 minutes at 4 oC, 25 µl of supernatant was added to 96-well plates (3 replicates/sample). 
Then 125 µl of ice-cold complete GSH reaction mixture (Table 3-3) was added to the 
supernatant. The plates were then briefly shaken at 500 rpm on a plate shaker. The 
absorbance at 405 nm was immediately measured and every 30 seconds up to 5 minutes (11 
cycles) by a microtiter plate reader (Infinite M200, Tecan). A GSH standard curve (0.012 – 25 
μM) was performed together with each assay. 
 
Table 3-3 Complete GSH reaction mixture composition for 6 samples; including GSH standard curve 
  Reagents Volume 
1 143 mM Sodium Phosphate Buffer containing 6.3 mM EDTA  
(Prepare by dissolving 0.470 g disodium EDTA in a solution consisting of 168 ml of 286 mM dibasic sodium 
phosphate and 32 ml of 286 mM monobasic sodium phosphate) 
7.5 ml 
2 2.39 mM NADPH solution  
(Prepare by dissolving 2 mg NADPH in 1 ml of Sod. Phosphate Buffer )  
1 ml 
3 Glutathione reductase 31.5 μl 
4 0.01 M DTNB (add just before the assay) 
(Prepare freshly by dissolving 3.96 mg DTNB in 1 ml of Sod. Phosphate Buffer)  
500 μl 
 
Calculation of GSH levels in samples 
The first curve was plotted by using the absorbance of each concentration of GSH standard 
(Y) against time (seconds, X) and slopes were calculated using MS Excel 2010. The second 
curve was done by plotting the slopes of each GSH standard (Y) against GSH concentration 
(X) (Figure 3-7). Then the sample curve was plotted in the same way with the first curve. To 
calculate GSH amount (x) in each sample, replacing y with the sample’s slope (Allen et al., 
2001). The results were expressed as GSH level per 1 mg of protein (µM/mg). The amount of 
protein was quantified using Lowry method (described in 3.2.8). 
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Figure 3-7 Example of GSH level calculation. From the second curve, m value was obtained from its 
slope and b value was obtained from y-intercept. GSH amount (x) was calculated by replacing y with 
the sample’s slope.  
 
3.2.8. Protein measurement  
Bio-Rad DCTM Protein Assay kit, which utilizes Lowry method, was used to determine the 
amount of protein. Before the assay was performed, working reagent A was prepared by 
addition of 20 µl of reagent S to 1 ml of reagent A. Five µl of cell lysate was added into 96-
well plate. Then twenty-five µl of working reagent A was added to each well followed by 200 
µl of reagent B. After that the plate was shaken and incubated at room temperature for 15 
minutes, protected from light, before an absorbance measurement at 750 nm with a microtiter 
plate reader (Infinite M200, Tecan). A BSA standard curve was generated and used to quantify 
the amount of protein in cell lysate. The curve was linear in the range of 0 – 1 mg/ml with R2 
> 0.99. 
3.2.9. Cytotoxicity of plant extracts in primary rat hepatocytes 
PrestoBlue® is a resazurin-based solution used to determine cell viability and proliferation. 
PrestoBlue can be reduced to highly fluorescent red colour solution by reducing environment 
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in living cells cytosol. There are several advantages to this assay. Firstly, it is non-toxic and 
does not require cell lysis. Cells can be allowed to continue to proliferate after the removal of 
the reagent and replacement with the fresh medium. Therefore, it is very suitable to be used 
with rat hepatocytes because they do not proliferate and cannot be sub-cultured. After one 
assay, the hepatocytes can be simply washed and then maintained in the serum-free medium 
with or without treatment to prepare them for the next assay. Secondly, the incubation time is 
very short, from 10 minutes. Thirdly, it is convenient and saves time because the reagent is 
ready to use. Lastly, the changes in colour can be detected using either fluorescence or 
absorbance measurements. So it is very flexible in any laboratory.   
The hepatocytes were plated at the density of 20,000 cells/well in collagen I-coated 96 well 
plates and left for initial attachment for 6 hours. Then the hepatocytes were treated with CGe, 
CHe, PS1e, TLe, or SR1e in various concentrations for 24 and 48 hours. Ethanol (0.0625 – 
10% v/v) was used as a positive control and fresh serum-free medium served as control. After 
the indicated incubation time, the medium was replaced by 10% PrestoBlue medium. The 
fluorescent intensity was scanned after 20 minutes at excitation wavelength of 535+9 nm and 
emission wavelength of 590+20 nm. Cytotoxicity was presented as % viability compared to 
the control. 
3.2.10. Statistical analysis 
Calculation of average, SD values, IC50 (the concentration of the extracts that inhibit the cell 
viability for 50%), and maximum non-toxic concentration (MNTC) (the concentration of the 
extracts that inhibit the cell viability for less than 20%), and one-way ANOVA analysis were 
performed using GraphPad Prism 5.01 software (GraphPad Software, Inc.). All experiment 
was performed at least N = 3. The level of significance was set at P < 0.05. 
3.3. Results and discussion 
3.3.1. Yield of plant extracts 
After the freeze drying, the percent yield of each extract was calculated. The yield ranged from 
0.63 to 85.14% (Table 3-4). Ethanol extract of Yadam (the resin from the leaf of Aloe spp.) 
gave the highest yield. 
 
Table 3-4 Percent yield of plant extracts. 
No Scientific name Local name Part Abbr. Extracts %Yield 
1 Allium ascalonicum  Homdaeng young shoot AAe Ethanol 1.61 
2 Allium ascalonicum  Homdaeng young shoot AAw Water 7.05 
3 Aloe spp. Yadam processed resin 
from leaf 
ALe Ethanol 85.14 
4 Aloe spp. Yadam processed resin 
from leaf 
ALw Water 27.97 
5 Allium sativum   Krathiam young shoot ASe Ethanol 1.88 
6 Allium sativum   Krathiam young shoot ASw Water 2.95 
7 Atractylodes lancea  Kotkamao dried rhizome ATe Ethanol 9.06 
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No Scientific name Local name Part Abbr. Extracts %Yield 
8 Atractylodes lancea  Kotkamao dried rhizome ATw Water 11.70 
9 Saussurea costus Kotkraduk dried root AUe Ethanol 21.89 
10 Saussurea costus Kotkraduk dried root AUw Water 9.95 
11 Coccinia grandis  Tamlueng leaf CGe Ethanol 8.53 
12 Coccinia grandis  Tamlueng leaf CGw Water 11.30 
13 Citrus hystrix Magrud, Kaffir lime leaf CHe Ethanol 11.53 
14 Citrus hystrix Magrud, Kaffir lime leaf CHw Water 12.41 
15 Capparis micracantha  Chingchi root CMe Ethanol 4.20 
16 Capparis micracantha  Chingchi root CMw Water 4.37 
17 Cladogynos orientalis   Chetphangkhi root COe Ethanol 5.40 
18 Cladogynos orientalis   Chetphangkhi root COw Water 2.68 
19 Derris scandens  Thaowanpriang stem DSe Ethanol 3.34 
20 Derris scandens  Thaowanpriang stem DSw Water 18.22 
21 Ferula assa-foetida  Mahahing resin from root FAe Ethanol 4.34 
22 Ferula assa-foetida  Mahahing resin from root FAw Water 22.20 
23 Imperata cylindrica Yakha root ICe Ethanol 3.15 
24 Imperata cylindrica Yakha root ICw Water 7.25 
25 Ligusticum striatum Kothuabua dried rhizome LSe Ethanol 5.00 
26 Ligusticum striatum Kothuabua dried rhizome LSw Water 1.90 
27 Piper ribesioides Sakhan stem PAe Ethanol 5.01 
28 Piper ribesioides Sakhan stem PAw Water 4.25 
29 Plumbaco indica Chettamunploengdaeng root PIe Ethanol 10.49 
30 Plumbaco indica Chettamunploengdaeng root PIw Water 18.99 
31 Peltophorum 
pterocarpum   
San-ngoen, Nonsi stem bark PPe Ethanol 10.91 
32 Peltophorum 
pterocarpum   
San-ngoen, Nonsi stem bark PPw Water 2.61 
33 Piper retrofractum  Dipli dried mature unripe 
fruit 
PRe Ethanol 6.05 
34 Piper retrofractum  Dipli dried mature unripe 
fruit 
PRw Water 11.20 
35 Piper sarmentosum  Chaphlu whole plant  PS1e Ethanol 5.32 
36 Piper sarmentosum  Chaphlu whole plant  PS1w Water 8.31 
37 Piper sarmentosum  Chaphlu leaf PS2e Ethanol 8.59 
38 Piper sarmentosum  Chaphlu leaf PS2w Water 3.18 
39 Smilax sp.  Khaoyennuea root SMe Ethanol 5.41 
40 Smilax sp.  Khaoyennuea root SMw Water 7.94 
41 Senegalia rugata Sompoi leaf SR1e Ethanol 10.56 
42 Senegalia rugata Sompoi leaf SR1w Water 10.95 
43 Senegalia rugata Sompoi pod SR2e Ethanol 20.97 
44 Senegalia rugata Sompoi pod SR2w Water 16.41 
45 Terminalia bellirica   Samophiphek, Naeton fruit TBe Ethanol 23.08 
46 Terminalia bellirica   Samophiphek, Naeton fruit TBw Water 18.55 
47 Tinospora crispa  Boraphet stem TCe Ethanol 1.49 
48 Tinospora crispa  Boraphet stem TCw Water 0.63 
49 Thunbergia laurifolia  Rangchued leave TLe Ethanol 7.84 
5 Thunbergia laurifolia  Rangchued leave TLw Water 4.37 
51 Tiliacora triandra Yanang stem TTe Ethanol 5.54 
52 Tiliacora triandra Yanang stem TTw Water 5.04 
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3.3.2. Cytotoxicity of plant extracts in HepG2 cells 
Paclitaxel and EGCG had IC50 values of 5.63 nM and 178.4 M, respectively. The MNTC value 
of EGCG was 119.3 M. Paclitaxel was used to validate the assay. After that EGCG served 
as positive control because it is a well-known potential chemopreventive agent (Landis-
Piwowar and Iyer, 2014). Table 3-5 shows IC50 and MNTC values of all extracts. According to 
National Cancer Institute’s criteria, cytotoxicity of plant extracts can be categorized into three 
groups; potent activity (log IC50 < 0), moderate activity (0 < log IC50 < 1.10), and weak activity 
(1.10 < log IC50 < 1.5) (Fouche et al., 2008). After cytotoxicity screening of 52 plant extracts 
(from 24 species), only SR2e exhibited moderate activity with log IC50 = 0.85. A hit rate of 
4.17% was obtained based on the number of species with moderate activity expressed as a 
percentage of the 24 species tested. Interestingly, SR1e (ethanol extract of SR leaves) did 
not show comparable effect with SR2e (ethanol extract of SR pods). Until now, Senegalia 
rugata (synonym Acacia concinna) has never been reported for its cytotoxicity in HepG2 cells 
or anti-cancer activity before. Three extracts; SR2w, AUe, and ASe, showed weak activity with 
log IC50 values of 1.16, 1.21, and 1.49, respectively. There was no report for cytotoxicity in 
HepG2 for extract from young shoots of Allium ascalonicum (AS). Unlike SR and AS, 
Saussurea costus (AU) was reported for anti-cancer activity of its isolated compounds; 
alantolactone, isoalantolactone, and contunolide (Rasul et al., 2013a, Khan et al., 2013). 
However, as this PhD project focused on chemopreventive agents, the main attention was not 
on finding extracts with potent cytotoxicity, but rather on other activities related to 
chemoprevention. For example, EGCG did not show a strong cytotoxic effect in previous 
studies, with concentration that inhibited cancer cell growth ranging from 5 M to 44 mM (48 
hours incubation) (Darvesh and Bishayee, 2013). Cytotoxicity assay was an important step in 














Table 3-5 IC50 and MNTC values of plant extracts in HepG2 cells 
No Extract 
codes 
IC50 (µg/ml) MNTC (µg/ml) 
Ethanol extract (e) Water extract (w) Ethanol extract (e) Water extract (w) 
1 AA >200 >200 31.25 200 
2 AS 31.04 >200 25.08 200 
3 AL >200 >200 50 200 
4 AT 51.57 >200 12.15 200 
5 AU 16.19 >200 7.954 200 
6 CM >200 >200 200 200 
7 CH 88.39 >200 50.17 200 
8 CO 50.07 >200 24.71 200 
9 CG >200 >200 100 100 
10 DS 98.57 >200 65.84 150 
11 FA 196.6 >200 12.5 200 
12 IC 62.24 >200 33.12 200 
13 LS 100.5 >200 36.02 200 
14 PA  >200 >200 44.44 200 
15 PI 48.65 >200 37.06 89.81 
16 PP 65.78 70.73 37.63 42.97 
17 PR 154.3 >200 111.3 50 
18 PS1 >200 >200 100 200 
19 PS2 >200 >200 100 200 
20 SR1  >200 >200 100 200 
21 SR2  7.101 14.67 1.219 7.221 
22 SM >200 >200 200 200 
23 TB 115.0 198.5 10 23.85 
24 TC >200 >200 150 200 
25 TL >200 >200 50 200 
26 TT 81.06 >200 53.47 18.04 
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3.3.3. Plant extracts possessed protective effect against oxidative stress-induced cell 
death 
After a three hours-incubation with 0.5 mM t-BHP, the cell viability was reduced to 31.47%. 
Pre-treatment with 50 M EGCG and 15 extracts significantly reduced t-BHP-induced cell 
death (Figure 3-8). TBw at 30 g/ml showed the most potent activity. It could restore the cell 
viability to 59.3%, which was higher than EGCG. This might due to the antioxidant activity of 
the water extracts that showed comparable DPPH radical scavenging activity to vitamin C 
(Chalise et al., 2010). Previous studies have reported some activities which might contribute 
to the protective effect of these plant extracts. Isoalantolactone isolated from AU activated 
Nrf2 (Rasul et al., 2013b). CH extracts exhibited hydroxyl radicals scavenging activity and 
inhibited lipid peroxidation in HepG2 cells (Laohavechvanich et al., 2010). Hydromethanolic 
extract of CG showed free radical scavenging and antioxidant activities (Umamaheswari and 
Chatterjee, 2007). TL extracts exhibited DPPH radical scavenging activity (Rojsanga et al., 
2012) and protective activity against ethanol-induced liver damage in rats and rat hepatocytes 
(Pramyothin et al., 2005). Water extract of DS showed antioxidant effect (Laupattarakasem et 
al., 2003). Ethanol extracts of the stem, leaf, and fruit and water extracts of the fruit and stem 
of PS showed weak antioxidant activity in DPPH assay (Hussain et al., 2009). Therefore, its 
protective effect might largely depend on other mechanisms. For AS, the protective effect 
might due to the ability of organosulfur compounds and allyl derivatives in the induction of 
GST, which is an important defensive enzyme (Bianchini, 2001).  





Figure 3-8 Protective effects of plant extracts against tBHP-induced cell death. Cell viability of HepG2 cells was measured by AlamarBlue assay after an induction of cell death 
by 0.5 mM t-BHP for three hours. One-way ANOVA analysis showed that pre-treatment with 15 extracts for 24 hours significantly protected HepG2 cells from t-BHP-induced 
cell death, *P < 0.05 (N >3). 
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3.3.4. Plant extracts induced NQO1 activity 
Fifteen extracts; namely TBw, AUw, ALw, CHe, AUe, CGe, TLe, TLw, TBe, DSw, SR1e, PIw, 
PS1e, ASw, and CMw, were tested for the ability to induce NQO1 activity. After 72-hour 
incubation, five extracts; CHe, CGe, TLe, SR1e, and PS1e, significantly increased NQO1 level 
in a dose-dependent manner (p < 0.01) (Figure 3-9). Dicoumarol, an NQO1 inhibitor, reduced 
NQO1 activity by 50%. Menadione, an NQO1 inducer, enhanced NQO1 activity significantly 
in a dose-dependent manner. The use of negative and positive controls showed that the assay 
was working properly. 0.1% and 0.2% DMSO, which were equal to the amount of DMSO in 
the extract treatment, did not affect the enzyme activity. NQO1 activity induction might be one 
of the main protective mechanisms of CHe, CGe, TLe, SR1e, and PS1e. Our result is in 
agreement with a previous study which reported that T.laurifolia extracts induced NQO1 
activity (Oonsivilai et al., 2007). This is the first time that NQO1 induction activity of ethanol 
extracts from C.hystrix, C.grandis, S.rugata, and P.sarmentosum was reported.  
Even though potential cancer chemopreventive compounds must be proven to prevent tumour 
induction in animal models, phase II enzyme assays in cell cultures have been used for rapid 
screening for such compounds. The induction of phase II enzymes, such as GST and NQO1, 
is a major mechanism of a large number of anti-neoplastic and anti-mutagenic agents 
(Prochaska, 1994). NQO1 is important for prevention from toxic quinones, oxidative damage, 
and carcinogenesis (Nioi and Hayes, 2004). One of the protective actions of NQO1 is 
scavenging of superoxide and superoxide-like radicals (Zhu et al., 2007). T-BHP produces 
superoxide which results in cell damage (Slamenova et al., 2013). Therefore, induction of 
NQO1 activity is relevant to the protective effect of the plant extracts against t-BHP induced 
cell death, as well as helping to select potential candidates for the discovery of 




Figure 3-9 NQO1 specific activity of HepG2 cells after 72 hour-treatment with indicated compounds 
(M)/ extracts (g/ml). One-way ANOVA analysis showed the significant effect of tested substances, 
*P < 0.05 (N >3). 
 
3.3.5. Plant extracts restored glutathione level after t-BHP treatment 
After the treatment with 0.7 mM t-BHP for 4 hours, GSH level dropped from 32.22 + 8.05 to 
7.87 + 3.08 µM/ mg protein. Pre-treatment with SR1e and TLe significantly restored GSH level 
in a dose-dependent manner (P < 0.05) (Figure 3-10). SR1e 50, 100 µg/ml, and TLe 50 µg/ml 
restored GSH level to 27.57 + 3.60, 30.85 + 4.88, and 22.72 + 4.89 µM/ mg protein, 
respectively, which were almost equal to the baseline (no t-BHP). CHe also reversed the effect 
of t-BHP but not significantly. On the other hand, pre-treatment with PS1e and high 
concentration of CGe reduced GSH level more than t-BHP treatment alone, even though the 
effects were not significantly different. Prevention of the depletion of GSH might be one of the 
main protective mechanisms of SR1e and TLe against oxidative damage. T.laurifolia is well-
known for its detoxifying properties and have shown hepatoprotective activity in several rat 
models, as well as in cell cultures (Junsi and Siripongvutikorn, 2016). However, this is the first 
time that ethanol extracts from S.rugata and T.laurifolia were reported for their ability to 
prevent GSH depletion by t-BHP.  
Glutathione has roles in the defence against oxidative stress, which is an important factor in 
carcinogenesis. Many potential chemopreventive agents have been reported to induce GSH 
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level. For example, quercetin, a well-studied plant polyphenol found in onions, apples, berries, 
tea, and red wine, showed the ability to increase GSH level, as well as to block the reduction 
of GSH both in vivo and in vitro (Stagos et al., 2012). Therefore, GSH induction activity of the 
ethanol extract from S.rugata and T.laurifolia provide another evidence to support their 
traditional uses in cancer prevention and their role as candidates for cancer chemopreventive 
agent discovery. 
 
Figure 3-10 GSH level after t-BHP treatment. One-way ANOVA analysis showed that pre-treatment 
with SR1e and TLe for 24 hours significantly attenuated GSH depletion effect of t-BHP, *P < 0.05 
compared to no pre-treatment (N >3). 
 
3.3.6. The effects of plant extracts on cell viability in primary rat hepatocytes 
The preliminary safety data of CHe, CGe, Ps1e, SR1e, and TLe (concentration 0 – 200 µg/ml) 
were assessed by cytotoxicity assay in primary rat hepatocytes. The % viability of hepatocytes 
treated with the extracts for 24 and 48 hours were between 77.8 – 104.52% and 73.1 – 
102.38%, respectively. The IC50 values of all extracts were more than 200 µg/ml. This shows 
that all five extracts were not toxic to the hepatocytes (Figure 3-11). The cytotoxicity of these 
plant extracts in primary rat hepatocytes has never been published before, when searched 
using Web of Science and manual searches on Google. In addition, Pramyothin et al. (2005) 
reported that co-treatment of water extract from TL leaves at 2.5, 5.0 and 7.5 mg/ml with 
ethanol significantly reduced the cell death of primary rat hepatocytes, compared to ethanol-
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treatment alone (Pramyothin et al., 2005). This helps to confirm that TL extracts produced 
protective effect rather than toxic effect in hepatocytes in in vitro.  
 
Figure 3-11 Cytotoxicity of CGe, CHe, PS1e, SR1e, and TLe in primary rat hepatocytes. (A) after 24 
hours-incubation (B) after 48 hours-incubation (C) %viability of the hepatocytes after ethanol (0.06 – 
10% v/v) treatment for 24 hours (N > 3) 
 
3.4. Conclusion  
Thai traditional medicine (TTM) has become a popular alternative way for cancer patients in 
Thailand, especially those in terminal stages. In this chapter, cytotoxicity, protective effect 
against oxidative stress, and effects on glutathione and NQO1 enzyme activities of extracts 
from selected plants used for cancer/mareng prevention were studied in in vitro. The 
pharmacological assays were developed on the basis of characteristics of cancer as defined 
in TTM. Almost a third of the extracts tested showed protective effects against oxidative stress. 
Furthermore, 10% of them induced antioxidant enzyme activity and 4% restored GSH level 
from oxidative damage. These extracts also showed no toxicity in primary rat hepatocytes. 
Ethanol extracts from S.rugata and T.laurifolia showed the most promising protective activities 
by giving significant positive results from t-BHP induced cell death assay, NQO1 activity 
assay, GSH assay, and cytotoxicity in rat hepatocytes. These results show that TTM is a good 
source for chemopreventive drug discovery. Our work provides in vitro evidence that support 
these traditional uses of decoctions and macerated preparations of at least thirteen plants in 
cancer and disease prevention.  
Oxidative stress plays a crucial role in carcinogenesis, as well as other chronic diseases. 
Krasai is an important factor for chronic illnesses development in TTM. In this report, krasai 
was linked to oxidative stress for the first time. The results from pharmacological investigation 
demonstrate that oxidative stress models can be utilized to test herbal medicine used for 
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krasai. Therefore, this basis can be applied in other areas wider than cancer, such as 
inflammation and most chronic conditions in TTM.   
In this study, a cancer prevention strategy based on TTM concepts was proposed for the first 
time. The strategy is not only useful for TTM practitioners, but also helpful for scientists to 
develop bioassays to investigate herbal medicine that are used in a specific cultural context 
for conditions linked to cancerous diseases. We showed that TTM theory can provide useful 
information for planning pharmacological experiment. It also provides a model for developing 
in vitro assays in order to investigate TTM knowledge, especially in cancer, inflammation, and 
other chronic diseases. In the future, the strategy should be applied to in vivo and clinical 
studies in order to further confirm the validity of such a strategy. Other traditional medical 
systems that use holistic approach can also use our strategy as a model to develop traditional 
medicine with a better evidence-base.   
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Chapter 4. Chemopreventive profiles of Senegalia 
rugata and Thunbergia laurifolia: the effect on 
antioxidant gene expression in HepG2 cells, high-
resolution radical scavenging profiles, and active 
phytochemicals 
4.1. Introduction 
According to the data gathered during the fieldwork (chapter 2), Senegalia rugata (Lam.) 
Britton & Rose (Fabaceae) and Thunbergia laurifolia Lindl. (Acanthaceae) were among 
medicinal plants used to prevent mareng. During the screening for pharmacological properties 
(chapter 3), their ethanol extracts showed the most promising in vitro activities by significantly 
protecting HepG2 cells from t-BHP induced cell death, inducing NQO1 activity, restoring 
glutathione level after t-BHP treatment, and showing no cytotoxicity to rat hepatocytes. These 
properties are crucial for cancer chemopreventive agents. Therefore, the ethanol extracts from 
these two species were selected for further investigation. 
4.1.1. Senegalia rugata (Lam.) Britton & Rose: traditional uses, chemopreventive or 
related properties, and phytochemistry 
4.1.1.1. Traditional uses 
‘Sompoi’ or soap pod or Senegalia rugata (Lam.) Britton & Rose (synonym Acacia concinna 
(Willd.) DC.) from Fabaceae is a scandent shrub with thorny stem 2-5 m high. The leaves are 
bipinnate, alternate with pinnae 8-12 pairs, 7-20 cm long with 9-25 pairs of leaflets, linear or 
oblong. The inflorescence is in terminal and axillary, compound globose head. The flowers 
are yellowish white. The pods are thick, dark brown in colour, juicy, but rugose when dry 
(Saralamp et al., 1996). 
 
Figure 4-1 Sompoi tree and dried pods (lower right) 
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In Thai traditional medicine, the stem is used to treat Namtaphikan16. The leaf is used for eye 
diseases and to cleanse the small and large intestines from diseases. While the flower is used 
to treat joint diseases, the fruit is used to treat fever in children, as well as thick mucus. 
Moreover, the root is used to treat fever. The plant is used in combination with other plants as 
anti-flatulent, expectorant, and externally to relieve abscess (Foundation for the promotion of 
Thai traditional medicine and Ayurved Thamrong School Center of applied Thai traditional 
medicine, 2007a). According to the national list of essential medicines of Thailand (2013), the 
leaf and pod are ingredients in a laxative formula. The pod is among the main ingredients of 
Ya Faihakong recipe which is used to repel lochia and help re-positioning the uterus in women 
after giving birth. Moreover, the leaf is used in Ya Prakhob (herbal compress) which is used 
externally to relieve muscle and joint pain (National Drug Committee, 2013).       
As the plant is native to tropical Asia, it is also used in other traditional medicines. For instance, 
in India the pod is used as expectorant, shampoo, skin tonic, a purgative and as an emetic 
(Khory and Katrak, 1999).    
4.1.1.2. Chemopreventive or related properties 
Using Web of Science database there were 49 results after searching for ‘Senegalia rugata’ 
or ‘Acacia concinna’. One article reported its immunological adjuvant activities. A methanol 
fraction from saponin fractions of the pod extract (MAC) induced splenocyte proliferations at 
the concentrations of 200, 400, 800 and 1000 µg/ml. OVA-specific IgG, IgG1 IgG2a and IgG2b 
antibody levels in serum were significantly enhanced by MAC as compared with the control 
group. This finding suggested that MAC might affect Th1 and Th2 helper T cells 
(Kukhetpitakwong et al., 2006). Its water extract was reported to possess antimicrobial and 
anthelmintic activities (Medisetti et al., 2016, Todkar et al., 2010). 
4.1.1.3. Phytochemistry 
The seeds contain a monoterpenoidal carboxamide, concinnamide (Sekine et al., 1997). The 
beans without seeds contain a saponin glycoside, sonuside (Sharma and Walia, 1977). The 
pods contain saponins; including prosapogenols, concinnosides A-F (Abul Gafur et al., 1997, 
Kukhetpitakwong et al., 2006), kinmoonosides A and C (Kukhetpitakwong et al., 2006);  
monoterpenes, including menthiafolic acid, (2E)-6-hydroxy-2-hydroxymethyl-6-methyl-2,7-
octadienoic acid, and their glycosides which are (6R)- and (6S)-menthiafolic acid-6-O-β-D-
xyloside (Kiuchi et al., 1997); four glycosides which are acaciaside, julibroside A1, julibroside 
A3, albiziasaponin C, and their aglycone, acacic acid lactone (Kukhetpitakwong et al., 2006). 
                                                     
16 The symptoms of namtaphikan are blurred vision and dry eyes (Khamphi Roknithan).  
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4.1.2. Thunbergia laurifolia Lindl.: traditional uses, chemopreventive or related 
properties, and phytochemistry 
4.1.2.1. Traditional uses 
‘Rangchued’ or laurel clock vine or Thunbergia laurifolia Lindl. from Acanthaceae is a climbing 
plant. The leaves are simple, opposite along the stem, oblong or ovate, 4-5 cm wide, 8-10 cm 
long, broad based, narrowing to a pointed tip, usually with scalloped lobes towards the base. 
The flowers are bluish purple, trumpet-shaped and the seed pod is cone-shaped, 1 cm long, 
with a round base. The bracts are green with reddish brown blotches. The fruits are capsule. 
In Thailand, T. laurifolia has several names, such as rangchued, yawkaew, kobshanang, 
gumlungchangpuak, or kruanannae. (Junsi and Siripongvutikorn, 2016, Saralamp et al., 1996) 
 
Figure 4-2 Rangchued plant 
 
In Thai traditional medicine, the leaf is used as universal antidote, treatment for fever and thirst 
(National Drug Committee, 2013). Moreover, it is also used to treat abnormal menstruation, 
ear pain, removal of toxins from the liver, and used externally for treatment of swelling. 
Nowadays it is a well-known detoxifying herbal medicine in Thailand. The most popular 
dosage form is herbal tea. 
The plant is native to India, Indochina and Malaysia. In Malaysia, juice from the leaf is used 
for the treatment of menorrhagia, placed into the ears for deafness, and externally for cuts 
and burns (Wonkchalee et al., 2012).  
4.1.2.2. Chemopreventive or related properties 
There were 36 results when searched for ‘thunbergia laurifolia’ on Web of Science. Eight 
references were related to our focus, which are anti-inflammatory, detoxifying, and protective 
effects. These studies supported its traditional use in detoxification. 
Protective and detoxifying effects 
Multiple lines of evidence supported the use of Thunbergia laurifolia (TL) in the detoxification 
against toxic substances. Pre-treatment of TL extract reduced toxicity signs and organ 
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damages caused by cadmium in rats (Ruangyuttikarn et al., 2013). Food supplemented with 
50% ethanol extract increased the growth rate of fish exposed to Pb(NO3)2. The extract also 
normalized blood chemistry, haematological and histological parameters in Pb(NO3)2-treated 
fish (Palipoch et al., 2011). Moreover, its water extract attenuated the effect of ethanol in the 
increase in ALT, AST, hepatic triglyceride, and centrilobular hydropic degeneration of 
hepatocytes in in vivo, as well as protected primary rat hepatocytes from ethanol toxicity 
(Pramyothin et al., 2005).  
In vitro experiment showed some mechanisms related to cytoprotection. Acetone extract, 
ethanol extract, and water extract increased NQO1 activity in Hepa 1C1C7 cells by 2.8 fold, 
1.35 fold, and 1.56 fold, respectively. In addition, all extracts also showed strong dose-
dependent anti-mutagenic activity by inhibition of aminoanthracene-induced mutagenesis up 
to 87% in Salmonella typhimurium TA 98 (Oonsivilai et al., 2007). Its ethanol extract induced 
the mRNA expression of CYP1A1, CYP1A2, CYP2B6, CYP3A4, and PPAR gamma, while it 
inhibited the mRNA expression of CYP3A7, CYP2D6, and CYP2E1. The extract also 
increased the activity of P-glycoprotein, which accelerated the excretion of xenobiotic and 
toxic substances from HepG2 cells (Rocejanasaroj et al., 2014). 
Anti-inflammatory effects 
Administration of TL reduced the inflammation in Syrian hamsters infected with human liver 
fluke Opisthorchis viverrini or treated with N-nitrosodimethylamine (Wonkchalee et al., 2012). 
Rosmarinic acid isolated from the leaves (at the doses of 50, 100, and 150 mg/kg) exhibited 
significant anti-nociceptive effect in the hot-plate test. At doses of 50 and 100 mg/kg, it 
decreased acetic acid-induced writhing by 52% and 85%, respectively. At 100 mg/kg, it 
inhibited formalin-induced pain in the early and late phases and suppressed carrageenan-
induced paw oedema at 3, 4, 5 and 6 h after carrageenan injection, and showed significant 
activity against PGE2-induced paw oedema. It also inhibited cotton pellet-induced granuloma 
formation in mice (Boonyarikpunchai et al., 2014).  
Antioxidant effects 
Rosmarinic acid isolated from the leaves exhibited DPPH-scavenging property with an EC50 
value of 2.71 µg/ml (Suwanchaikasem et al., 2014). The compound has also shown 
remarkable biological properties both in vitro and in vivo, such as antioxidant, anti-
inflammatory, antimutagenic, antigenotoxic, cytotoxic, antimetastatic, antiangiogenic, 
neuroprotective, antimicrobial, and immunomodulatory effects. For instance, it reduced kidney 
injury in several mice models, including cisplatin-induced, diabetes-induced, and gentamicin 
sulphate-induced injury. It exhibited liver protection against cholestatic fibrosis, ischemia-
reperfusion injury, CCl4-induced, and lipopolysaccharide-induced injury in vivo. These effects 
have been linked to its antioxidant and radical scavenging effects (Amoah et al., 2016).  
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4.1.2.3. Phytochemistry 
The leaf contains rosmarinic acid (Suwanchaikasem et al., 2014), sterols, including β-
sitosterol, stigmasterol, alphaspinasterol; phenolics, including apigenin, caffeic acid, gallic 
acid and protocatechuic,; carotenoids, including lutein and steroids; and glycosides, including 
8-epigrandifloric acid, 3’-O-β-glucopyranosyl-stilbericoside, grandifloric acid, benzyl β-
glucopyranoside, benzyl β-(2’-O-β-glucopyranosyl)-glucopyranoside, 6-C-glucopyranosyl 
apigenin, 6,8-di-C-glucopyranosyl apigenin, (E)2-hexenyl-β-glucopyranoside, and hexanol-β-
glucopyranoside (Junsi and Siripongvutikorn, 2016). The aerial part contains two iridoid 
glucosides, which are 8-epi-grandifloric acid and 3′-O-β-glucopyranosyl-stilbericoside; benzyl 
β-glucopyranoside, benzyl β-(2′-O-β-glucopyranosyl) glucopyranoside, grandifloric acid, (E)-
2-hexenyl β-glucopyranoside, hexanol β-glucopyranoside, 6-C-glucopyranosyl apigenin, and 
6,8-di-C-glucopyranosyl apigenin (Kanchanapoom et al., 2002). 
Primary constituents of water extracts are caffeic acid and apigenin. Acetone and ethanol 
extracts contain chlorophyll a and b, pheophorbide a, pheophytin a, and lutein identified by 
HPLC analysis (Oonsivilai et al., 2007). 
4.1.3. Cytoprotection: an important mechanism for cancer prevention 
Modulation of cytoprotective enzyme activation is among important property of blocking 
agents. Nrf2 (NF-E2-related factor 2) is a transcription factor which is now recognized as a 
master regulator of antioxidant defences. Nrf2 is bound by Keap1 in normal condition within 
the cytoplasm. Under stress condition, Nrf2 is released and translocated into the nucleus. 
Then it forms a heterodimer with Maf and then binds to ARE (antioxidant-responsive 
elements), which then encodes detoxifying and antioxidant enzymes, such as GSTs 
(glutathione S-transferases) and NQO1 (NADPH: quinone oxidoreductase) (Figure 4-3). 
Therefore, any agents that activate Nrf2 signaling would be beneficial to prevent or reduce 
DNA damage by oxidative stress (Landis-Piwowar and Iyer, 2014). Many of Nrf2 activators 
are from natural origins, especially from plants, such as Protandim®- a dietary supplement 
containing five herbal extracts, including Silybum marianum, Bacopa monniera, Withania 
somnifera, Camellia sinensis, and Curcuma Ionga. Protandim was reported to reduce skin 
tumour incidence in vivo and p53 suppression and mitochondrial SOD induction might be the 
mechanism of the tumour prevention (Hybertson et al., 2011). This data show that medicinal 
plants are possible sources in a search for Nrf2 activator for chemoprevention.  
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Figure 4-3 Mechanism of Nrf2 signalling. Modified from (Landis-Piwowar and Iyer, 2014) 
 
When xenobiotics, including carcinogens, enter the body, they will be metabolized by phase 
I, or II, or III enzymes. Cytochrome P450s (CYPs) are phase I enzymes which initiate the 
detoxification process by transforming hydrophobic into hydrophilic compounds. However, 
sometimes CYPs reaction results in reactive intermediates which form covalent bonds with 
DNA and lead to the initiation of carcinogenesis. Among 18 families known to present in 
mammalian cells, CYP1A1 is well-known for its role in the activation of carcinogens, especially 
polycyclic aromatic hydrocarbons (PAHs) and heterocyclic amines. It is extra-hepatic, but 
present in the liver after induction (Kamenickova et al., 2013). Increase in mRNA expression 
of CYP1A1 has been associated with cancer initiation. Therefore, it becomes a target for 
chemopreventive agents (Badal and Delgoda, 2014).  
Phase II enzymes, such as NQO1, and heme oxygenase-1 (HMOX-1) are enzyme that can 
inactivate reactive metabolites. NQO1 is a key enzyme involved in the defence against 
carcinogens (please see chapter 3 for more details). HMOX-1 protects from ROS by Fenton 
reaction. Firstly, it metabolizes pro-oxidant heme into antioxidant bilirubin which then 
increases the expression of ferritin. Ferritin sequesters ferrous ions which results in the 
prevention of the formation of ROS. Several cancer chemopreventive agents, such as 
dithiolethiones, possess the ability to induce the expression of HMOX-1 (Primiano et al., 
1996).  
Phase III enzymes comprise various ATP-binding cassette (ABC) transporter families which 
are involved in the exclusion of xenobiotics and their metabolites (Döring and Petzinger, 
 142 
2014). However, this type of metabolizing enzymes is beyond the scope of this thesis. 
Therefore, they were not included in the experimental section.     
4.1.4. Measurement of gene expression using real-time PCR technique 
Gene expression comprises two major phases; transcription and translation (Figure 4-4). 
Studying how a gene is expressed can be done by studying of the RNA transcript or translated 
proteins (Dale and Schantz, 2002). 
 
 
Figure 4-4 Fundamentals of gene expression. The first step is transcription of DNA to RNA. For most 
genes, RNA is then translated into a protein molecule to function. For some genes, such as tRNA or 
rRNA, RNA itself is the functional molecule. Modified from 
 
Many techniques have been developed to study transcription. Polymerase chain reaction 
(PCR) is one of the major methods for studying genes because it is very sensitive and can 
detect extremely low level of expression (Dale and Schantz, 2002). The result of PCR is a 
selective amplification of a chosen region of a DNA molecule by the use of DNA polymerase 
enzyme which is thermostable. Any region of DNA can be selected as long as the sequences 
at the borders of the region are known. This can be done by the addition of specific 
oligonucleotide primers. After a mix of target DNA, DNA polymerase, forward and reverse 
oligonucleotide primers, and a supply of nucleotides, the PCR cycle is performed according 
to (Figure 4-5) (Brown, 2016). Normally these cycles are repeated 40 - 50 times to amplify the 
DNA template. Then the PCR products can be studied in various ways to gather information 
about the DNA template. 
Nowadays quantitative PCR (qPCR) is usually performed using real-time PCR which 
measures the products over time. This method utilizes the use of a dye that emits fluorescent 
signal when it binds to double-stranded DNA or a probe that emits fluorescent signal when it 
hybridizes to the specific PCR product. The amount of RNA can also be measured by the use 
of reverse transcriptase PCR. In this technique, RNA is converted to complementary DNA 
(cDNA) by reverse transcriptase enzyme prior to standard real-time PCR reaction (Brown, 




Figure 4-5 A PCR cycle comprises three steps; denaturation (A) – annealing (B) – synthesis (C). The 
PCR reaction starts by heating the mixture to 94-95oC in order to break double-stranded DNA into 
single-stranded (A). Then the temperature is lowered to 50-60oC to allow the primers to bind to gene of 
interest (B) before raised to 72-74oC to make it suitable for the polymerase to copy the DNA strand (C). 
The image is obtained from Primerdesign® available from: 
http://www.primerdesign.co.uk/assets/files/beginners_guide_to_real_time_pcr.pdf    
     
4.1.5. Studying protein expression by western blot analysis 
DNA is the basic genetic material that carries information from one generation to the next. To 
affect the characteristics of the cell, it requires the production of the RNA copy of the DNA 
(transcription). Then the mRNA is translated into a polypeptide by ribosomes (Figure 4-4). 
Later processes called post-translational modifications; such as polypeptide folding or 
glycosylation or phosphorylation, are required in order to make the translated protein become 
functional. Studying of gene expression should be performed on both levels which are analysis 
of RNA transcription and protein translation.  
Western blot analysis is the conventional way to study protein expressed in cells. Firstly, it 
involves protein separation by electrophoresis through a polyacrylamide gel in the presence 
of sodium dodecyl sulphate (SDS-PAGE). Then the proteins are transferred to a membrane; 
nitrocellulose or PVDF. Since there are too many proteins presented on the gel/membrane, 
the detection of interested proteins relies on the use of specific antibodies. These primary 
antibodies are commonly detected by the use of a secondary antibody followed by colorimetric 
or chemiluminescent detection. This technique allows researchers to study the presence or 
absence of interested proteins, as well as their sizes and relative levels of expression (Dale 
and Schantz, 2002). Figure 4-6 illustrates western blot steps.  
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Figure 4-6 Western blot steps. The image is obtained from (Bass et al., 2017). 
 
4.1.6. High-resolution radical scavenging assay-HPLC-HRMS-SPE-ttNMR technique 
Conventional methods in the discovery of novel bioactive natural products are often labour 
and time consuming involving repeated bio-guided isolation steps and then structure 
elucidation. Regardless the effort investing in such isolation, there is still a high chance that 
 145 
we would find already known compounds. Thus, knowing phytochemical profiles of interesting 
extracts prior to fractionation or isolation could save a lot of time and resources (Lambert et 
al., 2005). Dereplication by using hyphenated techniques based on the use of high-
performance liquid chromatography (HPLC) system to perform separations and collections of 
micro-fractions directly into microtiter plates prior to high-throughput screening or bioassay 
has been used widely and can speed up the process (Gaudencio and Pereira, 2015).   
HR-(bio)assay-HPLC-HRMS-SPE-ttNMR technique offers a fast and efficient analysis of the 
chemical composition of plant extracts, together with some information on bioactivities. It is a 
hyphenated system that combines high-resolution screening assays with high-performance 
liquid chromatography (HPLC), high-resolution mass spectrometry (HRMS), solid-phase 
extraction (SPE) and automated tube transfer nuclear magnetic resonance spectroscopy 
(ttNMR) (Figure 4-7). The system is used to identify bioactive chemical constituents with 
radical scavenging and α-glucosidase inhibition properties in sea aster and sea rocket 
(Wubshet et al., 2013a) and identify high-resolution radical scavenging profile and, for the first 
time, reported the direct detection of 13C NMR spectra of metabolites from a crude extract of 
the endophytic fungus Penicillium namyslowskii (Wubshet et al., 2013b). Furthermore, the 
system was also used to identify antidiabetic constituents in Radix Scutellariae crude extract 
and its high-resolution triple aldose reductase, α-glucosidase, and radical scavenging profile 
(Tahtah et al., 2015).   
 
Figure 4-7 Workflow of HR-(bio)assay-HPLC-HRMS-SPE-ttNMR analysis. The first step is to separate 
and collect micro-fractions from a crude extract into 96-well plate(s). Then an assay is performed 
directly with the plates containing these fractions and a biochromatogram is created. Active peaks are 
then targeted and analysed with high-resolution mass spectrometry (HRMS) and NMR using a 
hyphenated and automated system; HPLC-HRMS-SPE-ttNMR. Modified from (Wubshet et al., 2013b). 
 
4.1.7. Objectives 
The objectives of this chapter are to investigate mechanisms related to the protective effects 
of ethanol extracts of S.rugata and T.laurifolia, to identify the potential fractions of the extracts, 
and to provide information on their phytochemistry.   
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4.2. Materials and methods  
4.2.1. Materials 
TRIzolTM (15596018), UltraPure™ DNase/RNase-free distilled water (10977035), qPCR 
master mix (PowerUpTM SYBR Green Master Mix), pre-cast SDS PAGE gels (Bolt 4-12% Bis-
Tris Plus), LDS Sample Buffer (4X Bolt), reducing agent dithiothreitol (10X Bolt), transfer buffer 
for semi-dry transfer (Pierce 1-Step), Novex® Sharp Pre-Stained Protein Standard (LC5800), 
and MES SDS running buffer (20X Bolt)  were ordered from Thermo Fisher Scientific. NQO1 
(A180, sc-32793, Lot B0116) and β-actin (C4, sc-47778, Lot C0916) monoclonal antibodies 
were purchased from Santa Cruz Biotechnology, INC. Sodium chloride (S/3160/53) was from 
Fisher Scientific. DC Protein Assay kit (500-0116) was from Bio-Rad Laboratories, Inc. ABTS 
(2,2’-Azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt) (A1888), potassium 
persulfate (60489), sodium phosphate dibasic dehydrate (S0876), sodium phosphate 
monobasic dihydrate (71500), Trolox (238813),  HPLC-grade acetonitrile, Trizma® base 
(T6066), tween-20 (P-1379), and protease inhibitor cocktail (EDTA-free mini cOmplete™ 
tablets, 11836170001 Roche) were purchased from Sigma–Aldrich. Formic acid and 10X 
RIPA buffer (0.5M Tris-HCl, pH 7.4, 1.5M NaCl, 2.5% deoxycholic acid, 10% NP-40, 10mM 
EDTA) were obtained from Merck. Other solvents were HPLC grade. MilliQ water was purified 
by deionization and 0.22 µm membrane filtration (Millipore, Billerica, MA). DNase treatment 
kit (Precision DNase) and reverse transcription kit (nanoScript 2) were purchased from 
Primerdesign Ltd.  
4.2.2. Real-time PCR analysis 
4.2.2.1. Cell treatment 
HepG2 3 x 105 cells were seeded into a 6-well plate. After two days to allow the cells to 
proliferate, fresh medium containing 0.1% DMSO (control), or menadione 10 M (positive 
control), or SR1e at 25, 50, 100 g/ml, or TLe 12.5, 25, and 50 g/ml were replaced and 
incubated for 24 hours. Then the treatment was discarded and RNA isolation was performed. 
4.2.2.2. RNA isolation  
Total RNA was isolated with TRIzol reagent according to the company’s protocol. Briefly, 1 ml 
of TRIzol was added to each well, mixed with the cells by a cell scraper, and transferred into 
a reaction tube. Then 0.2 ml of chloroform was added to each tube and vortex to mix the 
content together. To separate the chloroform from TRIzol, the tube was centrifuged at 
11,300xg at 4oC for 15 minutes. Then the clear upper layer containing RNA was transferred 
to a new clean reaction tube. 0.5 ml of isopropanol was added, vortex, and incubated for 10 
minutes to precipitate RNA. Centrifugation at 11,300 x g at 4 oC for 10 minutes was then 
applied to remove the solvent. The RNA pellet was washed with 1 ml 75% ethanol (freshly 
prepared) twice. After centrifugation at 11,300 x g at 4 oC for 10 minutes and discard the 
ethanol, the pellet was left to air-dry. The RNA was kept at -80 oC until use.  
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4.2.2.3. RNAs quality assessment 
RNAs were dissolved in 30 l of the ultrapure water. Quality and quantity of the RNAs were 
determined using Agilent RNA ScreenTape assay with TapeStation system (Agilent 
Technologies) performed at UCL Genomics (London, UK). RINe is presented as a value 
between 1 and 10, where 10 represent the highest quality RNA sample. RNAs with RNA 
integrity number equivalent (RINe) above 8.0 were used for real-time PCR analysis in this 
project.    
4.2.2.4. Real-time qPCR analysis 
Elimination of genomic DNA contamination from RNAs was performed by DNase treatment 
according to Primerdesign protocol. Each 30 µl of RNA solution was mixed with 0.3 µl of 
DNase enzyme and 3 µl of the reaction buffer. DNase treatment was performed at 30 oC for 
30 minutes and DNase inactivation was performed at 55 oC for 5 minutes in a thermal cycler 
(Bio-Rad MJ Mini). Then DNase-treated RNAs were diluted with Ultrapure water to obtain 
1500 ng/9 µl. Reverse transcription was performed according to Primerdesign protocol. After 
the addition of 1 µl of Oligo dT primer into each 9 µl of diluted solution of DNase-treated RNA, 
the reaction tubes were incubated at 65 oC for 5 minutes. Ten µl of RT reaction mix was 
prepared freshly by mixing 5 µl of 4x buffer, 1 µl of 10 mM dNTP mix, 3 µl of Ultrapure water, 
and 1 µl of nanoScript enzyme together. This RT mix was added to the tube containing the 
RNA and the primer, and then the tube was incubated at 42 oC for 20 minutes followed by 75 
oC for 10 minutes to inactivate the reaction. The synthesized cDNA was stored at -20 oC until 
use. 
Quantitative PCR was performed following the manufacturer protocol. After cDNAs were 
obtained, 140 ng of cDNAs (2 µL) was mixed with 10 μl of qPCR mastermix with SYBRgreen 
probes, 6 pmols of forward primer, 6 pmols of reverse primer, and filled up to 20 μl with 
Ultrapure water. Then 20 μl of the assay mixture was added into 96-well PCR plate and real-
time PCR analysis was performed using PikoReal™ Real-Time PCR System (Thermo 
Scientific). The cDNAs amplification started with the activation of UDG and DNA polymerase 
at 50 oC for 2 minutes and 95 oC for 2 minutes, respectively. Then each PCR cycle comprises 
three steps; 95 oC (15 seconds) is applied to separate double-stranded DNA, 58 oC (15 
seconds) to let primers anneal to the DNAs, and then 72 oC (1 minute) which is the suitable 
temperature for the polymerase to copy DNA strand. This temperature cycling is repeated 40 
times to amplify the DNA template.   
Forward and reverse primers were designed using NCBI Primer-BLAST 
(https://www.ncbi.nlm.nih.gov/tools/primer-blast/index.cgi?LINK_LOC=BlastHome) (Table 
4-1). Relative mRNA expression level was calculated by comparative CT method (2-ΔΔCT) using 
the expression of GAPDH gene as an internal control described in (Livak and Schmittgen, 
2001). The calculation is presented below where GOI is gene of interest eg. Nrf2, NQO1, 
HMOX-1, CYP1A1 and calibrator is untreated control. CT (threshold cycle) is defined as the 
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PCR cycle at which the fluorescent signal of the SYBR green crosses an arbitrarily placed 
threshold.  
CT GOI of sample – CT GAPDH of sample = ΔCT Sample 
CT GOI of calibrator – CT GAPDH of calibrator = ΔCT calibrator 
ΔΔCT = ΔCT Sample – ΔCT calibrator 
Fold change = 2-ΔΔCt 
Table 4-1 Primer sequences for real-time PCR analysis 
Gene 5’-3’ Primer sequence Product length (bp) Tm (oC) 
NQO1 Forward: CCG TGG ATC CCT TGC AGA GA 
Reverse: AGG ACC CTT CCG GAG TAA GA 
84 61.62 
59.29 
Nrf2 Forward: AGT GGA TCT GCC AAC TAC TC 
Reverse: CAT CTA CAA ACG GGA ATG TCT G 
106 56.64 
57.14 
HMOX1 Forward: AAG AGG CCA AGA CTG CGT TC 
Reverse: GGC AGA ATC TTG CAC TTT GTT G 
143 60.60 
58.95 
GAPDH Forward: ATG CTG GCG CTG AGT ACG TC 
Reverse: GGG CAG AGA GAT GAC CCT T 
107 62.89 
61.55 
CYP1A1 Forward: AGA TGG TCA AGG AGG ACT ACA 




4.2.3. Western blot analysis 
4.2.3.1. Cell treatment 
HepG2 6 x 105 cells were seeded into a 25 cm3 TC flask and left for three days to allow the 
cell proliferation. Then the cells were treated with 0.1% DMSO or TLe 12.5 µg/ml, or 25 µg/ml, 
or 50 µg/ml, or SR1e 25 µg/ml, or 50 µg/ml, or 100 µg/ml, or menadione 10 µM for 24 hours.  
4.2.3.2. Whole cell lysate preparation 
To prepare whole cell lysate, the cells were washed twice with ice-cold PBS. The cells were 
rapidly scraped off and suspend in 1 ml of PBS and transferred to a 1.5 ml reaction tube. The 
PBS was removed after centrifugation at 1000 x g for 5 minutes at 4 oC. Then 100 µl of RIPA 
buffer supplemented with protease inhibitor cocktail (100 μl of 7xComplete minitab solution for 
each 600 μl of RIPA buffer) was added to the cell pellet, vortex, and kept in ice for 30 minutes 
with vortexing to lyse the cells every five minutes. After allowing complete cell lysis, the tube 
was centrifuged at 17000 x g for 20 minutes at 4 oC. The clear supernatant was kept at -80 oC 
until use. 
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4.2.3.3. Protein measurement 
Bio-Rad DCTM Protein Assay kit, which utilizes Lowry method, was used to determine the 
amount of protein. Before the assay was performed, working reagent A was prepared by 
addition of 20 µl of reagent S to 1 ml of reagent A. Five µl of cell lysate was added into 96-well 
plate. Then twenty-five µl of working reagent A was added to each well followed by 200 µl of 
reagent B. After that the plate was shaken and incubated at room temperature for 15 minutes, 
protected from light, before an absorbance measurement at 750 nm with a microtiter plate 
reader (Infinite M200, Tecan). A BSA standard curve was generated and used to quantify the 
amount of protein in cell lysate. 
4.2.3.4. Western blot analysis 
Prior to the experiment, the amount of protein loaded, transfer time, the strength of blocking 
buffer, and the concentration of antibodies were optimized. NQO1 protein was measured 
because it was abundantly expressed in the HepG2 cells. 
Ten µg of protein was loaded into each well of SDS-PAGE gels along with molecular weight 
markers. Ice-cold running buffer was filled into the electrophoresis chamber (Mini gel tank, 
Thermo Fisher Scientific) and the gel was run at 50 V for 5 minutes and then at 125 V for 1 
hour 10 minutes. After that the protein was transferred to a PVDF membrane using Pierce™ 
Power Blotter (Thermo Fisher Scientific) for 15 minutes with the maximum voltage at 25V and 
1.3A. Then the membrane was blocked in 10 ml of 3% dried skim milk for 1 hour at room 
temperature on a rocking platform. Primary antibodies; NQO1 (1:500) and β-actin (1:1000) 
were then added and incubated with the membrane over night at 4 oC on a rocking platform. 
The membrane was washed with TBST three times before the incubation with secondary 
antibody (1:2500) in 3% dried skim milk for 1 hour at room temperature on a rocking platform. 
After the incubation, the membrane was washed with TBST three times. The 
chemiluminescent substrate was then applied to the blot for 5 minutes. Then the signal was 
captures using GeneGnome system (Syngene) with 3-minute exposure. ImageJ 1.50i 
software (Schneider et al., 2012) was used to read the band intensities and MS Excel 2013 
was used to calculate the NQO1/β-actin relative ratio.  
4.2.4.    ABTS•+ radical scavenging assay 
Crude extracts (concentration between 6.25 – 200 µg/ml) and micro-fractions were screened 
for their antioxidant property using ABTS•+ microplate assay (Wubshet et al., 2013a). An 
advantage of ABTS•+ assay is that it can be used to the study both water-soluble and lipid-
soluble antioxidants, pure compounds, and herbal/food extracts (Re et al., 1999). Briefly, 
ABTS•+ stock solution consisting of 2.5 mM ABTS and 0.875 mM potassium persulfate in MilliQ 
water was prepared at least 16 hours before the assay. This is to allow complete ABTS•+ 
radicals forming which results in blue/green colour solution (Re et al., 1999). Before the assay 
began, the ABTS•+ stock solution was diluted five times with 0.1 M sodium phosphate buffer, 
pH 7.4. The diluted solution was then added to each well 200 µl. Then the plate was shaken 
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for 15 seconds and the absorbance was measured at 620 nm every one minute up to 20 
minutes with a microplate reader (Thermo Scientific Multiskan FC, Waltham, MA, USA). Trolox 
(0 – 300 µM) was used as a standard. ABTS reduction values were calculated by; 
%ABTS reduction = (
𝐴𝑏𝑠𝑜𝑟𝑏𝑎𝑛𝑐𝑒 𝑜𝑓 𝑠𝑎𝑚𝑝𝑙𝑒
𝐴𝑏𝑠𝑜𝑟𝑏𝑎𝑛𝑐𝑒 𝑜𝑓 𝑚𝑒𝑡ℎ𝑎𝑛𝑜𝑙
) x 100 
4.2.5. HPLC analysis 
Prior to micro-fractionation, the extracts were injected to high-performance liquid 
chromatography (HPLC) to screen for common antioxidant compounds. The HPLC system 
was an Agilent 1200 series (Agilent Technologies) consisting of a G1311A quaternary pump, 
a G1322A degasser, a G1316A thermostatted column compartment, a G1315D diode array 
detector, and a G1329A thermostatted standard autosampler. Agilent ChemStation ver. 
B.04.01 software was used to control the instrument and acquire the data. The separation was 
performed using a reverse phase Luna C18 (Phenomenex, 150 x 2.0 mm, 3 µm, 100 Å) 
maintained at 40 oC. The mobile phase A was MilliQ water: Acetonitrile: Formic acid (95: 5: 
0.1 % v/v) and B was Acetonitrile: MilliQ water: Formic acid (95: 5: 0.1 % v/v). The flow rate 
was 0.3 mL/minute. The injection volume was 0.8 µl. Single reference compounds (1 mg/ml) 
and a reference cocktail solution in methanol were run in the same sequence with the extracts. 
The samples were dissolved in mobile phase B for TLe and methanol for SR1e at the 
concentration of 100 mg/ml and 50 mg/ml, respectively. For TLe, the gradient profile was 5-
60% B in 40 minutes. For SR1e, the gradient profile was 0-25% B in 40 minutes. The 
chromatograms were recorded at 254, 280, and 360 nm.   
4.2.6. High-resolution radical scavenging assay 
4.2.6.1. Micro-fractionations of plant extracts  
Fractionations of TLe and SR1e crude extracts were performed using HPLC. The HPLC 
system was Agilent 1100 series (Agilent Technologies) consisting of a G1311A quaternary 
pump, a G1322A degasser, a G1316A thermostated column compartment, a G1315B 
photodiode array detector, a G1367C high-performance autosampler, and a G1364C fraction 
collector. The instrument was controlled using Agilent ChemStation ver. B.03.02 software. The 
separation was performed using a reverse phase Luna C18 (Phenomenex, 150 x 4.6 mm, 3 
µm, 100 Å) maintained at 40 oC. The mobile phase A was MilliQ water: Acetonitrile: Formic 
acid (95: 5: 0.1 % v/v) and B was Acetonitrile: MilliQ water: Formic acid (95: 5: 0.1 % v/v). The 
flow rate was 0.8 mL/minute. The injection volume was 5 µl. The samples were dissolved in 
mobile phase B for TLe and methanol for SR1e at the concentration of 100 mg/ml. For TLe 
fractionation, the gradient profile was 5-60% B in 40 minutes. For SR1e, the gradient profile 
was 0-25% B in 40 minutes. The eluate from each sample was fractionated from 5 to 30 minute 
into two 96-well plates with the resolution approximately 7 points per minute. After that the 
mobile phase was removed immediately to avoid compound degradation by a vacuum 
concentrator (RVC 2-25 CDplus, Christ). Before starting the ABTS radical scavenging assay, 
100 µl of methanol (HPLC grade) was added into each well and the plate was shaken for 10 
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minutes to reconstitute the fractions. The work was carried out at the Department of Drug 
Design and Pharmacology, Faculty of Health and Medical Sciences, University of 
Copenhagen, Copenhagen, Denmark under the supervision of Professor Dan Stærk.     
4.2.6.2. Biochromatogram plot 
HPLC chromatogram at 280 nm was exported into DIF file and the fractions collection report 
was exported into text file. Average absorbance between 10 – 20 minutes of each well was 
obtained from the SkanIt software (Tahtah et al., 2015). Then ABTS reduction profile was 
plotted against its respective retention time underneath the HPLC chromatogram using MS 
Excel 2013. This plot is called ‘Biochromatogram’.   
4.2.7. Compounds identification of active fractions 
After high-resolution radical scavenging assay was performed, the extracts were separated 
using the same HPLC condition, with the outlet connected to HRMS and SPE cartridges for 
compounds identification. The analysis was performed at the Department of Drug Design and 
Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, 
Copenhagen, Denmark under the supervision of Professor Dan Stærk. 
4.2.7.1. HPLC-HRMS-SPE-NMR analysis 
A small volume (0.1 %) of the HPLC eluate was subjected to a microTOF-Q II mass 
spectrometer (Bruker) equipped with an electrospray ionization interface. Mass spectra were 
acquired in positive-ion mode, using a drying temperature of 200 °C, a capillary voltage of 
4100 V, a nebulizer pressure of 2.0 bar, and a drying gas flow of 7 L/min. A solution of sodium 
formate clusters was automatically injected in the beginning of each run to enable internal 
mass calibration. Data Analysis software (Bruker) was used to analyse MS data. The HPLC 
eluate was diluted with Milli-Q water at a flow rate of 1.0 mL/min prior to trapping in Resin GP 
SPE cartridges (10 × 2 mm ID, 5−15 μm, spherical shape, polydivinyl-benzenephase) (Spark), 
based on absorption thresholds at 280 nm and base peak chromatograms. Then the 
cartridges were dried with pressurized nitrogen gas for 30 minutes and the analytes were 
automatically eluted with MeOD into 1.7 mm NMR tubes using a Gilson Liquid Handler 
controlled by PrepGilson software 1.2 (Bruker Biospin). Chromatography, peak trapping, and 
solutions transfer from the SPE unit were controlled with HyStar ver. 3.2 software (Bruker 
Biospin). 
4.2.7.2. NMR experiment 
NMR experiment was performed with a Bruker Avance III 600 MHz NMR spectrometer (1H 
operating frequency 600.13 MHz) equipped with a Bruker SampleJet sample changer and a 
cryogenically cooled gradient inverse triple-resonance 1.7 mm TCI probe-head (Bruker 
Biospin). Bruker standard pulse sequences were used. IconNMR 4.2 (Bruker Biospin) was 
used to control automated acquisition of NMR data. 1H NMR spectra were recorded using 30° 
pulses and 64K data points, which were zero-filled to 128K and multiplied with an exponential 
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function (line-broadening = 0.3 Hz) prior to Fourier transformation. All samples were run in 
MeOD at 128 or 256 scan. Topspin 3.5 (Bruker Biospin) was used to process NMR data. 
4.2.8. Statistical analysis 
Mean, SD, student’s t-test, and ANOVA analysis followed by Dunnett’s test were performed 
using GraphPad Prism 5.01 software (GraphPad Software, Inc.). All experiment was 
performed at least N = 3. P < 0.05 was considered statistically significant. 
4.3. Results and discussion 
4.3.1. The effect of TLe and SR1e on antioxidant genes expression in HepG2 cells 
All RNAs used for real-time PCR analysis were of good quality with RINe between 8.6 and 10 
(Figure 4-8).  
 
Figure 4-8 RNA analysis. (A) Representative gel image showing the separation profile of each RNA 
sample. RINe value for each sample is shown below the gel image. (B) Representative 
electropherogram of total RNA. 
 
The effect of the extracts on the expression of important genes relevant for antioxidant effects; 
including Nrf2, NQO1, and HMOX-1 was investigated to determine their mechanisms. The 
level of CYP1A1 gene was also measured to assess the risk of DNA-adduct formation. 
Menadione (MQ), a toxic quinone known to induce NQO1 and cause DNA damage (Dietz et 
al., 2005) was used as a positive control. HepG2 cells were exposed to 10 µM of MQ for 24, 
48, and 72 hours to find a suitable incubation time (appendix). After 24 hour-incubation, MQ 
significantly induced NQO1 and CYP1A1 genes and also inhibited Nrf2 genes (Figure 4-9). 
The strong induction effect of MQ on CYP1A1 (35.6 + 5.0 folds for 5 µM and 33.9 +13.4 folds 
for 10 µM) illustrated its toxicity and this is in agreement with published literature (Sidorova et 
al., 2005). Therefore, 24 hours-incubation was used throughout the experiment. This time 
point also correlated with the assay investigating protective activity of the extracts against t-




Figure 4-9 HepG2 cells were treated with various concentrations of TLe and SR1e for 24 hours. Level 
of mRNA expression of Nrf2 (A), HMOX-1 (B), NQO1 (C), and CYP1A1 (D) genes were measured by 
real time PCR using GAPDH as internal gene control. (E) and (F) Level of NQO1 protein expression 
was measured by western blot analysis. Results are mean + SD (N > 3). Unpaired 2-tailed t-test and 
one-way ANOVA were used to determine p values of PCR and western blot analyses, respectively.  
P < 0.05 was considered statistically significant. 
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Western blot analysis showed that NQO1 was abundantly expressed in HepG2 cells. As 
presented in chapter 3, both extracts enhanced NQO1 activity after 72 hours. We 
hypothesized that this might be a result of an increase in NQO1 expression and/or an 
activation of its master regulator Nrf2. Therefore, real-time PCR and western blot analyses 
were performed to investigate this matter.  
SR1e and TLe did not change NQO1 mRNA expression (Figure 4-9 C). However, TLe 
exhibited a dose-dependent induction of NQO1 protein and significantly increased the 
expression to 1.6 + 0.3 folds at higher dose of 50 µg/ml (maximum non-toxic concentration) 
which is comparable with MQ10 (1.5 + 0.07 folds) (Figure 4-9 E and F). This illustrated that 
the increased activity of NQO1 enzyme in the cells exposed to TLe was due to NQO1 gene 
upregulation. A possible explanation that NQO1 mRNA level was not affected might be 
because of unsuitable incubation time, which should be less than 24 hours. For SR1e, NQO1 
protein expression was not altered which correlated with the result from PCR analysis (Figure 
4-9). In future work, various incubation times, especially between 0-24 hours, should be used 
in order to investigate the effect of the extracts on NQO1 gene expression in HepG2 cells. For 
instance, a lycopene metabolite and dieckol induced NQO1 gene and protein expression at 8 
and 16 hours, respectively (Yang et al., 2012, Lee et al., 2015d).  
SR1e at low dose of 25 µg/ml significantly upregulated Nrf2 mRNA expression (Figure 4-9 A). 
This might contribute to its protective effect against oxidative stress-induced cell death. 
However, the effect did not show a dose-response relationship in the concentration range that 
we investigated. Therefore, SR1e should be tested with broader concentration range and 
more time points in future work. TLe did not change the expression of Nrf2 after 24 hours-
incubation (Figure 4-9 A). It might affect this gene at another time point. In addition, the 
protective effect and increased NQO1 activity might be due to an induction of Nrf2 
translocation (Landis-Piwowar and Iyer, 2014) rather than its expression or act through 
another transcription factors that also bind to ARE, such as Nrf1 or Maf (Ross et al., 2000).   
Low dose SR1e also induced HMOX-1 expression (Figure 4-9 B). This upregulation, although 
not statistically significant, correlated with the increase in Nrf2 expression. HMOX-1 is known 
to protect the cells from ROS (Primiano et al., 1996). This might contribute to the protective 
effect against oxidative stress-induced cell death of SR1e. To provide a clearer information, 
SR1e should be tested with broader concentration range and more time points in future work. 
On the other hand, TLe did not affect HMOX-1 expression after 24 hours-treatment (Figure 
4-9 B). Therefore, its immediate protective effect (in 24 hours) was not a result from HMOX-
1.        
Exposure to both extracts resulted in the unchanged CYP1A1 mRNA expression (Figure 4-9 
D). The result suggested that the extracts were likely to be non-toxic rather than toxic. On the 
other hand, a toxic substance menadione induced CYP1A1 expressions to 35 folds. A 
previous study by Rocejanasaroj et al. (2014) reported that CYP1A1 mRNA expression in 
HepG2 was upregulated by TLe. However, the concentration of TLe in that study was 
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extremely high, 200 to 600 µg/ml and it enhanced the mRNA expression 1.5 and 1.8 folds, 
respectively (Rocejanasaroj et al., 2014). Compared to our data, the concentration above 50 
µg/ml produced some levels of cytotoxicity to the cells (see chapter 3). These results 
suggested that high dose of TLe might be able to produce some unwanted effects. In vivo 
experiment should be performed to investigate further safety profile.    
4.3.2. Antioxidant properties of the crude extracts 
ROS and free radicals can attack biological molecules and cause DNA damages, lipid 
peroxidation, and lead to many diseases, including cancer (Yoshikawa and Naito, 2002). 
Therefore, prevention of free radical formation is crucial to prevent oxidative stress which 
leads to carcinogenesis. This assay determines the ability of the extracts in the scavenging of 
stable cations formed through the reaction between ABTS and potassium persulfate (Re et 
al., 1999).   
Trolox standard curves were created for the calculation of TEAC value of the samples (Figure 
4-10). TEAC (Trolox equivalent antioxidant capacity) values of SR1e and TLe were 3.23+0.88 
and 2.25+0.41 mM/ g extract, respectively. ABTS•+ reduction profiles of SR1e and TLe crude 
extracts are shown in Figure 4-11. IC50 values of Trolox, SR1e and TLe were 158.66 µM, 
81.69 µg/ml, and 93.60 µg/ml, respectively. TEAC and IC50 values showed that SR1e 
exhibited slightly stronger ABTS radical scavenging activity than TLe.  
 
Figure 4-10 Representative Trolox standard curve. The linear equation (R2 > 0.99) was used to 
calculate TEAC values of the samples. The calculation of TEAC value was performed by replacing y 
with the absorbance recorded from Skanit software. 
 
Figure 4-11 ABTS•+ reduction profiles of SR1e and TLe crude extracts. SR1e showed slightly stronger 
ABTS•+ radical scavenging activity compared to TLe. 




















































4.3.3. HPLC analysis of SR1e and TLe 
The HPLC conditions gave satisfying separations for SR1e, TLe, and standard cocktail. The 
standard cocktail comprises eight common antioxidants from plants which were gallic acid 
(GA), chlorogenic acid (ChA), caffeic acid (CA), vanillin (V), ferulic acid (FA), hesperidin (H), 
rutin (R), and quercetin (Q). These antioxidants were selected to be marker compounds 
because they are well-known antioxidants which are widely found in green plant parts, fruits, 
and vegetables (Ow and Stupans, 2003, Alía et al., 2006, Sato et al., 2011, Lee et al., 2015a, 
Devi et al., 2015, Tai et al., 2011). Since SR1e and TLe showed protective properties against 
oxidative stress, they might contain these common antioxidants. HPLC chromatograms of 
antioxidant mixture are shown in Figure 4-12 and Figure 4-13.  
SR1e contained compounds with similar retention time (RT) to those of rutin and ferulic acid 
at 25.461 and 21.555, respectively. However, the UV spectra revealed that the peaks were 
not rutin and ferulic acid (Figure 4-14).  
Figure 4-15 reveals HPLC chromatogram of TLe at 280 nm. The extract contains compounds 
with similar RT to caffeic acid, vanillin, and rutin at 7.712, 10.994, and 12.975, respectively. 
The UV spectra comparison of these peaks and those of the reference standards showed that 
the peak at 7.712 was caffeic acid. Signal at 360 nm illustrated one TLe peak with close RT 
to that of rutin, but the UV spectrum was not matched (Figure 4-16). 
 
Figure 4-12 HPLC chromatogram at 280 nm (upper) and 360 nm (lower) of antioxidant mixture 
separated using a gradient mode; 0-25 % B in 40 minutes mobile phase system (SR1e condition). 
Gallic acid (GA), chlorogenic acid (ChA), caffeic acid (CA), vanillin (V), ferulic acid (FA), hesperidin (H), 
rutin (R), and quercetin (Q). 
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Figure 4-13 HPLC chromatogram at 280 nm (upper) and 360 nm (lower) of standard mixture separated 
using a gradient mode; 5-60 % B in 40 minutes mobile phase system (TLe condition). Gallic acid (GA), 
chlorogenic acid (ChA), caffeic acid (CA), vanillin (V), ferulic acid (FA), hesperidin (H), rutin (R), and 
quercetin (Q). Ferulic acid and rutin had very similar RT, but ferulic acid is not visible at 360 nm. 
 
Figure 4-14 HPLC chromatograms of SR1e at 254 nm (A), 280 nm (B), and 360 nm (C). SR1e peaks 
with similar retention time with those of the standard cocktail are marked by red boxes and their 
absorption spectra are shown on the right for comparison purposes. 
 
HPLC analysis shows that these common antioxidants were not present in SR1e, while caffeic 
acid was present in TLe. This finding is in agreement with a previous report that found caffeic 
acid in the leaf of T.laurifolia (Kanchanapoom et al., 2002). Caffeic acid (Figure 4-17) has been 
studied for its anti-tumour and anti-inflammatory activities. Chung et al. (2004) reported that it 
inhibited HepG2 growth both in in vitro and in vivo (Chung et al., 2004). Regarding the 
antioxidant activity, the compound is a scavenger for singlet oxygen O2−• and OH• (Asano and 
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Iwahashi, 2014). Therefore, caffeic acid might contribute to the cytotoxic (at high concentration 
of the extract) and ABTS•+ radical scavenging effects of TLe. 
 
Figure 4-15 (A) HPLC chromatogram at 280 nm of TLe. The peaks with similar retention time with 
those of the standard cocktail are marked by red boxes and their absorption spectra are shown in (B) 
for comparison purposes. 
 
 
Figure 4-16 HPLC chromatogram at 360 nm of TLe. The peak with similar retention time with that of the 




Figure 4-17 Caffeic acid 
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4.3.4. High-resolution radical scavenging profile 
To identify active peaks that contribute to protective effect of the extracts, micro-fractionation 
and high-resolution radical scavenging assay were performed in the dereplication process. 
High-resolution radical scavenging profiles of TLe and SR1e extracts are presented in Figure 
4-18 and Figure 4-19, respectively. ABTS•+ reduction profile of TLe was more discrete than 
that of SR1e. Four peaks from TLe with dominant scavenging property were selected for 
further analysis (Figure 4-18; Peak 2, 3, 4, and 8). SR1e contained three peaks which gave 
discrete responses (Figure 4-19; Peak 1, 5, and 6). Increasing the resolution of micro-fractions 
to more than 8 points per minute might improve the radical scavenging profile of SR1e. 
 
Figure 4-18 High-resolution radical scavenging profile of TLe extract with HPLC chromatogram at 280 
nm. Peak 2 (RT 9.58), peak 3 (RT 13.22), peak 4 (RT 17.28), and peak 8 (RT 26.29) show the most 
discrete radical scavenging activity.  
 
 
Figure 4-19 High-resolution radical scavenging profile of SR1e extract with HPLC chromatogram at 280 
nm. Peak 1 (RT 20.02), peak 5 (RT 23.29), and peak 6 (RT 25.17) show the most discrete radical 
scavenging activity. 
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4.3.5. HPLC-HRMS-SPE-ttNMR analysis 
4.3.5.1. TLe analysis 
Peak 2, 3, 4, 8 of TLe crude extract were analysed by HRMS and NMR. Peak 3 (m/z 433.1150 
[M+H]+) could be identified as isovitexin (6-C-glucopyranosyl apigenin) (Figure 4-20) by 
comparison with the literature (Hao et al., 2016a). Peak 4 (m/z 361.0903 [M+H]+) was 
assigned as rosmarinic acid (Figure 4-20) by comparison with the literature (Lu and Foo, 
1999). Previous studies also reported the identification of these two compounds in the leaves 
and aerial parts of TL (Suwanchaikasem et al., 2014, Junsi and Siripongvutikorn, 2016). 
Rosmarinic acid is a common ester derivative of caffeic acid (Amoah et al., 2016). This 
confirms the presence of caffeic acid in TLe.     
Peak 2 and 8 cannot be elucidated at this stage because the fractions were possibly mixtures 
and the concentrations were too low for structure elucidation even though the trapping was 
increased to 80 consecutive injections for each fraction. In future work, these two peaks should 
be purified prior to NMR analysis. HRMS and 1H NMR analysis of peak 3 and 4 are reported 
below. Ar refers to aromatic and Glu refers to glucosyl ring.  
Peak 3 
HRMS (m/z): 433.1150 [M+H]+; 1H-NMR (600 MHz, MeOD): δ 7.86 (d, 2H, J = 9 Hz, CHAr H2’, 
6’), 6.94 (d, 2H, J = 8.4 Hz, CHAr H3’, 5’), 6.63 (s, 1H, CHFlavone 3), 6.53 (s, 1H, CHFlavone 
8), 4.91 (d, 1H, J = 9.6 Hz, CHGlu H1”), 4.15 (t, 1H, J = 9.3 Hz, CHGlu H2”), 3.87 (dd, 1H, J 
= 12, 2.4 Hz, CHGlu H6a”), 3.74 (dd, 1H, J = 12, 5.4 Hz, CHGlu H6b”), 3.49 – 3.46 (m, 2H, 
CHGlu H3”, 4”). The spectral data presented are in agreement with published report on 
isovitexin (Hao et al., 2016a). However, one proton on glucosyl ring (δ 3.33, H5”) reported in 
Hao et al. (2016) was absent in our data due to MeOD solvent peak (δ 3.31).     
Peak 4 
HRMS (m/z): 361.0903 [M+H]+; 1H-NMR (600 MHz, MeOD): δ  7.54  (d, 1H, J = 15.6 Hz, CH 
7), 7.04 (d, 1H, J = 1.8 Hz, CHAr 2), 6.95 (dd, 1H, J = 8.4, 2.4 Hz, CHAr 6), 6.79 - 6.75 (m, 
2H, CHAr 2’, 5’), 6.69 (d, 1H, J = 8.4 Hz, CHAr 5), 6.61 (dd, 1H, CHAr 6’, J = 7.8, 2.0 Hz), 6.26 
(d, 1H, J = 16.2 Hz, CH 8), 5.17 (dd, 1H, J = 9.0, 4.2 Hz, CH 8’), 3.09 (dd, 1H, J = 14.4, 4.2 
Hz, CH 7a’), 2.99 (dd, 1H, J = 14.4, 9.0 Hz, CH 7b’). The spectral data presented are in 




Figure 4-20 Structures of isovitexin and rosmarinic acid 
 
Isovitexin, an isomer of vitexin, has been studied for its protective and antioxidant effects. 
Isovitexin exhibited a significant protective effect against amyloid β-induced toxicity in PC12 
rat adrenal pheochromocytoma cells by increasing the cell viability for 21% compared to the 
cells exposed to amyloid β-peptide alone. As amyloid β toxicity involves ROS generation, 
isovitexin might possess free radical scavenging properties (Guimarães et al., 2015). 
However, the compound showed weak DPPH scavenging activity with IC50 value of 370 µg/ml, 
weak total antioxidant capacity assessed by FRAP assay with TEAC value of 129.12 mg/g 
(Zhang et al., 2011), and weak ABTS radical scavenging property with IC50 value of 1224 µM 
(Shibano et al., 2008). Even though in another study its IC50 from DPPH assay was 18.9 µg/ml, 
but it also showed weak superoxide radical scavenging activity with IC50 value > 385 µg/ml 
(Shibano et al., 2008). Our result is in agreement with these published literature as can be 
seen from the biochromatogram of TLe that peak 3 did not give a narrow and sharp ABTS 
inhibition peak (Figure 4-18).  
Rosmarinic acid has been reported for its remarkable pharmacological activities, especially 
the protective effects in various tissues and cell lines. For instance, it decreased acute liver 
damage and fibrogenesis induced by CCl4 in mice. One of the protective mechanism was the 
ability in the upregulation of Nrf2 and HMOX-1 protein expression (Domitrović et al., 2013). 
Pre-treatment with rosmarinic acid protected from t-BHP damages by recovery of GSH level 
and reduction of malondialdehyde (MDA) formation in vitro and in vivo, as well as increased 
cell viability of HepG2 cells (Yang et al., 2013). Moreover, rosmarinic acid also illustrated 
protection against oxidative stress in various models, such as induced diabetic rats (Mushtaq 
et al., 2015, Govindaraj and Sorimuthu Pillai, 2015), neuronal cells (Ghaffari et al., 2014), 
HaCaT keratinocytes (Fernando et al., 2016), and etc. As this compound presented in TLe in 
high proportion, it is possible that rosmarinic acid largely contributed to the protective effect of 
TLe.      
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4.3.5.2. SR1e analysis 
Peak 1, 5, 6 of SR1e crude extract were analysed by HRMS and NMR.  Peak 1 (m/z 595.1682 
[M+H]+) was elucidated as 3,6-di-C-glucosylapigenin (Figure 4-21) by comparison with the 
literature (Matsubara et al., 1985). Peak 5 (m/z 565.1563 [M+H]+) was identified as 
isoschaftoside (Figure 4-21) by comparison with the literature (Oliveira et al., 2013). Peak 6 
(m/z 565.1553 [M+H]+) was assigned as schaftoside (Figure 4-21) by comparison with the 
literature (Norbaek et al., 2000). This is the first time that these compounds were found in 
S.rugata. HRMS and 1H NMR analysis of peak 1, 5, and 6 are reported below. Ar refers to 
aromatic, Glu refers to glucosyl ring, and Ara refers to arabinosyl ring. 
Peak 1 
HRMS (m/z): 595.1682 [M+H]+; 1H-NMR (600 MHz, MeOD): δ 8.11 (d, 1H, CHAr 6’, J = 8.4 
Hz), 8.02 (d, 1H, CHAr 2’, J = 7.2 Hz), 7.06 (d, 2H, J = 8.4 Hz, CHAr 3’, 5’), 6.76 (s, 1H, 
CHFlavone 8), 5.15 (d, 1H, CHGlu 1’’’, J = 9.6 Hz), 5.07 (d, 1H, CHGlu 1’’, J = 9.9 Hz), 4.22 
(t, 1H, CHGlu 2”’, J = 9 Hz), 4.05 (d, 1H, CHGlu 6b’’’, J = 10.9 Hz), 3.99 – 3.95 (m, 2H, CHGlu 
6a’’’, 6b’’), 3.93 (dd, 1H, CHGlu 6a”,  J = 13.8, 7.5 Hz), 3.77 (t, 1H, J = 12, 5.4 Hz, CHGlu H2”), 
3.70 – 3.65 (m, 3H, CHGlu 3”’, 5”’, 3’’), 3.63 – 3.56 (m, 2H, CHGlu 4’’’, 5’’), 3.45 (t, 1H, CHGlu 
4’’, J = 1.8 Hz). The spectral data showed are in agreement with published report on 3,6-di-C-
glucosyl apigenin (Matsubara et al., 1985).  
Peak 5 
HRMS (m/z): 565.1563 [M+H]+; 1H-NMR (600 MHz, MeOD): δ 7.99 (d, 2H, CHAr 2’, 6’, J = 8.4 
Hz), 6.94 (dd, 2H, CHAr 3’, 5’, J = 9, 4.2 Hz), 6.65 (s, 1H, CHFlavone 3), 5.03 (d, 1H, CHAra 
1’’’, J = 10.2 Hz), 4.88 (d, 1H, CHGlu 1’’, J = 10.2 Hz), 4.08 (d, 1H, CHAra 5b’’’, J = 10.2 Hz), 
4.04 – 3.99 (m, 2H, CHGlu 6b’’, CHAra 2’’’), 3.95 (d, 1H, CHGlu 6a’’, J = 10.2 Hz), 3.87 (m, 
2H, CHGlu 2’’, CHAra 4’’’), 3.77 (m, 2H, CHGlu 3’’, 5’’), 3.65 (m, 1H, CHAra 3’’’), 3.54 (t, 2H, 
CHGlu 4’’, CHAra 5a’’’, J = 8.7 Hz). The spectral data showed are in agreement with published 
report on isoschaftoside or apigenin 6-C-arabinoside-8-C-glucoside (Oliveira et al., 2013).   
Peak 6 
HRMS (m/z): 565.1553 [M+H]+; 1H-NMR (600 MHz, MeOD): δ 7.91 (d, 2H, CHAr 2’, 6’, J = 9 
Hz), 6.96 (d, 2H, CHAr 3’, 5’, J = 9 Hz), 6.65 (s, 1H, CHFlavone 3), 5.00 (d, 1H, CHAra 1’’, J 
= 10.2 Hz), 4.96 (d, 1H, CHGlu 1’’’, J = 9.6 Hz), 4.09 (dd, 1H, CHAra 5b’’, J = 10.8, 5.4 Hz), 
4.05 (t, 1H, J = 9.3 Hz, CHAra 2’’), 3.88 – 3.86 (m, 2H, CHGlu 2’’’, CHAra 4’’), 3.82 – 3.78 (m, 
2H, CHAra 5a’’, CHGlu 6b’’’), 3.73 – 3.69 (m, 1H, CHAra 3’’), 3.53 (d, 1H, CHGlu 6a’’’, J = 9 
Hz), 3.48 (t, 2H, CHGlu 3’’’, 5’’’, J = 9 Hz), 3.23 (t, 1H, CHGlu 4’’’J = 10.5 Hz). The spectral 
data presented are in agreement with published report on schaftoside or apigenin 6-C-
glucoside-8-C-arabinoside (Norbaek et al., 2000). 
 163 
 
Figure 4-21 Structures of 3,6-di-C-glucosylapigenin, isoschaftoside, and schaftoside 
 
Previous study regarding bioactivity of 3,6-di-C-glucosylapigenin, isoschaftoside, and 
schaftoside was limited. Peak 1 or 3,6-di-C-glucosylapigenin was the major constituent of 
SR1e and presented a distinctive free radical scavenging activity in our study (Figure 4-19). 
Therefore, it possibly plays an important role in ABTS scavenging property of SR1e, which 
might be a contribution from its apigenin skeleton. Previous study suggested that glucose 
substitution at 6-C can increase the antioxidant activity, while glucose substitution at 8-C can 
decrease the activity (Zielińska and Zieliński, 2011). Our result is in agreement with this 
statement as peak 1 (3,6-di-C-glucosylapigenin) exhibited stronger ABTS scavenging activity 
than peak 5 (apigenin 6-C-arabinoside-8-C-glucoside). For peak 6 (apigenin 6-C-glucoside-8-
C-arabinoside), even though it contains 6-C substitution, its proportion in SR1e was much 
lower than that of peak 5. This explains why peak 6 had lower ABTS scavenging activity than 
peak 5. However, there was no available report regarding the protective or antioxidant effect 
of these compounds to aid the confirmation. Only the group who discovered 3,6-di-C-
glucosylapigenin from the peels of Citrus unshiu (presumably a synonym of Citrus reticulata 
Blanco)  reported its hypotensive effect in vivo (Matsubara et al., 1985). To confirm whether 





4.4.  Conclusion 
Antioxidant genes play a crucial role in the protection against oxidative stress, which is one of 
the main targets in cancer chemoprevention. In this chapter, we reported the effect of SR1e 
and TLe on NQO1 and HMOX-1 expression, as well as the expression of their regulator; Nrf2. 
The study revealed that the protective activity of TLe was due to the upregulation of NQO1 
expression and radical scavenging property, while that of SR1e might be the result from the 
induction of Nrf2 and HMOX-1 expression and radical scavenging activity. This is the first time 
that the effect of TLe and SR1e on these antioxidant genes was reported. The effect on 
CYP1A1 expression suggested their low risk of toxicity from DNA damage. Future work using 
wider range of concentrations of the extracts and incubation times is needed to confirm these 
effects. Dereplication using HPLC-ABTS assay-HRMS-NMR technique identified that the 
major constituent of TLe is rosmarinic acid and that it contributed to the protective activities of 
the extract. Three known apigenin glucosides were present in SR1e. However, their 
contribution to the protective and antioxidant effect of SR1e deserves further research.  
The findings from this chapter help to conclude the whole thesis. The study of the protective 
mechanisms and dereplication lead to the identification of active constituents, which explained 
the effects from the screening steps and supported traditional uses of the plants. Even though 
some results are remained unclear and needed further study, we have provided several 




Cancer chemoprevention is an approach to tackle cancer, a global health problem. This 
approach aims to prevent, delay, or reverse carcinogenesis, rather than killing cancer cells. 
Since cancer is heterogeneous, our basic assumption is that it is important to prevent cancer 
development via several mechanisms at the same time, as well as to maintain cell 
homeostasis. Thai Traditional Medicine (TTM) is a holistic medicine which emphasises 
maintaining the balance of the body. It has been used among cancer patients in Thailand and 
has shown positive results, such as prolonged survival and improved quality of life. Therefore, 
we argue that TTM is a potential source for cancer preventive agents and – more broadly – 
that it could play a role in prevention. Using an ethnopharmacology approach this thesis aims 
to discover new extracts or compounds which could be useful in the prevention of cancer.  
From biomedical and TTM perspective, cancer has been on different ‘pages’. Currently 
available scientific evidence illustrates possible pharmacological actions that are involved in 
the benefits of medicinal plants used in cancer patients, such as anti-proliferation, anti-
metastasis, anti-angiogenesis, apoptosis induction, or immunomodulation. However, these 
could not describe ‘TTM actions’. Our fieldwork revealed the characteristics of cancer (or 
mareng) within the context of the theory and practice of TTM. Differently from the ‘hallmarks 
of cancer’ given by Hanahan and Weinberg (2011), mareng is associated with an 
accumulation of waste (khong sia), chronic inflammation (kan aksep), chronic illnesses 
(krasai), bad condition of body fluid (mainly ‘luead’ and ‘namlueang’), and imbalance of the 
four elements (dhātu si). Treatment and prevention strategies are based on these 
characteristics. Further analysis of preventive methods and herbal medicine considered to be 
useful in cancer prevention led to understanding strategies for mareng prevention, which are 
removal of waste, liver protection, prevention from krasai, maintaining the balance of dhātu si, 
and nourishment of leaud and namlueang. In an attempt to link TTM actions to pharmacology, 
we propose that the first three topics of mareng prevention strategy are related to the 
antioxidant system.  
After the initial screening of fifty-two extracts (from twenty-six herbal drugs frequently 
mentioned), fifteen (from twelve drugs) exhibited significant protective effect against oxidative 
stress-induced cell death in a liver cancer cell line. This result suggested that khong sia and 
krasai were possibly associated with oxidative stress as almost half of selected plant materials 
showed positive effect in the assay investigated. Next, these fifteen extracts were studied for 
the ability to induce NQO1 enzyme and glutathione as they are important targets in 
chemoprevention. Ethanol extracts from the leaf of Thunbergia laurifolia (TLe) and the leaf of 
Senegalia rugata (SR1e) exhibited the most potent activities and were then studied for their 
protective mechanisms and phytochemical profiles. 
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Upregulation of antioxidant genes and radical scavenging were among protective 
mechanisms of TLe and SR1e. While TLe induced NQO1 expression, SR1e upregulated the 
expression of Nrf2, the master regulator of antioxidant genes, including NQO1. However, the 
results should be confirmed by performing time-dependent experiment. Both extracts did not 
induce CYP1A1 expression and did not reduce cell viability of primary rat hepatocytes. These 
results could provide preliminary safety profiles of the extracts. Later phytochemical analysis 
revealed possible active constituents of TLe, with caffeic acid, isovitexin, and rosmarinic acid 
being identified tentatively, while SR1e contained several glycosyl apigenins. In conclusion, 
this is the first time that the above chemopreventive properties of TLe and SR1e have been 
revealed.  
This thesis presents, for the first time, TTM characteristics of cancer and TTM cancer 
prevention strategy. We also present the analysis of TTM knowledge and the link to 
pharmacological models using a scientific strategy to understand the effects of TTM plants 
using biomedical approaches. In a next step it will be essential to use this approach again with 
a higher number of TTM practitioners to further develop the results presented herein. 
Moreover, this thesis also contains other novel information, including chemical constituents of 
the leaf of S.rugata, promising cytotoxicity in HepG2 of water and ethanol extracts of the pod 
of S.rugata, and NQO1 induction activity of ethanol extracts from Citrus hystrix, Coccinia 
grandis, and Piper sarmentosum. These in vitro findings provide evidence that supports the 
promising use of these medicinal plants in cancer prevention, but in the future physiologically 
more relevant models will be important. As the medical uses of the plants investigated are 
different from the experiment, further studies to collect more information from the actual uses 
by TTM practitioners and to investigate the effects in in vivo should be performed.  
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Table A-1 Plant-derived materials used in the treatment or prevention of cancer by TTM practitioners 










Amaranthaceae Gomphrena globosa L. 








Apiaceae Centella asiatica (L.) Urb. 
6 Bualuang Lotus Nelumbonaceae Nelumbo nucifera Gaertn. 
7 Buk Stanlet's water tub Araceae 
Amorphophallus paeoniifolius (Dennst.) 
Nicolson 
8 Bunnak Iron wood Calophyllaceae Mesua ferrea L. 
9 Cha-em-thet Licorice Fabaceae Glycyrrhiza glabra L. 




Lavang Lata Rutaceae 
Luvunga scandens (Roxb.) Buch.-Ham. 
ex Wight & Arn. 
12 Chanthana - Rubiaceae Tarenna hoaensis Pit. 
13 Cha-om Pennata wattle Fabaceae Senegalia pennata (L.) Maslin 






Asteraceae Artemisia lactiflora Wall. ex DC. 












Menispermaceae Tinospora baenzigeri Forman 
19 Chingchi - Capparaceae Capparis micracantha DC. 




Fabaceae Senna alata (L.) Roxb. 
22 Di-pli Long pepper Piperaceae Piper retrofractum Vahl 
23 Do-mai-ru-lom - Asteraceae Elephantopus scaber L. 
24 Dongdueng Climbing lily Colchicaceae Gloriosa superba L. 
25 Duea-din - Apocynaceae 
Amphineurion marginatum (Roxb.) 
D.J.Middleton 
26 Dueai-hin Job's tears Poaceae Coix lachryma-jobi L.  
27 Fa Thalaai Andrographis herb Acanthaceae 
Andrographis paniculata (Burm. f.) Wall. 
ex Nees 
28 Fang Sappan tree Fabaceae Caesalpinia sappan L. 
29 Haem 
False calumba, Tree 
turmeric 
Menispermaceae 
Coscinium fenestratum (Goetgh.) 
Colebr. 
30 Haewmu Nutgrass Cyperaceae Cyperus rotundus L. 




- Araliaceae Schefflera leucantha R.Vig. 
33 Hinghai - Convulvulaceae Blinkworthia lycioides Choisy 
34 Homchang - Acanthaceae Phlogacanthus curviflorus (Wall.) Nees 
35 Homdaeng Shallot Alliaceae Allium ascalonicum L.  
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Zingiberaceae Kaempferia galanga L. 
39 Huaroiru Ant plant Rubiaceae Hydnophytum formicarum Jack 
40 Huawao 
Basket fern, Oak-
leaf fern, Squirrel 
head  




Kumarika  Smilacaceae Smilax ovalifolia Roxb. ex D.Don 
42 Hu-kwang - Combretaceae Terminalia catappa  L.  
43 Kae-lae Cockspur thorn Moraceae Maclura cochinchinensis (Lour.) Corner 
44 Ka-kruea Gac Cucurbitaceae 
Momordica cochinchinensis (Lour.) 
Spreng. 








- Celastraceae Salacia chinensis L. 
48 Kancha Marihuana Cannabidaceae Cannabis sativa L. 
49 Kanchathet Motherwort Lamiaceae Leonurus sibiricus Linn. 
50 Kang-hua-mu - Annonaceae 
Miliusa velutina (A.DC.) Hook.f. & 
Thomson 
51 Kangpladaeng - Phyllanthaceae Phyllanthus pulcher Wall. ex Müll. Arg. 
52 Kangplakhao - Phyllanthaceae Flueggea virosa (Roxb. ex Willd.) Royle. 
53 Kanplu Clove Myrtaceae 
Syzygium aromaticum (L.) Merr. & 
L.M.Perry 
54 Kaoki Wolfberry Solanaceae Lycium chinense Mill. 
55 Kapiadchang - Stemonaceae Stemona collinsae Craib. 
56 Kaprao Holy basil Lamiaceae Ocimum tenuiflorum L. 
57 Kasalak - Solanaceae Datura metel L. var. fastuosa Safford 
58 Kasalong Indian cork tree Bignoniaceae Millingtonia hortensis L.f. 




Zingiberaceae Alpinia galanga (L.) Willd. 
61 Khadkhao - Rubiaceae Oxyceros horridus Lour. 







Menispermaceae Arcangelisia flava (L.) Merr. 




Zingiberaceae Curcuma aromatica Salisb. 




- Euphorbiaceae Suregada multiflora (A.Juss.) Baill. 













Broomcorn, Milo  
Poaceae Sorghum bicolor (L.) Moench 
71 Khao Pod Corn Poaceae Zea mays L. 
72 Khaochao Rice Poaceae Oryza sativa L.  
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No Local name Other name Family Scientific name 
73 Khaoyennuea - Smilacaceae Smilax spp. 
74 Khaoyentai - Smilacaceae Smilax spp. 
75 Kha-pia - Lamiaceae Hymenopyramis parvifolia Moldenke   
76 Kha-ton - Lauraceae Cinnamomum ilicioides A.Chev. 
77 Khi-ka - Cucurbitaceae 
Gymnopetalum scabrum (Lour.) W.J.de 
Wilde & Duyfjes 
78 Khi-lek 
Cassod tree, Thai 
copper pod 
 Fabaceae Senna siamea (Lam.) Irwin et Barneby 
79 Khing Ginger Zingiberaceae Zingiber officinale Roscoe  









Moraceae Streblus asper Lour. 




Zygophyllaceae Tribulus terrestris L. 
85 Kho-klan - Euphorbiaceae Mallotus repandus (Willd.) Müll. Arg. 
86 Khontha - Rutaceae Harrisonia perforata (Blanco) Merr. 
87 Khui - Apocynaceae Willughbeia edulis Roxb. 
88 Kloi - Dioscoreaceae Dioscorea hispida Dennst. 
89 Kloi-chuet - Dioscoreaceae 














Caprifoliaceae Nardostachys jatamansi (D.Don) DC. 
92 Kot Namtao Rhubarb Polygonaceae 
Rheum Palmatum L.  Or R. officinale 
Bail. Or R. tanguticum (Maxim. Ex Regel) 















Apiaceae Ligusticum striatum  DC. 
96 Kotkamao Atractylodes Asteraceae Atractylodes lancea (Thunb.) DC. 
97 Kotkraduk 
Costus root, Mu 
Xiang 











 Angelica dahurica var. formosana 
(Boissieu) Yen 
100 Kra-bao - Achariaceae 
Hydnocarpus anthelminthicus Pierre ex 
Laness. 
101 Krachai Fingerroot Zingiberaceae Boesenbergia rotunda (L.) Mansf. 
102 Krachaidam 
Thai Ginseng, Black 
galingale 
Zingiberaceae Kaempferia parviflora  Wall. ex Baker 
103 Krachiap Roselle Malvaceae Hibiscus sabdariffa L. 
104 Kradaddaeng Red giant taro Araceae Alocasia macrorrhizos (L.) G.Don 
105 Kradadkhao  White giant taro Araceae Alocasia macrorrhizos (L.) G.Don 
106 Kradom - Cucurbitaceae Gymnopetalum chinense (Lour.) Merr.  
107 Kra-don Slow Match Tree Lecythidaceae Careya arborea Roxb. 
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108 Kradukkaidam - Acanthacaea Justicia fragilis Wall. 




- Menispermaceae Stephania venosa (Blume) Spreng. 
111 Kratungmaba - Apocynaceae Dregea volubilis (L.f.) Benth. ex Hook.f. 




Thymelaeaceae Aquilaria spp. 
114 Krungkhamao 
Icevine, Velvet leaf 
pareira 
Menispermaceae 
Cissampelos pareira L. var. hirsuta 





Pine, Umbrella tree 





















- Myristicaceae  
Knema cinerea var. glauca (Blume) Y.H. 
Li  




Cluster Fig Moraceae Ficus racemosa L.  




Hairy Fig, Devil fig Moraceae Ficus hispida L.f.  
125 Maduk - Celastraceae Siphonodon celastrineus Griff.  




- Apocynaceae Asclepias curassavica L. 
128 Mafueang Carambola, Starfruit Oxalidaceae Averrhoa carambola L. 
129 Magrud Kaffir lime Rutaceae Citrus hystrix DC. 
130 Mahahing 
 Asafoetida, Stinking 
gum, Devil’s dung 




Moraceae Artocarpus lakoocha Roxb. 
132 Mahuad - Sapindaceae Lepisanthes rubiginosa (Roxb.) Leenh. 
133 Maiyarab Sensitive plant  Fabaceae Mimosa pudica L. 





-  Fabaceae Afzelia xylocarpa (Kurz) Craib  
136 Ma-kham Tamarind  Fabaceae Tamarindus indica L. 
137 Makham Pom Emblic myrobalan Phyllanthaceae Phyllanthus emblica L. 
138 Makhamkai - Putranjivaceae Putranjiva roxburghii Wall. 
139 Maklam Tanu 
Crab's eye vine/ 
American pea 
 Fabaceae Abrus precatorius L. 




- Moraceae Ficus sarmentosa Buch.-Ham. ex Sm. 
142 Maktaek - Celastraceae Celastrus paniculatus Willd. 
143 Manao Lime Rutaceae 
Citrus aurantifolia (Christm. et Panz.) 
Swingle 
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144 Maprang  
marian plum, 
gandaria, and plum 
mango 




Anacardiaceae Bouea oppositifolia (Roxb.) Adelb.  
146 Mara Bitter cucumber Cucurbitaceae Momordica charantia L. 
147 Ma-ra-khi-nok Bitter cucumber Cucurbitaceae 
Momordica charanthia L. ssp. charanthia 




Moringaceae Moringa oleifera Lam. 










Purple fruited Pea 
Egg plant 
Solanaceae Solanum trilobatum L. 
152 Mon White mulberry Moraceae Morus alba Linn. 
153 Muakdaeng - Apocynaceae 
Wrightia coccinea (Roxb. ex Hornem.) 
Sims 
154 Muakkhao - Apocynaceae Wrightia pubescens subsp. pubescens 
155 Nad - Asteraceae Blumea balsamifera (L.) DC. 
156 Nadkham - Asteraceae Inula cappa (Buch.-Ham. ex D.Don) DC. 
157 Namchai Teripof plant  Fabaceae Caesalpinia digyna Rottler 




Coconut oil Arecaceae Cocos nucifera L. var. nucifera  
160 Namtao Bottle gourd Cucurbitaceae Lagenaria siceraria (Molina) Standl.  
161 Nao-nai - Aquifoliaceae Ilex umbellulata Loes. 
162 
Ngueak Pla 
Mo Dok Khao 
Sea holly Acanthaceae Acanthus ebracteatus Vahl 
163 
Ngueak Pla 
Mo Dok Muang 
- Acanthaceae Acanthus ilicifolius L. 




- Lamiaceae Clerodendrum schmidtii Clarke 
166 Nontaiyak - Stemonaceae Stemona tuberosa Lour. 
167 Nun - Malvaceae Ceiba pentandra (L.) Gaertn.  
168 O - Gramineae Arundo donax Linn.  
169 Oi-dam Sugar cane Poaceae Saccharum officinarum L. 
170 Op-choei - Lauraceae Cinnamomum spp. 





Asteraceae Atractylodes macrocephala Koidz.  
173 Phai Pa Giant thorny bamboo Poaceae Bambusa bambos (L.) Voss  
174 Phai Ruak Monastery bamboo Poaceae Thyrsostachys siamensis Gamble 




Morning Glory Convulvulaceae Ipomoea aquatica Forsk. 
177 Phakchi - Apiaceae Oenanthe javanica subsp. javanica 





Saururaceae Houttuynia cordata Thunb. 
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Joy weed Amaranthaceae 





Goatweed Plantaginaceae Scoparia dulcis L. 
185 Phaksianphi - Cleomaceae Cleome viscosa L. 
186 Phaktaew - Hypericaceae 
Cratoxylum formosum subsp. 
pruniflorum (Kurz) Gogelein 
187 Phakwanban - Phyllanthaceae Sauropus androgynus (L.) Mer.  
188 Phakwanpa - Opiliaceae Melientha suavis Pierre 




- Ebenaceae Diospyros defectrix Fletcher 
191 Pha-ya-yor - Acanthaceae Clinacanthus nutans (Burm. f.) Lindau 
192 Philangkasa - Primulaceae Ardisia polycephala Wall. ex A.DC. 
193 Phitsanad -  Fabaceae Sophora exigua Craib 




Zingiber montanum (J. König) Link ex 
A.Dietr. 
195 Phlu Chin Betel vine Piperaceae Piper betle L. 




- Opiliaceae Lepionurus sylvestris Blume 
198 Phungdo - Salvadoraceae 
Azima sarmentosa (Blume) Benth. & 
Hook.f. 
199 Plalaiphueak Tongkat ali Simaroubaceae Eurycoma longifolia Jack 
200 Po-bit 
Indian Screw Tree, 
Deer’s Horn 





Baikal skullcap Lamiaceae Scutellaria baicalensis Georgi 
202 Quinin Neem Meliaceae Azadirachta indica A. Juss. 
203 Rangchued 
Laurel clock vine, 
Blue trumpet vine 
Acanthaceae Thunbergia laurifolia Lindl. 
204 Reo noi - Zingiberaceae Amomum villosum Lour. 
205 Rong Gamboge Clusiaceae Garcinia lateriflora Blume  
206 Sa-dao Neem Meliaceae 
Azadirachta indica A. Juss. var. 
siamensis Valeton 
207 Sak Teak Lamiaceae Tectona grandis L.f. 
208 Sak -  Fabaceae Erythrophleum teysmannii (Kurz) Craib 
209 Sakae - Combretaceae Combretum quadrangulare Kurz 
210 Sakaesaeng - Annonaceae 
Cananga latifolia (Hook. f. & Thomson) 
Finet & Gagnep. 
211 Sakhan - Piperaceae Piper aff. pendulispicum C.DC. 
212 Sa-mae-san -  Fabaceae 
Senna garrettiana (Craib) H.S.Irwin & 
Barneby 
213 Sa-mae-ta-le - Acanthaceae Avicennia marina (Forsk.) Vierh. 
214 Samedkhao Shore Euginia Myrtaceae 
Syzygium antisepticum (Blume) Merr. & 
L.M.Perry 
215 Sam-ma-li-nga Garden quinine Lamiaceae Cleodendrum inerme (L.) Gaertn.  
216 Sa-mo-di-ngu - Combretaceae 





Beleric myrobalan Combretaceae Terminalia bellirica (Gaertn.) Roxb.  
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218 Samothet - Combretaceae Terminalia spp. 
219 Samsib - Asparagaceae Asparagus racemosus Willd. 
220 
Sa-mun-la-
waeng, Dun ye 
gui (Chinese) 
- Lauraceae 
Cinnamomum bejolghota (Buch.-Ham.) 
Sweet 
221 Sa-niad - Acanthaceae Justicia adhatoda L. 
222 Sankham 
Chinese albizia, silk 
tree 







Peltophorum pterocarpum (DC.) 
K.Heyne 
224 Singhamora - Araceae Cyrtosperma johnstonii (N.E.Br.) N.E.Br. 
225 Si-siad-thet Gambir  Rubiaceae Uncaria gambir (Hunter) Roxb. 
226 Som Poi Soap-pod  Fabaceae Acacia concinna (Willd.) DC. 
227 Somchin Orange Rutaceae Citrus sinensis (L.) Osbeck 
228 Tamlueng - Cucurbitaceae Coccinia grandis (L.) Voigt 
229 Tamsao Tembusu Gentianaceae Fagraea fragrans Roxb. 
230 Tandam - Ebenaceae Diospyros montana Roxb. 
231 Tankamoy - Boraginaceae Tournefortia ovata Wall. ex. G. Don.  
232 Tanmon - Asteraceae 
Tarlmounia elliptica (DC.) "H.Rob., 
S.C.Keeley, Skvarla & R.Chan" 
233 Tansian - Salicaceae Flacourtia indica (Burm. f.) Merr. 
234 Tantanod Fan palm Arecaceae Borassus flabellifer  L.  
235 Tao-khiad - Araceae 
Homalomena aromatica (Spreng.) 
Schott 
236 Taorang Fistail palm  Arecaceae Caryota mitis Lour. 








Jewel vine  Fabaceae Derris scandens (Roxb.) Benth. 
240 Thao-yai-mom - Lamiaceae Clerodendrum indicum (L.) Kuntze 
241 Theptharo Safrol laurel Lauraceae 
Cinnamomum porrectum (Roxb.) 
Kosterm. 
242 Thiandaeng Cress Brassicaceae Lepidium sativum Linn. 
243 Thiandam 
Fennel flower, Black 
caraway 
Ranunculaceae Nigella sativa L. 




Dill Apiaceae Anethum graveolens L. 
246 Thing Thon White siris  Fabaceae Albizia procera (Roxb.) Benth. 




- Acanthaceae Rhinacanthus nasutus (L.) Kurz 
249 Thua-phu Winged bean  Fabaceae Psophocarpus tetragonolobus (L.) DC. 
250 Thua-rae Pigeonpea  Fabaceae Cajanus cajan (L.) Millsp.  
251 Toei Pandan leaves  Pandanaceae Pandanus amaryllifolius Roxb. 
252 Wa Black plum Myrtaceae Syzygium cumini (L.) Skeels 




- Zingiberaceae Curcuma comosa Roxb. 




- Zingiberaceae Curcuma sp. 
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- Zingiberaceae Kaempferia sp.  
260 Wankainoi - Cibotiaceae Cibotium barometz (L.) J. Sm.  









Giant orchid, Tiger 
orchid 
Orchidaceae Grammatophyllum speciosum Blume 




- Urticaceae Gonostegia pentandra (Roxb.) Miq. 
266 Ya Lin-ngu Flat-top mille graines Rubiaceae Oldenlandia corymbosa L. 
267 Ya Nuadmaew Cat's whisker Lamiaceae Orthosiphon aristatus (Blume) Miq. 




Heteropogon contortus (L.) P.Beauv. ex 
Roem. & Schult. 
269 Ya Pakkhwai 
Egyptian crowfoot 
grass 
Poaceae Dactyloctenium aegyptium (L.) Willd. 
270 Ya Pakking - Commelinaceae 
Murdannia loriformis (Hassk.) R. S. Rao 
et Kammathy 
271 Ya Taibai Chamber bitter Phyllanthaceae Phyllanthus urinaria L. 
272 Ya Thotplong - Equisetaceae 
Equisetum ramosissimum subsp. debile 
(Roxb. ex Vaucher) Hauke 
273 Ya Tudma - Rubiaceae Paederia pilifera Hook. f. 
274 Yadam - Asparagaceae Aloe spp. 
275 Ya-kha 
Blady grass, Cogon 
grass 




- Asteraceae Vernonia cinerea (L.) Less.  
277 Yanang - Menispermaceae Tiliacora triandra (Colebr.) Diels 
278 Yo Indian mulberry Rubiaceae Morinda citrifolia L. 
 
Table A-2 Animal-derived materials used in the treatment or prevention of cancer by TTM practitioners 
No Local name English name Family Scientific name Part used 
1 Khwai-
phueak 
Swamp buffalo Bovidae Bubalus bubalis bone 
2 Khangkhok Toad (natural 
death) 
Bufonidae Bufo spp. whole death 
body 
3 Kwang Deer Cervidae Cervus spp. antler 
4 Chang Elephant Elephantidae Elephas maximus indicus bone 
5 Kaiban Chicken Phasianidae Gallus gallus domesticus feather 
6 Tao Lueang Elongated 
tortoise 
Testudinidae Indotestudo elongata (Blyth,1853) shell 
7 Tao Ta Malayan snail - 
eating turtle 
Bataguridae Malayemys subtrijuga (Schlegel 
and Muller, 1844) 
shell 
8 Ngu Hao Cobra Elapinae Naja spp.  bone 
9 Linglom Slow loris Lorisidae  Nycticebus spp. bone 
10 Suea Tiger Felidae Panther tigris Linn.  bone 
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11 Ngu Lueam Python Phytoninae Python reticulatus Schneider  bone 
12 Raet Rhino Rhinocerotidae Rhinoceros sondaicus Dermarest, 
1822 
jawbones 
13 Pu Crab Portunidae Scylla serrata (Forsskål) shell 
14 Hoi-khraeng Blood cockle Arcidae Tegillarca granosa (Linnaeus, 
1758) 
shell 
15 Mi Bear Ursidae  Ursus spp. bone 
 
Table A-3 Chemicals or minerals used in the treatment or prevention of cancer by TTM practitioners 
No Local name English name 
1 Ka-ra-bun Camphor 
2 Kammathandaeng Realgar, Arsenic disulfide 
3 Kammathanlueang Sulfur 
4 Kluea Salt, Sodium chloride 
5 Chunnasi Copper (II) sulphate 
6 Di-kluea Magnesium sulphate 
7 Parot mercury 
8 Phongfu baking powder 
9 Phimsen Borneol camphor 
10 Sannu Arsenic 
 
Table A-4 Mushrooms used in the treatment or prevention of cancer by TTM practitioners 
No Local name English name Family Scientific name 
 
1 Hed Danmi King Alfred's cakes Xylariaceae Daldinia concentrica (Bolt. ex Fr) Ces et De 
Not. 




Ganoderma lucidum (Curtis) P. Karst., 1881 
3 Hed Dang unresolved unresolved unresolved 
4 Hed Daeng unresolved unresolved unresolved 
 
Table A-5 Unresolved plant-derived materials used in the treatment or prevention of cancer by TTM 
practitioners 





5 Hora Mahura 
6 Khanghumu  
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No Local name 
7 Kra-duk-kai-dam 
8 Kutti 
9 Maklek  




14 Phaya Muelek 
15 Phow-kong-aen 
16 Phrik Pa, Phrik Naiphran 
17 Phuttharaksa 
18 Rak-kak-aen 















34 Wan Hokmokkhasak 
35 Wan Saklek 
36 Ya Khaemhom 
37 Ya Khaosan (Sanrangdid) 
38 Ya Lakna 
39 Ya Pluaknam 
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Figure A-1 Images of plant materials used for pharmacological activity screening 
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Figure A-2 Fluorescence intensity of resofurin from different cell density at different incubation time. 
The cell density at 5,000 cells per well has the best linearity between 0.5 – 8 hours. 
 








































Figure A-4 Representative BSA standard curve for calculation of protein amount in cell lysates used in 
NQO1 and GSH assays 
 
 
Figure A-5 Optimisation of incubation time for qPCR experiment by the use of 10 µM of menadione. 
Twenty-four showed the highest responses. Results are mean + SD (N > 3). Unpaired 2-tailed t-test 
was used to determine p values. P < 0.05 was considered statistically significant. 






























Figure A-6 1H-NMR spectra for TLe peak 3, which was later identified as isovitexin 
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Figure A-7 1H-NMR spectra for TLe peak 4, which was later identified as rosmarinic acid 
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Figure A-8 1H-NMR spectra for SR1e peak 1, which was later identified as 3,6-di-C-glucosyl apigenin 
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Figure A-9 1H-NMR spectra for SR1e peak 5, which was later identified as isoschaftoside 
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Figure A-10 1H-NMR spectra for SR1e peak 6, which was later identified as schaftoside 
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